| 1 | | GO:0006281 | DNA repair | 34 | 365 | 13 | 542 | 2.47e-05 | 0.09 | 0.02 | 3.6 |
| 2 | | GO:0006974 | response to DNA damage stimulus | 40 | 359 | 19 | 536 | 5.50e-05 | 0.10 | 0.03 | 2.9 |
| 3 | | GO:0007166 | cell surface receptor linked signal transduction | 61 | 338 | 144 | 411 | 8.48e-05 | 0.15 | 0.26 | 0.6 |
| 4 | | GO:0006259 | DNA metabolic process | 56 | 343 | 36 | 519 | 1.36e-04 | 0.14 | 0.06 | 2.2 |
| 5 | | GO:0006955 | immune response | 31 | 368 | 85 | 470 | 4.12e-04 | 0.08 | 0.15 | 0.5 |
| 6 | | GO:0006260 | DNA replication | 24 | 375 | 10 | 545 | 6.54e-04 | 0.06 | 0.02 | 3.3 |
| 7 | | GO:0007186 | G\-protein coupled receptor protein signaling pathway | 20 | 379 | 63 | 492 | 6.54e-04 | 0.05 | 0.11 | 0.4 |
| 8 | | GO:0009611 | response to wounding | 38 | 361 | 93 | 462 | 1.58e-03 | 0.10 | 0.17 | 0.6 |
| 9 | | GO:0006310 | DNA recombination | 19 | 380 | 7 | 548 | 1.86e-03 | 0.05 | 0.01 | 3.8 |
| 10 | | GO:0007187 | G\-protein signaling\, coupled to cyclic nucleotide second messenger | 1 | 398 | 16 | 539 | 1.93e-03 | 0.00 | 0.03 | 0.1 |
| 11 | | GO:0009605 | response to external stimulus | 58 | 341 | 124 | 431 | 2.60e-03 | 0.15 | 0.22 | 0.7 |
| 12 | | GO:0007165 | signal transduction | 153 | 246 | 266 | 289 | 3.61e-03 | 0.38 | 0.48 | 0.8 |
| 13 | | GO:0002376 | immune system process | 51 | 348 | 108 | 447 | 6.35e-03 | 0.13 | 0.19 | 0.7 |
| 14 | | GO:0006631 | fatty acid metabolic process | 8 | 391 | 30 | 525 | 7.29e-03 | 0.02 | 0.05 | 0.4 |
| 15 | | GO:0006302 | double\-strand break repair | 14 | 385 | 5 | 550 | 7.88e-03 | 0.04 | 0.01 | 3.9 |
| 16 | | GO:0006629 | lipid metabolic process | 32 | 367 | 75 | 480 | 9.10e-03 | 0.08 | 0.14 | 0.6 |
| 17 | | GO:0007126 | meiosis | 9 | 390 | 2 | 553 | 1.06e-02 | 0.02 | 0.00 | 6.3 |
| 18 | | GO:0051327 | M phase of meiotic cell cycle | 9 | 390 | 2 | 553 | 1.06e-02 | 0.02 | 0.00 | 6.3 |
| 19 | | GO:0051321 | meiotic cell cycle | 9 | 390 | 2 | 553 | 1.06e-02 | 0.02 | 0.00 | 6.3 |
| 20 | | GO:0006508 | proteolysis | 22 | 377 | 56 | 499 | 1.17e-02 | 0.06 | 0.10 | 0.5 |
| 21 | | GO:0007049 | cell cycle | 44 | 355 | 35 | 520 | 1.20e-02 | 0.11 | 0.06 | 1.7 |
| 22 | | GO:0007131 | meiotic recombination | 5 | 394 | 0 | 555 | 1.26e-02 | 0.01 | 0.00 | bZero |
| 23 | | GO:0007127 | meiosis I | 5 | 394 | 0 | 555 | 1.26e-02 | 0.01 | 0.00 | bZero |
| 24 | | GO:0006312 | mitotic recombination | 5 | 394 | 0 | 555 | 1.26e-02 | 0.01 | 0.00 | bZero |
| 25 | | GO:0000724 | double\-strand break repair via homologous recombination | 5 | 394 | 0 | 555 | 1.26e-02 | 0.01 | 0.00 | bZero |
| 26 | | GO:0000725 | recombinational repair | 5 | 394 | 0 | 555 | 1.26e-02 | 0.01 | 0.00 | bZero |
| 27 | | GO:0022403 | cell cycle phase | 24 | 375 | 15 | 540 | 1.27e-02 | 0.06 | 0.03 | 2.2 |
| 28 | | GO:0006954 | inflammatory response | 32 | 367 | 73 | 482 | 1.55e-02 | 0.08 | 0.13 | 0.6 |
| 29 | | GO:0007155 | cell adhesion | 26 | 373 | 62 | 493 | 1.69e-02 | 0.07 | 0.11 | 0.6 |
| 30 | | GO:0022610 | biological adhesion | 26 | 373 | 62 | 493 | 1.69e-02 | 0.07 | 0.11 | 0.6 |
| 31 | | GO:0019933 | cAMP\-mediated signaling | 1 | 398 | 11 | 544 | 1.80e-02 | 0.00 | 0.02 | 0.1 |
| 32 | | GO:0032501 | multicellular organismal process | 174 | 225 | 286 | 269 | 1.80e-02 | 0.44 | 0.52 | 0.8 |
| 33 | | GO:0007154 | cell communication | 184 | 215 | 299 | 256 | 1.83e-02 | 0.46 | 0.54 | 0.9 |
| 34 | | GO:0019935 | cyclic\-nucleotide\-mediated signaling | 3 | 396 | 17 | 538 | 1.96e-02 | 0.01 | 0.03 | 0.2 |
| 35 | | GO:0000723 | telomere maintenance | 8 | 391 | 2 | 553 | 2.05e-02 | 0.02 | 0.00 | 5.6 |
| 36 | | GO:0032200 | telomere organization and biogenesis | 8 | 391 | 2 | 553 | 2.05e-02 | 0.02 | 0.00 | 5.6 |
| 37 | | GO:0019932 | second\-messenger\-mediated signaling | 12 | 387 | 35 | 520 | 2.25e-02 | 0.03 | 0.06 | 0.5 |
| 38 | | GO:0006275 | regulation of DNA replication | 6 | 393 | 1 | 554 | 2.36e-02 | 0.02 | 0.00 | 8.3 |
| 39 | | GO:0051052 | regulation of DNA metabolic process | 14 | 385 | 7 | 548 | 2.46e-02 | 0.04 | 0.01 | 2.8 |
| 40 | | GO:0043283 | biopolymer metabolic process | 176 | 223 | 205 | 350 | 2.71e-02 | 0.44 | 0.37 | 1.2 |
| 41 | | GO:0006750 | glutathione biosynthetic process | 4 | 395 | 0 | 555 | 3.03e-02 | 0.01 | 0.00 | bZero |
| 42 | | GO:0006952 | defense response | 45 | 354 | 91 | 464 | 3.06e-02 | 0.11 | 0.16 | 0.7 |
| 43 | | GO:0006979 | response to oxidative stress | 28 | 371 | 21 | 534 | 3.64e-02 | 0.07 | 0.04 | 1.9 |
| 44 | | GO:0001501 | skeletal development | 5 | 394 | 19 | 536 | 3.69e-02 | 0.01 | 0.03 | 0.4 |
| 45 | | GO:0009314 | response to radiation | 16 | 383 | 9 | 546 | 3.77e-02 | 0.04 | 0.02 | 2.5 |
| 46 | | GO:0006284 | base\-excision repair | 7 | 392 | 2 | 553 | 3.94e-02 | 0.02 | 0.00 | 4.9 |
| 47 | | GO:0006261 | DNA\-dependent DNA replication | 7 | 392 | 2 | 553 | 3.94e-02 | 0.02 | 0.00 | 4.9 |
| 48 | | GO:0045087 | innate immune response | 4 | 395 | 17 | 538 | 4.22e-02 | 0.01 | 0.03 | 0.3 |
| 49 | | GO:0051726 | regulation of cell cycle | 22 | 377 | 16 | 539 | 4.48e-02 | 0.06 | 0.03 | 1.9 |
| 50 | | GO:0051186 | cofactor metabolic process | 23 | 376 | 17 | 538 | 4.89e-02 | 0.06 | 0.03 | 1.9 |
| 51 | | GO:0006732 | coenzyme metabolic process | 17 | 382 | 11 | 544 | 5.08e-02 | 0.04 | 0.02 | 2.1 |
| 52 | | GO:0048584 | positive regulation of response to stimulus | 5 | 394 | 18 | 537 | 5.47e-02 | 0.01 | 0.03 | 0.4 |
| 53 | | GO:0007275 | multicellular organismal development | 129 | 270 | 213 | 342 | 5.57e-02 | 0.32 | 0.38 | 0.8 |
| 54 | | GO:0000279 | M phase | 18 | 381 | 12 | 543 | 5.83e-02 | 0.05 | 0.02 | 2.1 |
| 55 | | GO:0048646 | anatomical structure formation | 15 | 384 | 37 | 518 | 5.98e-02 | 0.04 | 0.07 | 0.6 |
| 56 | | GO:0051881 | regulation of mitochondrial membrane potential | 8 | 391 | 3 | 552 | 6.04e-02 | 0.02 | 0.01 | 3.7 |
| 57 | | GO:0050878 | regulation of body fluid levels | 4 | 395 | 16 | 539 | 6.45e-02 | 0.01 | 0.03 | 0.3 |
| 58 | | GO:0006139 | nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 128 | 271 | 147 | 408 | 7.00e-02 | 0.32 | 0.26 | 1.2 |
| 59 | | GO:0006536 | glutamate metabolic process | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 60 | | GO:0032981 | mitochondrial respiratory chain complex I assembly | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 61 | | GO:0033108 | mitochondrial respiratory chain complex assembly | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 62 | | GO:0010257 | NADH dehydrogenase complex assembly | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 63 | | GO:0000019 | regulation of mitotic recombination | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 64 | | GO:0006303 | double\-strand break repair via nonhomologous end joining | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 65 | | GO:0000726 | non\-recombinational repair | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 66 | | GO:0006266 | DNA ligation | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 67 | | GO:0000084 | S phase of mitotic cell cycle | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 68 | | GO:0051320 | S phase | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 69 | | GO:0060048 | cardiac muscle contraction | 3 | 396 | 0 | 555 | 7.28e-02 | 0.01 | 0.00 | bZero |
| 70 | | GO:0022402 | cell cycle process | 27 | 372 | 22 | 533 | 7.34e-02 | 0.07 | 0.04 | 1.7 |
| 71 | | GO:0007596 | blood coagulation | 3 | 396 | 13 | 542 | 7.37e-02 | 0.01 | 0.02 | 0.3 |
| 72 | | GO:0007599 | hemostasis | 3 | 396 | 13 | 542 | 7.37e-02 | 0.01 | 0.02 | 0.3 |
| 73 | | GO:0050817 | coagulation | 3 | 396 | 13 | 542 | 7.37e-02 | 0.01 | 0.02 | 0.3 |
| 74 | | GO:0006767 | water\-soluble vitamin metabolic process | 6 | 393 | 2 | 553 | 7.41e-02 | 0.02 | 0.00 | 4.2 |
| 75 | | GO:0044255 | cellular lipid metabolic process | 30 | 369 | 62 | 493 | 7.48e-02 | 0.08 | 0.11 | 0.7 |
| 76 | | GO:0008284 | positive regulation of cell proliferation | 22 | 377 | 48 | 507 | 7.78e-02 | 0.06 | 0.09 | 0.6 |
| 77 | | GO:0009887 | organ morphogenesis | 31 | 368 | 63 | 492 | 7.79e-02 | 0.08 | 0.11 | 0.7 |
| 78 | | GO:0032787 | monocarboxylic acid metabolic process | 15 | 384 | 36 | 519 | 7.94e-02 | 0.04 | 0.06 | 0.6 |
| 79 | | GO:0042060 | wound healing | 5 | 394 | 17 | 538 | 8.04e-02 | 0.01 | 0.03 | 0.4 |
| 80 | | GO:0002253 | activation of immune response | 2 | 397 | 10 | 545 | 8.50e-02 | 0.01 | 0.02 | 0.3 |
| 81 | | GO:0050778 | positive regulation of immune response | 2 | 397 | 10 | 545 | 8.50e-02 | 0.01 | 0.02 | 0.3 |
| 82 | | GO:0048856 | anatomical structure development | 129 | 270 | 210 | 345 | 8.66e-02 | 0.32 | 0.38 | 0.9 |
| 83 | | GO:0006289 | nucleotide\-excision repair | 5 | 394 | 1 | 554 | 8.78e-02 | 0.01 | 0.00 | 7.0 |
| 84 | | GO:0051053 | negative regulation of DNA metabolic process | 5 | 394 | 1 | 554 | 8.78e-02 | 0.01 | 0.00 | 7.0 |
| 85 | | GO:0010212 | response to ionizing radiation | 5 | 394 | 1 | 554 | 8.78e-02 | 0.01 | 0.00 | 7.0 |
| 86 | | GO:0042981 | regulation of apoptosis | 84 | 315 | 92 | 463 | 9.05e-02 | 0.21 | 0.17 | 1.3 |
| 87 | | GO:0016042 | lipid catabolic process | 8 | 391 | 22 | 533 | 9.37e-02 | 0.02 | 0.04 | 0.5 |
| 88 | | GO:0006333 | chromatin assembly or disassembly | 9 | 390 | 5 | 550 | 1.04e-01 | 0.02 | 0.01 | 2.5 |
| 89 | | GO:0042136 | neurotransmitter biosynthetic process | 7 | 392 | 3 | 552 | 1.04e-01 | 0.02 | 0.01 | 3.2 |
| 90 | | GO:0048514 | blood vessel morphogenesis | 15 | 384 | 35 | 520 | 1.05e-01 | 0.04 | 0.06 | 0.6 |
| 91 | | GO:0008632 | apoptotic program | 26 | 373 | 23 | 532 | 1.05e-01 | 0.07 | 0.04 | 1.6 |
| 92 | | GO:0001568 | blood vessel development | 19 | 380 | 41 | 514 | 1.06e-01 | 0.05 | 0.07 | 0.6 |
| 93 | | GO:0001944 | vasculature development | 19 | 380 | 41 | 514 | 1.06e-01 | 0.05 | 0.07 | 0.6 |
| 94 | | GO:0009653 | anatomical structure morphogenesis | 63 | 336 | 111 | 444 | 1.07e-01 | 0.16 | 0.20 | 0.8 |
| 95 | | GO:0048731 | system development | 118 | 281 | 192 | 363 | 1.07e-01 | 0.30 | 0.35 | 0.9 |
| 96 | | GO:0043067 | regulation of programmed cell death | 84 | 315 | 93 | 462 | 1.08e-01 | 0.21 | 0.17 | 1.3 |
| 97 | | GO:0043281 | regulation of caspase activity | 15 | 384 | 11 | 544 | 1.09e-01 | 0.04 | 0.02 | 1.9 |
| 98 | | GO:0052548 | regulation of endopeptidase activity | 15 | 384 | 11 | 544 | 1.09e-01 | 0.04 | 0.02 | 1.9 |
| 99 | | GO:0052547 | regulation of peptidase activity | 15 | 384 | 11 | 544 | 1.09e-01 | 0.04 | 0.02 | 1.9 |
| 100 | | GO:0007005 | mitochondrion organization and biogenesis | 19 | 380 | 15 | 540 | 1.11e-01 | 0.05 | 0.03 | 1.8 |
| 101 | | GO:0009416 | response to light stimulus | 12 | 387 | 8 | 547 | 1.11e-01 | 0.03 | 0.01 | 2.1 |
| 102 | | GO:0007200 | G\-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | 3 | 396 | 12 | 543 | 1.13e-01 | 0.01 | 0.02 | 0.3 |
| 103 | | GO:0032502 | developmental process | 182 | 217 | 283 | 272 | 1.15e-01 | 0.46 | 0.51 | 0.9 |
| 104 | | GO:0043687 | post\-translational protein modification | 77 | 322 | 85 | 470 | 1.16e-01 | 0.19 | 0.15 | 1.3 |
| 105 | | GO:0007267 | cell\-cell signaling | 59 | 340 | 104 | 451 | 1.17e-01 | 0.15 | 0.19 | 0.8 |
| 106 | | GO:0007626 | locomotory behavior | 21 | 378 | 44 | 511 | 1.19e-01 | 0.05 | 0.08 | 0.7 |
| 107 | | GO:0007420 | brain development | 16 | 383 | 12 | 543 | 1.19e-01 | 0.04 | 0.02 | 1.9 |
| 108 | | GO:0043066 | negative regulation of apoptosis | 53 | 346 | 55 | 500 | 1.20e-01 | 0.13 | 0.10 | 1.3 |
| 109 | | GO:0043069 | negative regulation of programmed cell death | 53 | 346 | 55 | 500 | 1.20e-01 | 0.13 | 0.10 | 1.3 |
| 110 | | GO:0042127 | regulation of cell proliferation | 46 | 353 | 84 | 471 | 1.26e-01 | 0.12 | 0.15 | 0.8 |
| 111 | | GO:0001525 | angiogenesis | 14 | 385 | 32 | 523 | 1.26e-01 | 0.04 | 0.06 | 0.6 |
| 112 | | GO:0016337 | cell\-cell adhesion | 8 | 391 | 21 | 534 | 1.29e-01 | 0.02 | 0.04 | 0.5 |
| 113 | | GO:0008152 | metabolic process | 293 | 106 | 382 | 173 | 1.30e-01 | 0.73 | 0.69 | 1.1 |
| 114 | | GO:0006915 | apoptosis | 97 | 302 | 112 | 443 | 1.32e-01 | 0.24 | 0.20 | 1.2 |
| 115 | | GO:0007204 | elevation of cytosolic calcium ion concentration | 2 | 397 | 9 | 546 | 1.33e-01 | 0.01 | 0.02 | 0.3 |
| 116 | | GO:0051480 | cytosolic calcium ion homeostasis | 2 | 397 | 9 | 546 | 1.33e-01 | 0.01 | 0.02 | 0.3 |
| 117 | | GO:0019882 | antigen processing and presentation | 2 | 397 | 9 | 546 | 1.33e-01 | 0.01 | 0.02 | 0.3 |
| 118 | | GO:0045444 | fat cell differentiation | 2 | 397 | 9 | 546 | 1.33e-01 | 0.01 | 0.02 | 0.3 |
| 119 | | GO:0007610 | behavior | 35 | 364 | 66 | 489 | 1.36e-01 | 0.09 | 0.12 | 0.7 |
| 120 | | GO:0006935 | chemotaxis | 15 | 384 | 33 | 522 | 1.36e-01 | 0.04 | 0.06 | 0.6 |
| 121 | | GO:0042330 | taxis | 15 | 384 | 33 | 522 | 1.36e-01 | 0.04 | 0.06 | 0.6 |
| 122 | | GO:0006471 | protein amino acid ADP\-ribosylation | 5 | 394 | 2 | 553 | 1.36e-01 | 0.01 | 0.00 | 3.5 |
| 123 | | GO:0030258 | lipid modification | 5 | 394 | 2 | 553 | 1.36e-01 | 0.01 | 0.00 | 3.5 |
| 124 | | GO:0008380 | RNA splicing | 5 | 394 | 2 | 553 | 1.36e-01 | 0.01 | 0.00 | 3.5 |
| 125 | | GO:0051276 | chromosome organization and biogenesis | 21 | 378 | 18 | 537 | 1.37e-01 | 0.05 | 0.03 | 1.6 |
| 126 | | GO:0006749 | glutathione metabolic process | 8 | 391 | 4 | 551 | 1.38e-01 | 0.02 | 0.01 | 2.8 |
| 127 | | GO:0000041 | transition metal ion transport | 8 | 391 | 4 | 551 | 1.38e-01 | 0.02 | 0.01 | 2.8 |
| 128 | | GO:0051329 | interphase of mitotic cell cycle | 8 | 391 | 4 | 551 | 1.38e-01 | 0.02 | 0.01 | 2.8 |
| 129 | | GO:0051325 | interphase | 8 | 391 | 4 | 551 | 1.38e-01 | 0.02 | 0.01 | 2.8 |
| 130 | | GO:0009968 | negative regulation of signal transduction | 6 | 393 | 17 | 538 | 1.38e-01 | 0.02 | 0.03 | 0.5 |
| 131 | | GO:0009987 | cellular process | 355 | 44 | 510 | 45 | 1.42e-01 | 0.89 | 0.92 | 1.0 |
| 132 | | GO:0006690 | icosanoid metabolic process | 4 | 395 | 13 | 542 | 1.43e-01 | 0.01 | 0.02 | 0.4 |
| 133 | | GO:0006457 | protein folding | 17 | 382 | 14 | 541 | 1.43e-01 | 0.04 | 0.03 | 1.7 |
| 134 | | GO:0051239 | regulation of multicellular organismal process | 25 | 374 | 50 | 505 | 1.43e-01 | 0.06 | 0.09 | 0.7 |
| 135 | | GO:0008629 | induction of apoptosis by intracellular signals | 11 | 388 | 7 | 548 | 1.46e-01 | 0.03 | 0.01 | 2.2 |
| 136 | | GO:0006520 | amino acid metabolic process | 18 | 381 | 15 | 540 | 1.52e-01 | 0.05 | 0.03 | 1.7 |
| 137 | | GO:0006464 | protein modification process | 83 | 316 | 95 | 460 | 1.53e-01 | 0.21 | 0.17 | 1.2 |
| 138 | | GO:0008283 | cell proliferation | 66 | 333 | 113 | 442 | 1.53e-01 | 0.17 | 0.20 | 0.8 |
| 139 | | GO:0008610 | lipid biosynthetic process | 13 | 386 | 29 | 526 | 1.53e-01 | 0.03 | 0.05 | 0.6 |
| 140 | | GO:0012501 | programmed cell death | 97 | 302 | 113 | 442 | 1.54e-01 | 0.24 | 0.20 | 1.2 |
| 141 | | GO:0001505 | regulation of neurotransmitter levels | 14 | 385 | 11 | 544 | 1.55e-01 | 0.04 | 0.02 | 1.8 |
| 142 | | GO:0043412 | biopolymer modification | 85 | 314 | 97 | 458 | 1.55e-01 | 0.21 | 0.17 | 1.2 |
| 143 | | GO:0000278 | mitotic cell cycle | 19 | 380 | 16 | 539 | 1.62e-01 | 0.05 | 0.03 | 1.7 |
| 144 | | GO:0045454 | cell redox homeostasis | 11 | 388 | 8 | 547 | 1.65e-01 | 0.03 | 0.01 | 1.9 |
| 145 | | GO:0045333 | cellular respiration | 8 | 391 | 5 | 550 | 1.65e-01 | 0.02 | 0.01 | 2.2 |
| 146 | | GO:0042133 | neurotransmitter metabolic process | 8 | 391 | 5 | 550 | 1.65e-01 | 0.02 | 0.01 | 2.2 |
| 147 | | GO:0007004 | telomere maintenance via telomerase | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 148 | | GO:0006278 | RNA\-dependent DNA replication | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 149 | | GO:0008156 | negative regulation of DNA replication | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 150 | | GO:0032508 | DNA duplex unwinding | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 151 | | GO:0032392 | DNA geometric change | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 152 | | GO:0009072 | aromatic amino acid family metabolic process | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 153 | | GO:0046148 | pigment biosynthetic process | 4 | 395 | 1 | 554 | 1.67e-01 | 0.01 | 0.00 | 5.6 |
| 154 | | GO:0048771 | tissue remodeling | 5 | 394 | 15 | 540 | 1.69e-01 | 0.01 | 0.03 | 0.5 |
| 155 | | GO:0019221 | cytokine and chemokine mediated signaling pathway | 5 | 394 | 15 | 540 | 1.69e-01 | 0.01 | 0.03 | 0.5 |
| 156 | | GO:0048513 | organ development | 90 | 309 | 147 | 408 | 1.72e-01 | 0.23 | 0.26 | 0.9 |
| 157 | | GO:0048583 | regulation of response to stimulus | 15 | 384 | 32 | 523 | 1.74e-01 | 0.04 | 0.06 | 0.7 |
| 158 | | GO:0040012 | regulation of locomotion | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 159 | | GO:0048489 | synaptic vesicle transport | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 160 | | GO:0008053 | mitochondrial fusion | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 161 | | GO:0048284 | organelle fusion | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 162 | | GO:0010248 | establishment and/or maintenance of transmembrane electrochemical gradient | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 163 | | GO:0019852 | L\-ascorbic acid metabolic process | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 164 | | GO:0031638 | zymogen activation | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 165 | | GO:0048478 | replication fork protection | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 166 | | GO:0006376 | mRNA splice site selection | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 167 | | GO:0006270 | DNA replication initiation | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 168 | | GO:0051668 | localization within membrane | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 169 | | GO:0007090 | regulation of S phase of mitotic cell cycle | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 170 | | GO:0033261 | regulation of S phase | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 171 | | GO:0006414 | translational elongation | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 172 | | GO:0006829 | zinc ion transport | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 173 | | GO:0001539 | ciliary or flagellar motility | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 174 | | GO:0006590 | thyroid hormone generation | 2 | 397 | 0 | 555 | 1.75e-01 | 0.01 | 0.00 | bZero |
| 175 | | GO:0008217 | regulation of blood pressure | 8 | 391 | 20 | 535 | 1.76e-01 | 0.02 | 0.04 | 0.6 |
| 176 | | GO:0006519 | amino acid and derivative metabolic process | 25 | 374 | 23 | 532 | 1.76e-01 | 0.06 | 0.04 | 1.5 |
| 177 | | GO:0048145 | regulation of fibroblast proliferation | 6 | 393 | 3 | 552 | 1.76e-01 | 0.02 | 0.01 | 2.8 |
| 178 | | GO:0048144 | fibroblast proliferation | 6 | 393 | 3 | 552 | 1.76e-01 | 0.02 | 0.01 | 2.8 |
| 179 | | GO:0044249 | cellular biosynthetic process | 61 | 338 | 67 | 488 | 1.78e-01 | 0.15 | 0.12 | 1.3 |
| 180 | | GO:0043280 | positive regulation of caspase activity | 12 | 387 | 9 | 546 | 1.81e-01 | 0.03 | 0.02 | 1.9 |
| 181 | | GO:0008219 | cell death | 100 | 299 | 118 | 437 | 1.84e-01 | 0.25 | 0.21 | 1.2 |
| 182 | | GO:0016265 | death | 100 | 299 | 118 | 437 | 1.84e-01 | 0.25 | 0.21 | 1.2 |
| 183 | | GO:0042770 | DNA damage response\, signal transduction | 9 | 390 | 6 | 549 | 1.89e-01 | 0.02 | 0.01 | 2.1 |
| 184 | | GO:0006796 | phosphate metabolic process | 65 | 334 | 73 | 482 | 1.92e-01 | 0.16 | 0.13 | 1.2 |
| 185 | | GO:0006793 | phosphorus metabolic process | 65 | 334 | 73 | 482 | 1.92e-01 | 0.16 | 0.13 | 1.2 |
| 186 | | GO:0046394 | carboxylic acid biosynthetic process | 6 | 393 | 16 | 539 | 1.93e-01 | 0.02 | 0.03 | 0.5 |
| 187 | | GO:0016053 | organic acid biosynthetic process | 6 | 393 | 16 | 539 | 1.93e-01 | 0.02 | 0.03 | 0.5 |
| 188 | | GO:0009628 | response to abiotic stimulus | 33 | 366 | 33 | 522 | 1.96e-01 | 0.08 | 0.06 | 1.4 |
| 189 | | GO:0006807 | nitrogen compound metabolic process | 34 | 365 | 35 | 520 | 2.06e-01 | 0.09 | 0.06 | 1.4 |
| 190 | | GO:0006959 | humoral immune response | 4 | 395 | 12 | 543 | 2.07e-01 | 0.01 | 0.02 | 0.5 |
| 191 | | GO:0007586 | digestion | 4 | 395 | 12 | 543 | 2.07e-01 | 0.01 | 0.02 | 0.5 |
| 192 | | GO:0001503 | ossification | 2 | 397 | 8 | 547 | 2.07e-01 | 0.01 | 0.01 | 0.3 |
| 193 | | GO:0031214 | biomineral formation | 2 | 397 | 8 | 547 | 2.07e-01 | 0.01 | 0.01 | 0.3 |
| 194 | | GO:0007259 | JAK\-STAT cascade | 2 | 397 | 8 | 547 | 2.07e-01 | 0.01 | 0.01 | 0.3 |
| 195 | | GO:0044237 | cellular metabolic process | 277 | 122 | 363 | 192 | 2.09e-01 | 0.69 | 0.65 | 1.1 |
| 196 | | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 10 | 389 | 23 | 532 | 2.10e-01 | 0.03 | 0.04 | 0.6 |
| 197 | | GO:0002250 | adaptive immune response | 10 | 389 | 23 | 532 | 2.10e-01 | 0.03 | 0.04 | 0.6 |
| 198 | | GO:0050789 | regulation of biological process | 199 | 200 | 300 | 255 | 2.12e-01 | 0.50 | 0.54 | 0.9 |
| 199 | | GO:0009411 | response to UV | 10 | 389 | 7 | 548 | 2.14e-01 | 0.03 | 0.01 | 2.0 |
| 200 | | GO:0045786 | negative regulation of cell cycle | 10 | 389 | 7 | 548 | 2.14e-01 | 0.03 | 0.01 | 2.0 |
| 201 | | GO:0008635 | caspase activation via cytochrome c | 7 | 392 | 4 | 551 | 2.17e-01 | 0.02 | 0.01 | 2.4 |
| 202 | | GO:0042440 | pigment metabolic process | 7 | 392 | 4 | 551 | 2.17e-01 | 0.02 | 0.01 | 2.4 |
| 203 | | GO:0031497 | chromatin assembly | 7 | 392 | 4 | 551 | 2.17e-01 | 0.02 | 0.01 | 2.4 |
| 204 | | GO:0007167 | enzyme linked receptor protein signaling pathway | 20 | 379 | 39 | 516 | 2.22e-01 | 0.05 | 0.07 | 0.7 |
| 205 | | GO:0050896 | response to stimulus | 175 | 224 | 265 | 290 | 2.37e-01 | 0.44 | 0.48 | 0.9 |
| 206 | | GO:0006919 | caspase activation | 10 | 389 | 8 | 547 | 2.39e-01 | 0.03 | 0.01 | 1.7 |
| 207 | | GO:0015980 | energy derivation by oxidation of organic compounds | 10 | 389 | 8 | 547 | 2.39e-01 | 0.03 | 0.01 | 1.7 |
| 208 | | GO:0008637 | apoptotic mitochondrial changes | 10 | 389 | 8 | 547 | 2.39e-01 | 0.03 | 0.01 | 1.7 |
| 209 | | GO:0042108 | positive regulation of cytokine biosynthetic process | 5 | 394 | 14 | 541 | 2.40e-01 | 0.01 | 0.03 | 0.5 |
| 210 | | GO:0044242 | cellular lipid catabolic process | 5 | 394 | 14 | 541 | 2.40e-01 | 0.01 | 0.03 | 0.5 |
| 211 | | GO:0050776 | regulation of immune response | 5 | 394 | 14 | 541 | 2.40e-01 | 0.01 | 0.03 | 0.5 |
| 212 | | GO:0006091 | generation of precursor metabolites and energy | 25 | 374 | 25 | 530 | 2.41e-01 | 0.06 | 0.05 | 1.4 |
| 213 | | GO:0005975 | carbohydrate metabolic process | 25 | 374 | 25 | 530 | 2.41e-01 | 0.06 | 0.05 | 1.4 |
| 214 | | GO:0051495 | positive regulation of cytoskeleton organization and biogenesis | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 215 | | GO:0032273 | positive regulation of protein polymerization | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 216 | | GO:0006099 | tricarboxylic acid cycle | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 217 | | GO:0046356 | acetyl\-CoA catabolic process | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 218 | | GO:0009109 | coenzyme catabolic process | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 219 | | GO:0009060 | aerobic respiration | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 220 | | GO:0006825 | copper ion transport | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 221 | | GO:0048146 | positive regulation of fibroblast proliferation | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 222 | | GO:0006470 | protein amino acid dephosphorylation | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 223 | | GO:0016311 | dephosphorylation | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 224 | | GO:0001952 | regulation of cell\-matrix adhesion | 4 | 395 | 2 | 553 | 2.43e-01 | 0.01 | 0.00 | 2.8 |
| 225 | | GO:0006800 | oxygen and reactive oxygen species metabolic process | 20 | 379 | 19 | 536 | 2.47e-01 | 0.05 | 0.03 | 1.5 |
| 226 | | GO:0051640 | organelle localization | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 227 | | GO:0042157 | lipoprotein metabolic process | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 228 | | GO:0007338 | single fertilization | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 229 | | GO:0009566 | fertilization | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 230 | | GO:0031349 | positive regulation of defense response | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 231 | | GO:0042088 | T\-helper 1 type immune response | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 232 | | GO:0014031 | mesenchymal cell development | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 233 | | GO:0048762 | mesenchymal cell differentiation | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 234 | | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 235 | | GO:0006691 | leukotriene metabolic process | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 236 | | GO:0043449 | alkene metabolic process | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 237 | | GO:0019370 | leukotriene biosynthetic process | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 238 | | GO:0043450 | alkene biosynthetic process | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 239 | | GO:0007229 | integrin\-mediated signaling pathway | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 240 | | GO:0050679 | positive regulation of epithelial cell proliferation | 1 | 398 | 6 | 549 | 2.49e-01 | 0.00 | 0.01 | 0.2 |
| 241 | | GO:0006879 | cellular iron ion homeostasis | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 242 | | GO:0055072 | iron ion homeostasis | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 243 | | GO:0051187 | cofactor catabolic process | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 244 | | GO:0019748 | secondary metabolic process | 7 | 392 | 5 | 550 | 2.55e-01 | 0.02 | 0.01 | 1.9 |
| 245 | | GO:0009308 | amine metabolic process | 27 | 372 | 27 | 528 | 2.56e-01 | 0.07 | 0.05 | 1.4 |
| 246 | | GO:0016485 | protein processing | 11 | 388 | 9 | 546 | 2.56e-01 | 0.03 | 0.02 | 1.7 |
| 247 | | GO:0032147 | activation of protein kinase activity | 3 | 396 | 10 | 545 | 2.58e-01 | 0.01 | 0.02 | 0.4 |
| 248 | | GO:0009615 | response to virus | 6 | 393 | 15 | 540 | 2.66e-01 | 0.02 | 0.03 | 0.6 |
| 249 | | GO:0006633 | fatty acid biosynthetic process | 6 | 393 | 15 | 540 | 2.66e-01 | 0.02 | 0.03 | 0.6 |
| 250 | | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 15 | 384 | 30 | 525 | 2.80e-01 | 0.04 | 0.05 | 0.7 |
| 251 | | GO:0043524 | negative regulation of neuron apoptosis | 8 | 391 | 6 | 549 | 2.81e-01 | 0.02 | 0.01 | 1.9 |
| 252 | | GO:0010564 | regulation of cell cycle process | 8 | 391 | 6 | 549 | 2.81e-01 | 0.02 | 0.01 | 1.9 |
| 253 | | GO:0006576 | biogenic amine metabolic process | 8 | 391 | 6 | 549 | 2.81e-01 | 0.02 | 0.01 | 1.9 |
| 254 | | GO:0006323 | DNA packaging | 8 | 391 | 6 | 549 | 2.81e-01 | 0.02 | 0.01 | 1.9 |
| 255 | | GO:0007268 | synaptic transmission | 38 | 361 | 41 | 514 | 2.84e-01 | 0.10 | 0.07 | 1.3 |
| 256 | | GO:0007569 | cell aging | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 257 | | GO:0007006 | mitochondrial membrane organization and biogenesis | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 258 | | GO:0032271 | regulation of protein polymerization | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 259 | | GO:0006084 | acetyl\-CoA metabolic process | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 260 | | GO:0000077 | DNA damage checkpoint | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 261 | | GO:0031570 | DNA integrity checkpoint | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 262 | | GO:0031400 | negative regulation of protein modification process | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 263 | | GO:0045936 | negative regulation of phosphate metabolic process | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 264 | | GO:0010563 | negative regulation of phosphorus metabolic process | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 265 | | GO:0030384 | phosphoinositide metabolic process | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 266 | | GO:0006120 | mitochondrial electron transport\, NADH to ubiquinone | 5 | 394 | 3 | 552 | 2.90e-01 | 0.01 | 0.01 | 2.3 |
| 267 | | GO:0009888 | tissue development | 16 | 383 | 31 | 524 | 2.92e-01 | 0.04 | 0.06 | 0.7 |
| 268 | | GO:0006874 | cellular calcium ion homeostasis | 7 | 392 | 16 | 539 | 2.93e-01 | 0.02 | 0.03 | 0.6 |
| 269 | | GO:0055074 | calcium ion homeostasis | 7 | 392 | 16 | 539 | 2.93e-01 | 0.02 | 0.03 | 0.6 |
| 270 | | GO:0006875 | cellular metal ion homeostasis | 7 | 392 | 17 | 538 | 2.94e-01 | 0.02 | 0.03 | 0.6 |
| 271 | | GO:0055065 | metal ion homeostasis | 7 | 392 | 17 | 538 | 2.94e-01 | 0.02 | 0.03 | 0.6 |
| 272 | | GO:0016310 | phosphorylation | 61 | 338 | 71 | 484 | 2.96e-01 | 0.15 | 0.13 | 1.2 |
| 273 | | GO:0046849 | bone remodeling | 4 | 395 | 11 | 544 | 2.96e-01 | 0.01 | 0.02 | 0.5 |
| 274 | | GO:0016568 | chromatin modification | 4 | 395 | 11 | 544 | 2.96e-01 | 0.01 | 0.02 | 0.5 |
| 275 | | GO:0006812 | cation transport | 24 | 375 | 25 | 530 | 3.02e-01 | 0.06 | 0.05 | 1.3 |
| 276 | | GO:0007417 | central nervous system development | 24 | 375 | 25 | 530 | 3.02e-01 | 0.06 | 0.05 | 1.3 |
| 277 | | GO:0006839 | mitochondrial transport | 9 | 390 | 7 | 548 | 3.08e-01 | 0.02 | 0.01 | 1.8 |
| 278 | | GO:0051188 | cofactor biosynthetic process | 9 | 390 | 7 | 548 | 3.08e-01 | 0.02 | 0.01 | 1.8 |
| 279 | | GO:0051707 | response to other organism | 12 | 387 | 24 | 531 | 3.08e-01 | 0.03 | 0.04 | 0.7 |
| 280 | | GO:0051402 | neuron apoptosis | 13 | 386 | 12 | 543 | 3.11e-01 | 0.03 | 0.02 | 1.5 |
| 281 | | GO:0043086 | negative regulation of catalytic activity | 13 | 386 | 12 | 543 | 3.11e-01 | 0.03 | 0.02 | 1.5 |
| 282 | | GO:0009966 | regulation of signal transduction | 33 | 366 | 57 | 498 | 3.14e-01 | 0.08 | 0.10 | 0.8 |
| 283 | | GO:0043496 | regulation of protein homodimerization activity | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 284 | | GO:0043497 | regulation of protein heterodimerization activity | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 285 | | GO:0051900 | regulation of mitochondrial depolarization | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 286 | | GO:0051882 | mitochondrial depolarization | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 287 | | GO:0051899 | membrane depolarization | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 288 | | GO:0010165 | response to X\-ray | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 289 | | GO:0010332 | response to gamma radiation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 290 | | GO:0040011 | locomotion | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 291 | | GO:0006268 | DNA unwinding during replication | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 292 | | GO:0030503 | regulation of cell redox homeostasis | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 293 | | GO:0006342 | chromatin silencing | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 294 | | GO:0045814 | negative regulation of gene expression\, epigenetic | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 295 | | GO:0031507 | heterochromatin formation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 296 | | GO:0006739 | NADP metabolic process | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 297 | | GO:0019751 | polyol metabolic process | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 298 | | GO:0048008 | platelet\-derived growth factor receptor signaling pathway | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 299 | | GO:0001953 | negative regulation of cell\-matrix adhesion | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 300 | | GO:0046854 | phosphoinositide phosphorylation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 301 | | GO:0046834 | lipid phosphorylation | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 302 | | GO:0000398 | nuclear mRNA splicing\, via spliceosome | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 303 | | GO:0000377 | RNA splicing\, via transesterification reactions with bulged adenosine as nucleophile | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 304 | | GO:0000375 | RNA splicing\, via transesterification reactions | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 305 | | GO:0006779 | porphyrin biosynthetic process | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 306 | | GO:0033014 | tetrapyrrole biosynthetic process | 3 | 396 | 1 | 554 | 3.14e-01 | 0.01 | 0.00 | 4.2 |
| 307 | | GO:0006357 | regulation of transcription from RNA polymerase II promoter | 25 | 374 | 45 | 510 | 3.15e-01 | 0.06 | 0.08 | 0.8 |
| 308 | | GO:0051336 | regulation of hydrolase activity | 19 | 380 | 19 | 536 | 3.17e-01 | 0.05 | 0.03 | 1.4 |
| 309 | | GO:0006118 | electron transport | 34 | 365 | 37 | 518 | 3.17e-01 | 0.09 | 0.07 | 1.3 |
| 310 | | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 311 | | GO:0030534 | adult behavior | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 312 | | GO:0019395 | fatty acid oxidation | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 313 | | GO:0007179 | transforming growth factor beta receptor signaling pathway | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 314 | | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 2 | 397 | 7 | 548 | 3.18e-01 | 0.01 | 0.01 | 0.4 |
| 315 | | GO:0051345 | positive regulation of hydrolase activity | 14 | 385 | 13 | 542 | 3.25e-01 | 0.04 | 0.02 | 1.5 |
| 316 | | GO:0008016 | regulation of heart contraction | 5 | 394 | 12 | 543 | 3.33e-01 | 0.01 | 0.02 | 0.6 |
| 317 | | GO:0008203 | cholesterol metabolic process | 5 | 394 | 13 | 542 | 3.35e-01 | 0.01 | 0.02 | 0.5 |
| 318 | | GO:0016125 | sterol metabolic process | 5 | 394 | 13 | 542 | 3.35e-01 | 0.01 | 0.02 | 0.5 |
| 319 | | GO:0045597 | positive regulation of cell differentiation | 5 | 394 | 13 | 542 | 3.35e-01 | 0.01 | 0.02 | 0.5 |
| 320 | | GO:0006869 | lipid transport | 5 | 394 | 13 | 542 | 3.35e-01 | 0.01 | 0.02 | 0.5 |
| 321 | | GO:0007568 | aging | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 322 | | GO:0006778 | porphyrin metabolic process | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 323 | | GO:0033013 | tetrapyrrole metabolic process | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 324 | | GO:0008630 | DNA damage response\, signal transduction resulting in induction of apoptosis | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 325 | | GO:0006766 | vitamin metabolic process | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 326 | | GO:0042775 | organelle ATP synthesis coupled electron transport | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 327 | | GO:0042773 | ATP synthesis coupled electron transport | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 328 | | GO:0022904 | respiratory electron transport chain | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 329 | | GO:0022900 | electron transport chain | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 330 | | GO:0055114 | oxidation reduction | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 331 | | GO:0006397 | mRNA processing | 6 | 393 | 4 | 551 | 3.35e-01 | 0.02 | 0.01 | 2.1 |
| 332 | | GO:0009059 | macromolecule biosynthetic process | 81 | 318 | 128 | 427 | 3.41e-01 | 0.20 | 0.23 | 0.9 |
| 333 | | GO:0043065 | positive regulation of apoptosis | 37 | 362 | 42 | 513 | 3.44e-01 | 0.09 | 0.08 | 1.2 |
| 334 | | GO:0043068 | positive regulation of programmed cell death | 37 | 362 | 42 | 513 | 3.44e-01 | 0.09 | 0.08 | 1.2 |
| 335 | | GO:0007517 | muscle development | 15 | 384 | 29 | 526 | 3.48e-01 | 0.04 | 0.05 | 0.7 |
| 336 | | GO:0006006 | glucose metabolic process | 15 | 384 | 15 | 540 | 3.55e-01 | 0.04 | 0.03 | 1.4 |
| 337 | | GO:0006790 | sulfur metabolic process | 10 | 389 | 9 | 546 | 3.55e-01 | 0.03 | 0.02 | 1.5 |
| 338 | | GO:0051047 | positive regulation of secretion | 10 | 389 | 9 | 546 | 3.55e-01 | 0.03 | 0.02 | 1.5 |
| 339 | | GO:0006396 | RNA processing | 10 | 389 | 9 | 546 | 3.55e-01 | 0.03 | 0.02 | 1.5 |
| 340 | | GO:0042445 | hormone metabolic process | 10 | 389 | 9 | 546 | 3.55e-01 | 0.03 | 0.02 | 1.5 |
| 341 | | GO:0006996 | organelle organization and biogenesis | 64 | 335 | 77 | 478 | 3.57e-01 | 0.16 | 0.14 | 1.2 |
| 342 | | GO:0008015 | blood circulation | 23 | 376 | 41 | 514 | 3.60e-01 | 0.06 | 0.07 | 0.8 |
| 343 | | GO:0003013 | circulatory system process | 23 | 376 | 41 | 514 | 3.60e-01 | 0.06 | 0.07 | 0.8 |
| 344 | | GO:0006917 | induction of apoptosis | 31 | 368 | 34 | 521 | 3.62e-01 | 0.08 | 0.06 | 1.3 |
| 345 | | GO:0012502 | induction of programmed cell death | 31 | 368 | 34 | 521 | 3.62e-01 | 0.08 | 0.06 | 1.3 |
| 346 | | GO:0045941 | positive regulation of transcription | 24 | 375 | 42 | 513 | 3.69e-01 | 0.06 | 0.08 | 0.8 |
| 347 | | GO:0051704 | multi\-organism process | 24 | 375 | 43 | 512 | 3.69e-01 | 0.06 | 0.08 | 0.8 |
| 348 | | GO:0019226 | transmission of nerve impulse | 42 | 357 | 48 | 507 | 3.69e-01 | 0.11 | 0.09 | 1.2 |
| 349 | | GO:0007507 | heart development | 11 | 388 | 22 | 533 | 3.71e-01 | 0.03 | 0.04 | 0.7 |
| 350 | | GO:0046903 | secretion | 17 | 382 | 32 | 523 | 3.72e-01 | 0.04 | 0.06 | 0.7 |
| 351 | | GO:0006898 | receptor\-mediated endocytosis | 3 | 396 | 8 | 547 | 3.76e-01 | 0.01 | 0.01 | 0.5 |
| 352 | | GO:0032103 | positive regulation of response to external stimulus | 3 | 396 | 8 | 547 | 3.76e-01 | 0.01 | 0.01 | 0.5 |
| 353 | | GO:0045926 | negative regulation of growth | 3 | 396 | 8 | 547 | 3.76e-01 | 0.01 | 0.01 | 0.5 |
| 354 | | GO:0050673 | epithelial cell proliferation | 3 | 396 | 8 | 547 | 3.76e-01 | 0.01 | 0.01 | 0.5 |
| 355 | | GO:0030198 | extracellular matrix organization and biogenesis | 3 | 396 | 8 | 547 | 3.76e-01 | 0.01 | 0.01 | 0.5 |
| 356 | | GO:0006968 | cellular defense response | 3 | 396 | 8 | 547 | 3.76e-01 | 0.01 | 0.01 | 0.5 |
| 357 | | GO:0030001 | metal ion transport | 17 | 382 | 17 | 538 | 3.77e-01 | 0.04 | 0.03 | 1.4 |
| 358 | | GO:0019725 | cellular homeostasis | 43 | 356 | 50 | 505 | 3.78e-01 | 0.11 | 0.09 | 1.2 |
| 359 | | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3 | 396 | 9 | 546 | 3.78e-01 | 0.01 | 0.02 | 0.5 |
| 360 | | GO:0046879 | hormone secretion | 3 | 396 | 9 | 546 | 3.78e-01 | 0.01 | 0.02 | 0.5 |
| 361 | | GO:0016064 | immunoglobulin mediated immune response | 7 | 392 | 15 | 540 | 3.88e-01 | 0.02 | 0.03 | 0.6 |
| 362 | | GO:0019724 | B cell mediated immunity | 7 | 392 | 15 | 540 | 3.88e-01 | 0.02 | 0.03 | 0.6 |
| 363 | | GO:0048518 | positive regulation of biological process | 111 | 288 | 169 | 386 | 3.88e-01 | 0.28 | 0.30 | 0.9 |
| 364 | | GO:0008371 | obsolete biological process | 34 | 365 | 39 | 516 | 3.91e-01 | 0.09 | 0.07 | 1.2 |
| 365 | | GO:0050877 | neurological system process | 61 | 338 | 73 | 482 | 3.95e-01 | 0.15 | 0.13 | 1.2 |
| 366 | | GO:0009636 | response to toxin | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 367 | | GO:0042100 | B cell proliferation | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 368 | | GO:0045776 | negative regulation of blood pressure | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 369 | | GO:0007159 | leukocyte adhesion | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 370 | | GO:0050663 | cytokine secretion | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 371 | | GO:0051494 | negative regulation of cytoskeleton organization and biogenesis | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 372 | | GO:0033043 | regulation of organelle organization and biogenesis | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 373 | | GO:0051258 | protein polymerization | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 374 | | GO:0006887 | exocytosis | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 375 | | GO:0006814 | sodium ion transport | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 376 | | GO:0050729 | positive regulation of inflammatory response | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 377 | | GO:0046851 | negative regulation of bone remodeling | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 378 | | GO:0034104 | negative regulation of tissue remodeling | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 379 | | GO:0016071 | mRNA metabolic process | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 380 | | GO:0000018 | regulation of DNA recombination | 7 | 392 | 6 | 549 | 4.07e-01 | 0.02 | 0.01 | 1.6 |
| 381 | | GO:0042246 | tissue regeneration | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 382 | | GO:0002429 | immune response\-activating cell surface receptor signaling pathway | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 383 | | GO:0002768 | immune response\-regulating cell surface receptor signaling pathway | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 384 | | GO:0009620 | response to fungus | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 385 | | GO:0006473 | protein amino acid acetylation | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 386 | | GO:0043543 | protein amino acid acylation | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 387 | | GO:0006664 | glycolipid metabolic process | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 388 | | GO:0016202 | regulation of striated muscle development | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 389 | | GO:0046637 | regulation of alpha\-beta T cell differentiation | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 390 | | GO:0043370 | regulation of CD4\-positive\, alpha beta T cell differentiation | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 391 | | GO:0045622 | regulation of T\-helper cell differentiation | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 392 | | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 393 | | GO:0030278 | regulation of ossification | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 394 | | GO:0008277 | regulation of G\-protein coupled receptor protein signaling pathway | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 395 | | GO:0043010 | camera\-type eye development | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 396 | | GO:0030073 | insulin secretion | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 397 | | GO:0030072 | peptide hormone secretion | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 398 | | GO:0002790 | peptide secretion | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 399 | | GO:0045766 | positive regulation of angiogenesis | 1 | 398 | 4 | 551 | 4.07e-01 | 0.00 | 0.01 | 0.3 |
| 400 | | GO:0045123 | cellular extravasation | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 401 | | GO:0031099 | regeneration | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 402 | | GO:0002757 | immune response\-activating signal transduction | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 403 | | GO:0002764 | immune response\-regulating signal transduction | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 404 | | GO:0008344 | adult locomotory behavior | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 405 | | GO:0006958 | complement activation\, classical pathway | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 406 | | GO:0006956 | complement activation | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 407 | | GO:0002541 | activation of plasma proteins during acute inflammatory response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 408 | | GO:0048634 | regulation of muscle development | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 409 | | GO:0042093 | T\-helper cell differentiation | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 410 | | GO:0002294 | CD4\-positive\, alpha\-beta T cell differentiation during immune response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 411 | | GO:0002293 | alpha\-beta T cell differentiation during immune response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 412 | | GO:0002292 | T cell differentiation during immune response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 413 | | GO:0002286 | T cell activation during immune response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 414 | | GO:0002285 | lymphocyte activation during immune response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 415 | | GO:0002366 | leukocyte activation during immune response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 416 | | GO:0002263 | cell activation during immune response | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 417 | | GO:0043367 | CD4\-positive\, alpha beta T cell differentiation | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 418 | | GO:0003073 | regulation of systemic arterial blood pressure | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 419 | | GO:0042094 | interleukin\-2 biosynthetic process | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 420 | | GO:0032623 | interleukin\-2 production | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 421 | | GO:0022407 | regulation of cell\-cell adhesion | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 422 | | GO:0007498 | mesoderm development | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 423 | | GO:0045765 | regulation of angiogenesis | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 424 | | GO:0007172 | signal complex assembly | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 425 | | GO:0016055 | Wnt receptor signaling pathway | 1 | 398 | 5 | 550 | 4.10e-01 | 0.00 | 0.01 | 0.3 |
| 426 | | GO:0010557 | positive regulation of macromolecule biosynthetic process | 8 | 391 | 17 | 538 | 4.12e-01 | 0.02 | 0.03 | 0.7 |
| 427 | | GO:0002526 | acute inflammatory response | 8 | 391 | 17 | 538 | 4.12e-01 | 0.02 | 0.03 | 0.7 |
| 428 | | GO:0000060 | protein import into nucleus\, translocation | 4 | 395 | 10 | 545 | 4.17e-01 | 0.01 | 0.02 | 0.6 |
| 429 | | GO:0043410 | positive regulation of MAPKKK cascade | 4 | 395 | 10 | 545 | 4.17e-01 | 0.01 | 0.02 | 0.6 |
| 430 | | GO:0043408 | regulation of MAPKKK cascade | 4 | 395 | 10 | 545 | 4.17e-01 | 0.01 | 0.02 | 0.6 |
| 431 | | GO:0051129 | negative regulation of cellular component organization and biogenesis | 4 | 395 | 10 | 545 | 4.17e-01 | 0.01 | 0.02 | 0.6 |
| 432 | | GO:0046456 | icosanoid biosynthetic process | 4 | 395 | 10 | 545 | 4.17e-01 | 0.01 | 0.02 | 0.6 |
| 433 | | GO:0001956 | positive regulation of neurotransmitter secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 434 | | GO:0048169 | regulation of long\-term neuronal synaptic plasticity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 435 | | GO:0030644 | cellular chloride ion homeostasis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 436 | | GO:0030320 | cellular monovalent inorganic anion homeostasis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 437 | | GO:0030002 | cellular anion homeostasis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 438 | | GO:0055081 | anion homeostasis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 439 | | GO:0055083 | monovalent inorganic anion homeostasis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 440 | | GO:0055064 | chloride ion homeostasis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 441 | | GO:0000002 | mitochondrial genome maintenance | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 442 | | GO:0015866 | ADP transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 443 | | GO:0051935 | glutamate uptake during transmission of nerve impulse | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 444 | | GO:0051933 | amino acid uptake during transmission of nerve impulse | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 445 | | GO:0051938 | L\-glutamate import | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 446 | | GO:0043090 | amino acid import | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 447 | | GO:0043092 | L\-amino acid import | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 448 | | GO:0015807 | L\-amino acid transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 449 | | GO:0007252 | I\-kappaB phosphorylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 450 | | GO:0009437 | carnitine metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 451 | | GO:0043071 | positive regulation of non\-apoptotic programmed cell death | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 452 | | GO:0006010 | glucose 6\-phosphate utilization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 453 | | GO:0051156 | glucose 6\-phosphate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 454 | | GO:0006098 | pentose\-phosphate shunt | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 455 | | GO:0006740 | NADPH regeneration | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 456 | | GO:0016188 | synaptic vesicle maturation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 457 | | GO:0048488 | synaptic vesicle endocytosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 458 | | GO:0048499 | synaptic vesicle membrane organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 459 | | GO:0005997 | xylulose metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 460 | | GO:0019321 | pentose metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 461 | | GO:0042732 | D\-xylose metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 462 | | GO:0006540 | glutamate decarboxylation to succinate | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 463 | | GO:0006538 | glutamate catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 464 | | GO:0006105 | succinate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 465 | | GO:0043648 | dicarboxylic acid metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 466 | | GO:0018352 | protein\-pyridoxal\-5\-phosphate linkage | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 467 | | GO:0018065 | protein\-cofactor linkage | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 468 | | GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 469 | | GO:0010046 | response to mycotoxin | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 470 | | GO:0007207 | muscarinic acetylcholine receptor\, phospholipase C activating pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 471 | | GO:0001302 | replicative cell aging | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 472 | | GO:0010259 | multicellular organismal aging | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 473 | | GO:0035315 | hair cell differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 474 | | GO:0000717 | nucleotide\-excision repair\, DNA duplex unwinding | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 475 | | GO:0033683 | nucleotide\-excision repair\, DNA incision | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 476 | | GO:0000737 | DNA catabolic process\, endonucleolytic | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 477 | | GO:0006283 | transcription\-coupled nucleotide\-excision repair | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 478 | | GO:0006684 | sphingomyelin metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 479 | | GO:0018279 | protein amino acid N\-linked glycosylation via asparagine | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 480 | | GO:0018196 | peptidyl\-asparagine modification | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 481 | | GO:0006496 | protein amino acid terminal N\-glycosylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 482 | | GO:0006494 | protein amino acid terminal glycosylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 483 | | GO:0034097 | response to cytokine stimulus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 484 | | GO:0031397 | negative regulation of protein ubiquitination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 485 | | GO:0046685 | response to arsenic | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 486 | | GO:0006307 | DNA dealkylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 487 | | GO:0030539 | male genitalia development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 488 | | GO:0048806 | genitalia development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 489 | | GO:0031639 | plasminogen activation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 490 | | GO:0035229 | positive regulation of glutamate\-cysteine ligase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 491 | | GO:0051351 | positive regulation of ligase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 492 | | GO:0051340 | regulation of ligase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 493 | | GO:0035227 | regulation of glutamate\-cysteine ligase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 494 | | GO:0051409 | response to nitrosative stress | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 495 | | GO:0045950 | negative regulation of mitotic recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 496 | | GO:0045910 | negative regulation of DNA recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 497 | | GO:0046641 | positive regulation of alpha\-beta T cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 498 | | GO:0046640 | regulation of alpha\-beta T cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 499 | | GO:0046633 | alpha\-beta T cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 500 | | GO:0000085 | G2 phase of mitotic cell cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 501 | | GO:0051319 | G2 phase | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 502 | | GO:0051782 | negative regulation of cell division | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 503 | | GO:0051302 | regulation of cell division | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 504 | | GO:0051106 | positive regulation of DNA ligation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 505 | | GO:0051105 | regulation of DNA ligation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 506 | | GO:0000183 | chromatin silencing at rDNA | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 507 | | GO:0006348 | chromatin silencing at telomere | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 508 | | GO:0031509 | telomeric heterochromatin formation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 509 | | GO:0006980 | redox signal response | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 510 | | GO:0051775 | response to redox state | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 511 | | GO:0043043 | peptide biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 512 | | GO:0007016 | cytoskeletal anchoring | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 513 | | GO:0002328 | pro\-B cell differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 514 | | GO:0002320 | lymphoid progenitor cell differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 515 | | GO:0002244 | hemopoietic progenitor cell differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 516 | | GO:0033152 | immunoglobulin V(D)J recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 517 | | GO:0033151 | V(D)J recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 518 | | GO:0033153 | T cell receptor V(D)J recombination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 519 | | GO:0002681 | somatic recombination of T cell receptor gene segments | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 520 | | GO:0002568 | somatic diversification of T cell receptor genes | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 521 | | GO:0000389 | nuclear mRNA 3'\-splice site recognition | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 522 | | GO:0007021 | tubulin folding | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 523 | | GO:0015979 | photosynthesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 524 | | GO:0015995 | chlorophyll biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 525 | | GO:0015994 | chlorophyll metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 526 | | GO:0015919 | peroxisomal membrane transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 527 | | GO:0043574 | peroxisomal transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 528 | | GO:0001783 | B cell apoptosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 529 | | GO:0001844 | protein insertion into mitochondrial membrane during induction of apoptosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 530 | | GO:0051204 | protein insertion into mitochondrial membrane | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 531 | | GO:0051205 | protein insertion into membrane | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 532 | | GO:0032594 | protein transport within lipid bilayer | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 533 | | GO:0002358 | B cell homeostatic proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 534 | | GO:0006922 | cleavage of lamin | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 535 | | GO:0006923 | cleavage of cytoskeletal proteins during apoptosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 536 | | GO:0032976 | release of matrix enzymes from mitochondria | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 537 | | GO:0043653 | mitochondrial fragmentation during apoptosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 538 | | GO:0046674 | induction of retinal programmed cell death | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 539 | | GO:0046670 | positive regulation of retinal cell programmed cell death | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 540 | | GO:0060011 | Sertoli cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 541 | | GO:0008542 | visual learning | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 542 | | GO:0007632 | visual behavior | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 543 | | GO:0045749 | negative regulation of S phase of mitotic cell cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 544 | | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 545 | | GO:0050758 | regulation of thymidylate synthase biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 546 | | GO:0050757 | thymidylate synthase biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 547 | | GO:0001766 | membrane raft polarization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 548 | | GO:0031580 | membrane raft distribution | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 549 | | GO:0051665 | membrane raft localization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 550 | | GO:0031579 | membrane raft organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 551 | | GO:0007516 | hemocyte development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 552 | | GO:0042386 | hemocyte differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 553 | | GO:0045176 | apical protein localization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 554 | | GO:0008105 | asymmetric protein localization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 555 | | GO:0006287 | base\-excision repair\, gap\-filling | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 556 | | GO:0006566 | threonine metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 557 | | GO:0048665 | neuron fate specification | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 558 | | GO:0048663 | neuron fate commitment | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 559 | | GO:0050922 | negative regulation of chemotaxis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 560 | | GO:0048521 | negative regulation of behavior | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 561 | | GO:0006564 | L\-serine biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 562 | | GO:0000076 | DNA replication checkpoint | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 563 | | GO:0032297 | negative regulation of DNA replication initiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 564 | | GO:0030174 | regulation of DNA replication initiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 565 | | GO:0009755 | hormone\-mediated signaling | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 566 | | GO:0006587 | serotonin biosynthetic process from tryptophan | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 567 | | GO:0042427 | serotonin biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 568 | | GO:0046219 | indolalkylamine biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 569 | | GO:0006568 | tryptophan metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 570 | | GO:0006586 | indolalkylamine metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 571 | | GO:0042428 | serotonin metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 572 | | GO:0042434 | indole derivative metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 573 | | GO:0042430 | indole and derivative metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 574 | | GO:0042435 | indole derivative biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 575 | | GO:0006583 | melanin biosynthetic process from tyrosine | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 576 | | GO:0042438 | melanin biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 577 | | GO:0006582 | melanin metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 578 | | GO:0006726 | eye pigment biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 579 | | GO:0042441 | eye pigment metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 580 | | GO:0048069 | eye pigmentation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 581 | | GO:0048066 | pigmentation during development | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 582 | | GO:0042840 | D\-glucuronate catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 583 | | GO:0006064 | glucuronate catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 584 | | GO:0042839 | D\-glucuronate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 585 | | GO:0019585 | glucuronate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 586 | | GO:0006063 | uronic acid metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 587 | | GO:0019853 | L\-ascorbic acid biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 588 | | GO:0046185 | aldehyde catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 589 | | GO:0001833 | inner cell mass cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 590 | | GO:0001832 | blastocyst growth | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 591 | | GO:0006978 | DNA damage response\, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 592 | | GO:0042772 | DNA damage response\, signal transduction resulting in transcription | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 593 | | GO:0007141 | male meiosis I | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 594 | | GO:0007140 | male meiosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 595 | | GO:0033595 | response to genistein | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 596 | | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 597 | | GO:0051298 | centrosome duplication | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 598 | | GO:0007098 | centrosome cycle | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 599 | | GO:0051297 | centrosome organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 600 | | GO:0031023 | microtubule organizing center organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 601 | | GO:0008228 | opsonization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 602 | | GO:0018350 | protein amino acid esterification | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 603 | | GO:0030157 | pancreatic juice secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 604 | | GO:0044258 | intestinal lipid catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 605 | | GO:0046514 | ceramide catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 606 | | GO:0006931 | substrate\-bound cell migration\, cell attachment to substrate | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 607 | | GO:0032023 | trypsinogen activation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 608 | | GO:0007030 | Golgi organization and biogenesis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 609 | | GO:0006072 | glycerol\-3\-phosphate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 610 | | GO:0006071 | glycerol metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 611 | | GO:0046168 | glycerol\-3\-phosphate catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 612 | | GO:0019563 | glycerol catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 613 | | GO:0046174 | polyol catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 614 | | GO:0006288 | base\-excision repair\, DNA ligation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 615 | | GO:0051103 | DNA ligation during DNA repair | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 616 | | GO:0017055 | negative regulation of transcriptional preinitiation complex assembly | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 617 | | GO:0045898 | regulation of transcriptional preinitiation complex assembly | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 618 | | GO:0051123 | transcriptional preinitiation complex assembly | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 619 | | GO:0006102 | isocitrate metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 620 | | GO:0045663 | positive regulation of myoblast differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 621 | | GO:0045661 | regulation of myoblast differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 622 | | GO:0043353 | enucleate erythrocyte differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 623 | | GO:0043030 | regulation of macrophage activation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 624 | | GO:0001553 | luteinization | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 625 | | GO:0007538 | primary sex determination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 626 | | GO:0006298 | mismatch repair | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 627 | | GO:0045005 | maintenance of fidelity during DNA\-dependent DNA replication | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 628 | | GO:0030224 | monocyte differentiation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 629 | | GO:0000731 | DNA synthesis during DNA repair | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 630 | | GO:0035308 | negative regulation of protein amino acid dephosphorylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 631 | | GO:0035305 | negative regulation of dephosphorylation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 632 | | GO:0043666 | regulation of phosphoprotein phosphatase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 633 | | GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 634 | | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 635 | | GO:0015904 | tetracycline transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 636 | | GO:0046677 | response to antibiotic | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 637 | | GO:0046676 | negative regulation of insulin secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 638 | | GO:0002792 | negative regulation of peptide secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 639 | | GO:0032024 | positive regulation of insulin secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 640 | | GO:0002793 | positive regulation of peptide secretion | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 641 | | GO:0006559 | L\-phenylalanine catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 642 | | GO:0009074 | aromatic amino acid family catabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 643 | | GO:0006558 | L\-phenylalanine metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 644 | | GO:0006729 | tetrahydrobiopterin biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 645 | | GO:0042559 | pteridine and derivative biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 646 | | GO:0019438 | aromatic compound biosynthetic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 647 | | GO:0042558 | pteridine and derivative metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 648 | | GO:0046146 | tetrahydrobiopterin metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 649 | | GO:0051066 | dihydrobiopterin metabolic process | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 650 | | GO:0065002 | intracellular protein transport across a membrane | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 651 | | GO:0001101 | response to acid | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 652 | | GO:0045056 | transcytosis | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 653 | | GO:0046628 | positive regulation of insulin receptor signaling pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 654 | | GO:0048011 | nerve growth factor receptor signaling pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 655 | | GO:0051385 | response to mineralocorticoid stimulus | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 656 | | GO:0007217 | tachykinin signaling pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 657 | | GO:0007320 | insemination | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 658 | | GO:0007620 | copulation | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 659 | | GO:0032205 | negative regulation of telomere maintenance | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 660 | | GO:0032204 | regulation of telomere maintenance | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 661 | | GO:0042267 | natural killer cell mediated cytotoxicity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 662 | | GO:0001909 | leukocyte mediated cytotoxicity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 663 | | GO:0002228 | natural killer cell mediated immunity | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 664 | | GO:0051225 | spindle assembly | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 665 | | GO:0006122 | mitochondrial electron transport\, ubiquinol to cytochrome c | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 666 | | GO:0007223 | Wnt receptor signaling pathway\, calcium modulating pathway | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 667 | | GO:0030321 | transepithelial chloride transport | 1 | 398 | 0 | 555 | 4.18e-01 | 0.00 | 0.00 | bZero |
| 668 | | GO:0006308 | DNA catabolic process | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 669 | | GO:0007283 | spermatogenesis | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 670 | | GO:0048232 | male gamete generation | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 671 | | GO:0006119 | oxidative phosphorylation | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 672 | | GO:0001836 | release of cytochrome c from mitochondria | 8 | 391 | 7 | 548 | 4.32e-01 | 0.02 | 0.01 | 1.6 |
| 673 | | GO:0045595 | regulation of cell differentiation | 16 | 383 | 29 | 526 | 4.40e-01 | 0.04 | 0.05 | 0.8 |
| 674 | | GO:0044260 | cellular macromolecule metabolic process | 127 | 272 | 191 | 364 | 4.44e-01 | 0.32 | 0.34 | 0.9 |
| 675 | | GO:0022414 | reproductive process | 25 | 374 | 43 | 512 | 4.44e-01 | 0.06 | 0.08 | 0.8 |
| 676 | | GO:0008104 | protein localization | 31 | 368 | 36 | 519 | 4.44e-01 | 0.08 | 0.06 | 1.2 |
| 677 | | GO:0033036 | macromolecule localization | 31 | 368 | 36 | 519 | 4.44e-01 | 0.08 | 0.06 | 1.2 |
| 678 | | GO:0048519 | negative regulation of biological process | 92 | 307 | 141 | 414 | 4.45e-01 | 0.23 | 0.25 | 0.9 |
| 679 | | GO:0001508 | regulation of action potential | 5 | 394 | 11 | 544 | 4.52e-01 | 0.01 | 0.02 | 0.6 |
| 680 | | GO:0016049 | cell growth | 10 | 389 | 20 | 535 | 4.52e-01 | 0.03 | 0.04 | 0.7 |
| 681 | | GO:0002684 | positive regulation of immune system process | 10 | 389 | 20 | 535 | 4.52e-01 | 0.03 | 0.04 | 0.7 |
| 682 | | GO:0009408 | response to heat | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 683 | | GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 684 | | GO:0007281 | germ cell development | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 685 | | GO:0007595 | lactation | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 686 | | GO:0042326 | negative regulation of phosphorylation | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 687 | | GO:0042401 | biogenic amine biosynthetic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 688 | | GO:0042398 | amino acid derivative biosynthetic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 689 | | GO:0007612 | learning | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 690 | | GO:0006094 | gluconeogenesis | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 691 | | GO:0019319 | hexose biosynthetic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 692 | | GO:0046364 | monosaccharide biosynthetic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 693 | | GO:0046165 | alcohol biosynthetic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 694 | | GO:0006733 | oxidoreduction coenzyme metabolic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 695 | | GO:0000082 | G1/S transition of mitotic cell cycle | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 696 | | GO:0000096 | sulfur amino acid metabolic process | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 697 | | GO:0006334 | nucleosome assembly | 4 | 395 | 3 | 552 | 4.61e-01 | 0.01 | 0.01 | 1.9 |
| 698 | | GO:0065007 | biological regulation | 232 | 167 | 336 | 219 | 4.63e-01 | 0.58 | 0.61 | 1.0 |
| 699 | | GO:0048468 | cell development | 120 | 279 | 154 | 401 | 4.68e-01 | 0.30 | 0.28 | 1.1 |
| 700 | | GO:0050794 | regulation of cellular process | 186 | 213 | 272 | 283 | 4.71e-01 | 0.47 | 0.49 | 1.0 |
| 701 | | GO:0006916 | anti\-apoptosis | 36 | 363 | 42 | 513 | 4.73e-01 | 0.09 | 0.08 | 1.2 |
| 702 | | GO:0009893 | positive regulation of metabolic process | 43 | 356 | 69 | 486 | 4.76e-01 | 0.11 | 0.12 | 0.9 |
| 703 | | GO:0050768 | negative regulation of neurogenesis | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 704 | | GO:0034103 | regulation of tissue remodeling | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 705 | | GO:0046850 | regulation of bone remodeling | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 706 | | GO:0030225 | macrophage differentiation | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 707 | | GO:0046467 | membrane lipid biosynthetic process | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 708 | | GO:0015833 | peptide transport | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 709 | | GO:0042692 | muscle cell differentiation | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 710 | | GO:0044236 | multicellular organismal metabolic process | 2 | 397 | 6 | 549 | 4.80e-01 | 0.01 | 0.01 | 0.5 |
| 711 | | GO:0045137 | development of primary sexual characteristics | 9 | 390 | 9 | 546 | 4.81e-01 | 0.02 | 0.02 | 1.4 |
| 712 | | GO:0042542 | response to hydrogen peroxide | 9 | 390 | 9 | 546 | 4.81e-01 | 0.02 | 0.02 | 1.4 |
| 713 | | GO:0046942 | carboxylic acid transport | 9 | 390 | 9 | 546 | 4.81e-01 | 0.02 | 0.02 | 1.4 |
| 714 | | GO:0015849 | organic acid transport | 9 | 390 | 9 | 546 | 4.81e-01 | 0.02 | 0.02 | 1.4 |
| 715 | | GO:0006575 | amino acid derivative metabolic process | 9 | 390 | 9 | 546 | 4.81e-01 | 0.02 | 0.02 | 1.4 |
| 716 | | GO:0045893 | positive regulation of transcription\, DNA\-dependent | 20 | 379 | 35 | 520 | 4.82e-01 | 0.05 | 0.06 | 0.8 |
| 717 | | GO:0051254 | positive regulation of RNA metabolic process | 20 | 379 | 35 | 520 | 4.82e-01 | 0.05 | 0.06 | 0.8 |
| 718 | | GO:0001666 | response to hypoxia | 12 | 387 | 22 | 533 | 4.83e-01 | 0.03 | 0.04 | 0.8 |
| 719 | | GO:0018193 | peptidyl\-amino acid modification | 12 | 387 | 22 | 533 | 4.83e-01 | 0.03 | 0.04 | 0.8 |
| 720 | | GO:0009165 | nucleotide biosynthetic process | 6 | 393 | 13 | 542 | 4.83e-01 | 0.02 | 0.02 | 0.6 |
| 721 | | GO:0048015 | phosphoinositide\-mediated signaling | 6 | 393 | 13 | 542 | 4.83e-01 | 0.02 | 0.02 | 0.6 |
| 722 | | GO:0006366 | transcription from RNA polymerase II promoter | 33 | 366 | 54 | 501 | 4.94e-01 | 0.08 | 0.10 | 0.9 |
| 723 | | GO:0051093 | negative regulation of developmental process | 56 | 343 | 69 | 486 | 4.96e-01 | 0.14 | 0.12 | 1.1 |
| 724 | | GO:0048609 | reproductive process in a multicellular organism | 10 | 389 | 10 | 545 | 4.97e-01 | 0.03 | 0.02 | 1.4 |
| 725 | | GO:0032504 | multicellular organism reproduction | 10 | 389 | 10 | 545 | 4.97e-01 | 0.03 | 0.02 | 1.4 |
| 726 | | GO:0022607 | cellular component assembly | 10 | 389 | 10 | 545 | 4.97e-01 | 0.03 | 0.02 | 1.4 |
| 727 | | GO:0044238 | primary metabolic process | 256 | 143 | 344 | 211 | 4.98e-01 | 0.64 | 0.62 | 1.0 |
| 728 | | GO:0042493 | response to drug | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 729 | | GO:0051716 | cellular response to stimulus | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 730 | | GO:0043491 | protein kinase B signaling cascade | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 731 | | GO:0042168 | heme metabolic process | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 732 | | GO:0040029 | regulation of gene expression\, epigenetic | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 733 | | GO:0009108 | coenzyme biosynthetic process | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 734 | | GO:0009064 | glutamine family amino acid metabolic process | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 735 | | GO:0044272 | sulfur compound biosynthetic process | 5 | 394 | 4 | 551 | 5.03e-01 | 0.01 | 0.01 | 1.7 |
| 736 | | GO:0007010 | cytoskeleton organization and biogenesis | 23 | 376 | 39 | 516 | 5.06e-01 | 0.06 | 0.07 | 0.8 |
| 737 | | GO:0006606 | protein import into nucleus | 7 | 392 | 14 | 541 | 5.06e-01 | 0.02 | 0.03 | 0.7 |
| 738 | | GO:0051170 | nuclear import | 7 | 392 | 14 | 541 | 5.06e-01 | 0.02 | 0.03 | 0.7 |
| 739 | | GO:0022603 | regulation of anatomical structure morphogenesis | 7 | 392 | 14 | 541 | 5.06e-01 | 0.02 | 0.03 | 0.7 |
| 740 | | GO:0030155 | regulation of cell adhesion | 7 | 392 | 14 | 541 | 5.06e-01 | 0.02 | 0.03 | 0.7 |
| 741 | | GO:0009891 | positive regulation of biosynthetic process | 14 | 385 | 25 | 530 | 5.09e-01 | 0.04 | 0.05 | 0.8 |
| 742 | | GO:0043170 | macromolecule metabolic process | 220 | 179 | 294 | 261 | 5.11e-01 | 0.55 | 0.53 | 1.0 |
| 743 | | GO:0043523 | regulation of neuron apoptosis | 11 | 388 | 11 | 544 | 5.13e-01 | 0.03 | 0.02 | 1.4 |
| 744 | | GO:0001775 | cell activation | 25 | 374 | 41 | 514 | 5.21e-01 | 0.06 | 0.07 | 0.8 |
| 745 | | GO:0045860 | positive regulation of protein kinase activity | 15 | 384 | 26 | 529 | 5.22e-01 | 0.04 | 0.05 | 0.8 |
| 746 | | GO:0045935 | positive regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 26 | 373 | 43 | 512 | 5.27e-01 | 0.07 | 0.08 | 0.8 |
| 747 | | GO:0017038 | protein import | 8 | 391 | 15 | 540 | 5.29e-01 | 0.02 | 0.03 | 0.7 |
| 748 | | GO:0031347 | regulation of defense response | 8 | 391 | 15 | 540 | 5.29e-01 | 0.02 | 0.03 | 0.7 |
| 749 | | GO:0018108 | peptidyl\-tyrosine phosphorylation | 8 | 391 | 15 | 540 | 5.29e-01 | 0.02 | 0.03 | 0.7 |
| 750 | | GO:0018212 | peptidyl\-tyrosine modification | 8 | 391 | 15 | 540 | 5.29e-01 | 0.02 | 0.03 | 0.7 |
| 751 | | GO:0030029 | actin filament\-based process | 8 | 391 | 15 | 540 | 5.29e-01 | 0.02 | 0.03 | 0.7 |
| 752 | | GO:0048523 | negative regulation of cellular process | 86 | 313 | 130 | 425 | 5.31e-01 | 0.22 | 0.23 | 0.9 |
| 753 | | GO:0033674 | positive regulation of kinase activity | 16 | 383 | 28 | 527 | 5.32e-01 | 0.04 | 0.05 | 0.8 |
| 754 | | GO:0051347 | positive regulation of transferase activity | 16 | 383 | 28 | 527 | 5.32e-01 | 0.04 | 0.05 | 0.8 |
| 755 | | GO:0040007 | growth | 27 | 372 | 44 | 511 | 5.34e-01 | 0.07 | 0.08 | 0.9 |
| 756 | | GO:0006351 | transcription\, DNA\-dependent | 61 | 338 | 94 | 461 | 5.34e-01 | 0.15 | 0.17 | 0.9 |
| 757 | | GO:0032774 | RNA biosynthetic process | 61 | 338 | 94 | 461 | 5.34e-01 | 0.15 | 0.17 | 0.9 |
| 758 | | GO:0050798 | activated T cell proliferation | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 759 | | GO:0006417 | regulation of translation | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 760 | | GO:0043542 | endothelial cell migration | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 761 | | GO:0006639 | acylglycerol metabolic process | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 762 | | GO:0046486 | glycerolipid metabolic process | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 763 | | GO:0006638 | neutral lipid metabolic process | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 764 | | GO:0050678 | regulation of epithelial cell proliferation | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 765 | | GO:0046883 | regulation of hormone secretion | 3 | 396 | 7 | 548 | 5.34e-01 | 0.01 | 0.01 | 0.6 |
| 766 | | GO:0031325 | positive regulation of cellular metabolic process | 42 | 357 | 66 | 489 | 5.36e-01 | 0.11 | 0.12 | 0.9 |
| 767 | | GO:0008585 | female gonad development | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 768 | | GO:0046545 | development of primary female sexual characteristics | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 769 | | GO:0046660 | female sex differentiation | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 770 | | GO:0006309 | DNA fragmentation during apoptosis | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 771 | | GO:0030262 | apoptotic nuclear changes | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 772 | | GO:0006921 | cell structure disassembly during apoptosis | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 773 | | GO:0022411 | cellular component disassembly | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 774 | | GO:0000079 | regulation of cyclin\-dependent protein kinase activity | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 775 | | GO:0050707 | regulation of cytokine secretion | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 776 | | GO:0050715 | positive regulation of cytokine secretion | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 777 | | GO:0006813 | potassium ion transport | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 778 | | GO:0000075 | cell cycle checkpoint | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 779 | | GO:0007346 | regulation of mitotic cell cycle | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 780 | | GO:0051346 | negative regulation of hydrolase activity | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 781 | | GO:0032535 | regulation of cellular component size | 6 | 393 | 5 | 550 | 5.41e-01 | 0.02 | 0.01 | 1.7 |
| 782 | | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 17 | 382 | 29 | 526 | 5.42e-01 | 0.04 | 0.05 | 0.8 |
| 783 | | GO:0051241 | negative regulation of multicellular organismal process | 9 | 390 | 17 | 538 | 5.47e-01 | 0.02 | 0.03 | 0.7 |
| 784 | | GO:0006897 | endocytosis | 9 | 390 | 17 | 538 | 5.47e-01 | 0.02 | 0.03 | 0.7 |
| 785 | | GO:0010324 | membrane invagination | 9 | 390 | 17 | 538 | 5.47e-01 | 0.02 | 0.03 | 0.7 |
| 786 | | GO:0007264 | small GTPase mediated signal transduction | 9 | 390 | 17 | 538 | 5.47e-01 | 0.02 | 0.03 | 0.7 |
| 787 | | GO:0006801 | superoxide metabolic process | 13 | 386 | 14 | 541 | 5.55e-01 | 0.03 | 0.03 | 1.3 |
| 788 | | GO:0007276 | gamete generation | 13 | 386 | 14 | 541 | 5.55e-01 | 0.03 | 0.03 | 1.3 |
| 789 | | GO:0006913 | nucleocytoplasmic transport | 10 | 389 | 18 | 537 | 5.64e-01 | 0.03 | 0.03 | 0.8 |
| 790 | | GO:0051169 | nuclear transport | 10 | 389 | 18 | 537 | 5.64e-01 | 0.03 | 0.03 | 0.8 |
| 791 | | GO:0009725 | response to hormone stimulus | 14 | 385 | 15 | 540 | 5.67e-01 | 0.04 | 0.03 | 1.3 |
| 792 | | GO:0048534 | hemopoietic or lymphoid organ development | 20 | 379 | 33 | 522 | 5.69e-01 | 0.05 | 0.06 | 0.8 |
| 793 | | GO:0006997 | nuclear organization and biogenesis | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 794 | | GO:0042554 | superoxide release | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 795 | | GO:0042744 | hydrogen peroxide catabolic process | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 796 | | GO:0032844 | regulation of homeostatic process | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 797 | | GO:0050864 | regulation of B cell activation | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 798 | | GO:0006469 | negative regulation of protein kinase activity | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 799 | | GO:0033673 | negative regulation of kinase activity | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 800 | | GO:0051348 | negative regulation of transferase activity | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 801 | | GO:0015813 | L\-glutamate transport | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 802 | | GO:0015800 | acidic amino acid transport | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 803 | | GO:0006865 | amino acid transport | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 804 | | GO:0007088 | regulation of mitosis | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 805 | | GO:0031960 | response to corticosteroid stimulus | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 806 | | GO:0007050 | cell cycle arrest | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 807 | | GO:0007601 | visual perception | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 808 | | GO:0050953 | sensory perception of light stimulus | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 809 | | GO:0030900 | forebrain development | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 810 | | GO:0048732 | gland development | 6 | 393 | 6 | 549 | 5.71e-01 | 0.02 | 0.01 | 1.4 |
| 811 | | GO:0022415 | viral reproductive process | 4 | 395 | 9 | 546 | 5.74e-01 | 0.01 | 0.02 | 0.6 |
| 812 | | GO:0016032 | viral reproduction | 4 | 395 | 9 | 546 | 5.74e-01 | 0.01 | 0.02 | 0.6 |
| 813 | | GO:0019722 | calcium\-mediated signaling | 4 | 395 | 9 | 546 | 5.74e-01 | 0.01 | 0.02 | 0.6 |
| 814 | | GO:0030301 | cholesterol transport | 4 | 395 | 9 | 546 | 5.74e-01 | 0.01 | 0.02 | 0.6 |
| 815 | | GO:0015918 | sterol transport | 4 | 395 | 9 | 546 | 5.74e-01 | 0.01 | 0.02 | 0.6 |
| 816 | | GO:0030595 | leukocyte chemotaxis | 4 | 395 | 9 | 546 | 5.74e-01 | 0.01 | 0.02 | 0.6 |
| 817 | | GO:0043473 | pigmentation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 818 | | GO:0030264 | nuclear fragmentation during apoptosis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 819 | | GO:0006927 | transformed cell apoptosis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 820 | | GO:0042062 | long\-term strengthening of neuromuscular junction | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 821 | | GO:0001906 | cell killing | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 822 | | GO:0043070 | regulation of non\-apoptotic programmed cell death | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 823 | | GO:0016244 | non\-apoptotic programmed cell death | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 824 | | GO:0031116 | positive regulation of microtubule polymerization | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 825 | | GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 826 | | GO:0031113 | regulation of microtubule polymerization | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 827 | | GO:0046785 | microtubule polymerization | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 828 | | GO:0006983 | ER overload response | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 829 | | GO:0048147 | negative regulation of fibroblast proliferation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 830 | | GO:0015671 | oxygen transport | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 831 | | GO:0015669 | gas transport | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 832 | | GO:0009650 | UV protection | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 833 | | GO:0033599 | regulation of mammary gland epithelial cell proliferation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 834 | | GO:0033598 | mammary gland epithelial cell proliferation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 835 | | GO:0006081 | aldehyde metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 836 | | GO:0008634 | negative regulation of survival gene product expression | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 837 | | GO:0006570 | tyrosine metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 838 | | GO:0030890 | positive regulation of B cell proliferation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 839 | | GO:0006626 | protein targeting to mitochondrion | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 840 | | GO:0016050 | vesicle organization and biogenesis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 841 | | GO:0046855 | inositol phosphate dephosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 842 | | GO:0006020 | inositol metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 843 | | GO:0046838 | phosphorylated carbohydrate dephosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 844 | | GO:0046856 | phosphoinositide dephosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 845 | | GO:0046839 | phospholipid dephosphorylation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 846 | | GO:0048738 | cardiac muscle development | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 847 | | GO:0051895 | negative regulation of focal adhesion formation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 848 | | GO:0051893 | regulation of focal adhesion formation | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 849 | | GO:0051898 | negative regulation of protein kinase B signaling cascade | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 850 | | GO:0051896 | regulation of protein kinase B signaling cascade | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 851 | | GO:0030879 | mammary gland development | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 852 | | GO:0046887 | positive regulation of hormone secretion | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 853 | | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 854 | | GO:0007176 | regulation of epidermal growth factor receptor activity | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 855 | | GO:0010469 | regulation of receptor activity | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 856 | | GO:0040009 | regulation of growth rate | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 857 | | GO:0030838 | positive regulation of actin filament polymerization | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 858 | | GO:0006534 | cysteine metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 859 | | GO:0031396 | regulation of protein ubiquitination | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 860 | | GO:0032436 | positive regulation of proteasomal ubiquitin\-dependent protein catabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 861 | | GO:0032434 | regulation of proteasomal ubiquitin\-dependent protein catabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 862 | | GO:0033044 | regulation of chromosome organization and biogenesis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 863 | | GO:0045079 | negative regulation of chemokine biosynthetic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 864 | | GO:0000245 | spliceosome assembly | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 865 | | GO:0007031 | peroxisome organization and biogenesis | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 866 | | GO:0006783 | heme biosynthetic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 867 | | GO:0046521 | sphingoid catabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 868 | | GO:0030325 | adrenal gland development | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 869 | | GO:0042403 | thyroid hormone metabolic process | 2 | 397 | 1 | 554 | 5.75e-01 | 0.01 | 0.00 | 2.8 |
| 870 | | GO:0009117 | nucleotide metabolic process | 14 | 385 | 16 | 539 | 5.79e-01 | 0.04 | 0.03 | 1.2 |
| 871 | | GO:0034404 | nucleobase\, nucleoside and nucleotide biosynthetic process | 14 | 385 | 16 | 539 | 5.79e-01 | 0.04 | 0.03 | 1.2 |
| 872 | | GO:0006753 | nucleoside phosphate metabolic process | 14 | 385 | 16 | 539 | 5.79e-01 | 0.04 | 0.03 | 1.2 |
| 873 | | GO:0009719 | response to endogenous stimulus | 14 | 385 | 16 | 539 | 5.79e-01 | 0.04 | 0.03 | 1.2 |
| 874 | | GO:0008202 | steroid metabolic process | 11 | 388 | 20 | 535 | 5.80e-01 | 0.03 | 0.04 | 0.8 |
| 875 | | GO:0042089 | cytokine biosynthetic process | 11 | 388 | 20 | 535 | 5.80e-01 | 0.03 | 0.04 | 0.8 |
| 876 | | GO:0042107 | cytokine metabolic process | 11 | 388 | 20 | 535 | 5.80e-01 | 0.03 | 0.04 | 0.8 |
| 877 | | GO:0045321 | leukocyte activation | 22 | 377 | 36 | 519 | 5.84e-01 | 0.06 | 0.06 | 0.9 |
| 878 | | GO:0055086 | nucleobase\, nucleoside and nucleotide metabolic process | 15 | 384 | 17 | 538 | 5.88e-01 | 0.04 | 0.03 | 1.2 |
| 879 | | GO:0044271 | nitrogen compound biosynthetic process | 15 | 384 | 17 | 538 | 5.88e-01 | 0.04 | 0.03 | 1.2 |
| 880 | | GO:0019318 | hexose metabolic process | 15 | 384 | 17 | 538 | 5.88e-01 | 0.04 | 0.03 | 1.2 |
| 881 | | GO:0005996 | monosaccharide metabolic process | 15 | 384 | 17 | 538 | 5.88e-01 | 0.04 | 0.03 | 1.2 |
| 882 | | GO:0006355 | regulation of transcription\, DNA\-dependent | 59 | 340 | 90 | 465 | 5.88e-01 | 0.15 | 0.16 | 0.9 |
| 883 | | GO:0050793 | regulation of developmental process | 98 | 301 | 128 | 427 | 5.90e-01 | 0.25 | 0.23 | 1.1 |
| 884 | | GO:0051252 | regulation of RNA metabolic process | 60 | 339 | 91 | 464 | 5.91e-01 | 0.15 | 0.16 | 0.9 |
| 885 | | GO:0001776 | leukocyte homeostasis | 7 | 392 | 7 | 548 | 5.91e-01 | 0.02 | 0.01 | 1.4 |
| 886 | | GO:0042743 | hydrogen peroxide metabolic process | 7 | 392 | 7 | 548 | 5.91e-01 | 0.02 | 0.01 | 1.4 |
| 887 | | GO:0006835 | dicarboxylic acid transport | 7 | 392 | 7 | 548 | 5.91e-01 | 0.02 | 0.01 | 1.4 |
| 888 | | GO:0016051 | carbohydrate biosynthetic process | 7 | 392 | 7 | 548 | 5.91e-01 | 0.02 | 0.01 | 1.4 |
| 889 | | GO:0065004 | protein\-DNA complex assembly | 7 | 392 | 7 | 548 | 5.91e-01 | 0.02 | 0.01 | 1.4 |
| 890 | | GO:0009607 | response to biotic stimulus | 23 | 376 | 38 | 517 | 5.92e-01 | 0.06 | 0.07 | 0.8 |
| 891 | | GO:0008361 | regulation of cell size | 12 | 387 | 21 | 534 | 5.92e-01 | 0.03 | 0.04 | 0.8 |
| 892 | | GO:0050790 | regulation of catalytic activity | 45 | 354 | 56 | 499 | 5.94e-01 | 0.11 | 0.10 | 1.1 |
| 893 | | GO:0009967 | positive regulation of signal transduction | 24 | 375 | 39 | 516 | 5.98e-01 | 0.06 | 0.07 | 0.9 |
| 894 | | GO:0007565 | female pregnancy | 5 | 394 | 10 | 545 | 6.04e-01 | 0.01 | 0.02 | 0.7 |
| 895 | | GO:0019228 | regulation of action potential in neuron | 5 | 394 | 10 | 545 | 6.04e-01 | 0.01 | 0.02 | 0.7 |
| 896 | | GO:0007423 | sensory organ development | 5 | 394 | 10 | 545 | 6.04e-01 | 0.01 | 0.02 | 0.7 |
| 897 | | GO:0002009 | morphogenesis of an epithelium | 5 | 394 | 10 | 545 | 6.04e-01 | 0.01 | 0.02 | 0.7 |
| 898 | | GO:0006953 | acute\-phase response | 5 | 394 | 10 | 545 | 6.04e-01 | 0.01 | 0.02 | 0.7 |
| 899 | | GO:0006928 | cell motility | 42 | 357 | 65 | 490 | 6.04e-01 | 0.11 | 0.12 | 0.9 |
| 900 | | GO:0051674 | localization of cell | 42 | 357 | 65 | 490 | 6.04e-01 | 0.11 | 0.12 | 0.9 |
| 901 | | GO:0006810 | transport | 111 | 288 | 145 | 410 | 6.04e-01 | 0.28 | 0.26 | 1.1 |
| 902 | | GO:0010556 | regulation of macromolecule biosynthetic process | 13 | 386 | 22 | 533 | 6.05e-01 | 0.03 | 0.04 | 0.8 |
| 903 | | GO:0006809 | nitric oxide biosynthetic process | 8 | 391 | 8 | 547 | 6.11e-01 | 0.02 | 0.01 | 1.4 |
| 904 | | GO:0046209 | nitric oxide metabolic process | 8 | 391 | 8 | 547 | 6.11e-01 | 0.02 | 0.01 | 1.4 |
| 905 | | GO:0065009 | regulation of molecular function | 50 | 349 | 63 | 492 | 6.12e-01 | 0.13 | 0.11 | 1.1 |
| 906 | | GO:0042221 | response to chemical stimulus | 77 | 322 | 100 | 455 | 6.14e-01 | 0.19 | 0.18 | 1.1 |
| 907 | | GO:0010468 | regulation of gene expression | 72 | 327 | 108 | 447 | 6.15e-01 | 0.18 | 0.19 | 0.9 |
| 908 | | GO:0016477 | cell migration | 28 | 371 | 44 | 511 | 6.22e-01 | 0.07 | 0.08 | 0.9 |
| 909 | | GO:0000165 | MAPKKK cascade | 15 | 384 | 25 | 530 | 6.26e-01 | 0.04 | 0.05 | 0.8 |
| 910 | | GO:0002521 | leukocyte differentiation | 15 | 384 | 25 | 530 | 6.26e-01 | 0.04 | 0.05 | 0.8 |
| 911 | | GO:0042098 | T cell proliferation | 6 | 393 | 11 | 544 | 6.30e-01 | 0.02 | 0.02 | 0.8 |
| 912 | | GO:0003001 | generation of a signal involved in cell\-cell signaling | 6 | 393 | 11 | 544 | 6.30e-01 | 0.02 | 0.02 | 0.8 |
| 913 | | GO:0030036 | actin cytoskeleton organization and biogenesis | 6 | 393 | 11 | 544 | 6.30e-01 | 0.02 | 0.02 | 0.8 |
| 914 | | GO:0009310 | amine catabolic process | 6 | 393 | 11 | 544 | 6.30e-01 | 0.02 | 0.02 | 0.8 |
| 915 | | GO:0044270 | nitrogen compound catabolic process | 6 | 393 | 11 | 544 | 6.30e-01 | 0.02 | 0.02 | 0.8 |
| 916 | | GO:0048598 | embryonic morphogenesis | 6 | 393 | 12 | 543 | 6.31e-01 | 0.02 | 0.02 | 0.7 |
| 917 | | GO:0009617 | response to bacterium | 6 | 393 | 12 | 543 | 6.31e-01 | 0.02 | 0.02 | 0.7 |
| 918 | | GO:0043062 | extracellular structure organization and biogenesis | 6 | 393 | 12 | 543 | 6.31e-01 | 0.02 | 0.02 | 0.7 |
| 919 | | GO:0050730 | regulation of peptidyl\-tyrosine phosphorylation | 6 | 393 | 12 | 543 | 6.31e-01 | 0.02 | 0.02 | 0.7 |
| 920 | | GO:0043285 | biopolymer catabolic process | 20 | 379 | 24 | 531 | 6.41e-01 | 0.05 | 0.04 | 1.2 |
| 921 | | GO:0006461 | protein complex assembly | 17 | 382 | 28 | 527 | 6.44e-01 | 0.04 | 0.05 | 0.8 |
| 922 | | GO:0007566 | embryo implantation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 923 | | GO:0019430 | removal of superoxide radicals | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 924 | | GO:0051055 | negative regulation of lipid biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 925 | | GO:0045833 | negative regulation of lipid metabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 926 | | GO:0042472 | inner ear morphogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 927 | | GO:0042471 | ear morphogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 928 | | GO:0006446 | regulation of translational initiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 929 | | GO:0006413 | translational initiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 930 | | GO:0043193 | positive regulation of gene\-specific transcription | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 931 | | GO:0032583 | regulation of gene\-specific transcription | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 932 | | GO:0007026 | negative regulation of microtubule depolymerization | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 933 | | GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 934 | | GO:0031114 | regulation of microtubule depolymerization | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 935 | | GO:0007019 | microtubule depolymerization | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 936 | | GO:0051261 | protein depolymerization | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 937 | | GO:0042254 | ribosome biogenesis and assembly | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 938 | | GO:0043535 | regulation of blood vessel endothelial cell migration | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 939 | | GO:0043534 | blood vessel endothelial cell migration | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 940 | | GO:0030195 | negative regulation of blood coagulation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 941 | | GO:0050819 | negative regulation of coagulation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 942 | | GO:0050818 | regulation of coagulation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 943 | | GO:0030193 | regulation of blood coagulation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 944 | | GO:0043691 | reverse cholesterol transport | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 945 | | GO:0019233 | sensory perception of pain | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 946 | | GO:0051924 | regulation of calcium ion transport | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 947 | | GO:0046627 | negative regulation of insulin receptor signaling pathway | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 948 | | GO:0009084 | glutamine family amino acid biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 949 | | GO:0001919 | regulation of receptor recycling | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 950 | | GO:0031645 | negative regulation of neurological system process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 951 | | GO:0045084 | positive regulation of interleukin\-12 biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 952 | | GO:0009395 | phospholipid catabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 953 | | GO:0050851 | antigen receptor\-mediated signaling pathway | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 954 | | GO:0050852 | T cell receptor signaling pathway | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 955 | | GO:0016197 | endosome transport | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 956 | | GO:0043087 | regulation of GTPase activity | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 957 | | GO:0030902 | hindbrain development | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 958 | | GO:0007606 | sensory perception of chemical stimulus | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 959 | | GO:0007628 | adult walking behavior | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 960 | | GO:0030031 | cell projection biogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 961 | | GO:0016573 | histone acetylation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 962 | | GO:0006687 | glycosphingolipid metabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 963 | | GO:0045624 | positive regulation of T\-helper cell differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 964 | | GO:0043372 | positive regulation of CD4\-positive\, alpha beta T cell differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 965 | | GO:0046638 | positive regulation of alpha\-beta T cell differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 966 | | GO:0045582 | positive regulation of T cell differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 967 | | GO:0045621 | positive regulation of lymphocyte differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 968 | | GO:0045064 | T\-helper 2 cell differentiation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 969 | | GO:0003014 | renal system process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 970 | | GO:0001976 | regulation of systemic arterial blood pressure by neurological process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 971 | | GO:0048706 | embryonic skeletal development | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 972 | | GO:0030574 | collagen catabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 973 | | GO:0044254 | multicellular organismal protein catabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 974 | | GO:0044266 | multicellular organismal macromolecule catabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 975 | | GO:0044268 | multicellular organismal protein metabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 976 | | GO:0044259 | multicellular organismal macromolecule metabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 977 | | GO:0032963 | collagen metabolic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 978 | | GO:0044256 | protein digestion | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 979 | | GO:0009581 | detection of external stimulus | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 980 | | GO:0001824 | blastocyst development | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 981 | | GO:0045088 | regulation of innate immune response | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 982 | | GO:0045086 | positive regulation of interleukin\-2 biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 983 | | GO:0045076 | regulation of interleukin\-2 biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 984 | | GO:0007589 | body fluid secretion | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 985 | | GO:0045351 | type I interferon biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 986 | | GO:0032606 | type I interferon production | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 987 | | GO:0000097 | sulfur amino acid biosynthetic process | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 988 | | GO:0022604 | regulation of cell morphogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 989 | | GO:0002027 | regulation of heart rate | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 990 | | GO:0007512 | adult heart development | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 991 | | GO:0030049 | muscle filament sliding | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 992 | | GO:0033275 | actin\-myosin filament sliding | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 993 | | GO:0055010 | ventricular cardiac muscle morphogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 994 | | GO:0055008 | cardiac muscle morphogensis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 995 | | GO:0048644 | muscle morphogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 996 | | GO:0001707 | mesoderm formation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 997 | | GO:0001704 | formation of primary germ layer | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 998 | | GO:0007369 | gastrulation | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 999 | | GO:0048332 | mesoderm morphogenesis | 1 | 398 | 3 | 552 | 6.44e-01 | 0.00 | 0.01 | 0.5 |
| 1000 | | GO:0007548 | sex differentiation | 9 | 390 | 10 | 545 | 6.44e-01 | 0.02 | 0.02 | 1.3 |
| 1001 | | GO:0048872 | homeostasis of number of cells | 9 | 390 | 10 | 545 | 6.44e-01 | 0.02 | 0.02 | 1.3 |
| 1002 | | GO:0015837 | amine transport | 9 | 390 | 10 | 545 | 6.44e-01 | 0.02 | 0.02 | 1.3 |
| 1003 | | GO:0007067 | mitosis | 9 | 390 | 10 | 545 | 6.44e-01 | 0.02 | 0.02 | 1.3 |
| 1004 | | GO:0000087 | M phase of mitotic cell cycle | 9 | 390 | 10 | 545 | 6.44e-01 | 0.02 | 0.02 | 1.3 |
| 1005 | | GO:0051130 | positive regulation of cellular component organization and biogenesis | 9 | 390 | 10 | 545 | 6.44e-01 | 0.02 | 0.02 | 1.3 |
| 1006 | | GO:0046483 | heterocycle metabolic process | 9 | 390 | 10 | 545 | 6.44e-01 | 0.02 | 0.02 | 1.3 |
| 1007 | | GO:0001817 | regulation of cytokine production | 7 | 392 | 13 | 542 | 6.49e-01 | 0.02 | 0.02 | 0.7 |
| 1008 | | GO:0045892 | negative regulation of transcription\, DNA\-dependent | 7 | 392 | 13 | 542 | 6.49e-01 | 0.02 | 0.02 | 0.7 |
| 1009 | | GO:0051253 | negative regulation of RNA metabolic process | 7 | 392 | 13 | 542 | 6.49e-01 | 0.02 | 0.02 | 0.7 |
| 1010 | | GO:0001934 | positive regulation of protein amino acid phosphorylation | 7 | 392 | 13 | 542 | 6.49e-01 | 0.02 | 0.02 | 0.7 |
| 1011 | | GO:0030888 | regulation of B cell proliferation | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1012 | | GO:0045736 | negative regulation of cyclin\-dependent protein kinase activity | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1013 | | GO:0043161 | proteasomal ubiquitin\-dependent protein catabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1014 | | GO:0010498 | proteasomal protein catabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1015 | | GO:0048009 | insulin\-like growth factor receptor signaling pathway | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1016 | | GO:0001937 | negative regulation of endothelial cell proliferation | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1017 | | GO:0045862 | positive regulation of proteolysis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1018 | | GO:0042771 | DNA damage response\, signal transduction by p53 class mediator resulting in induction of apoptosis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1019 | | GO:0030330 | DNA damage response\, signal transduction by p53 class mediator | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1020 | | GO:0001708 | cell fate specification | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1021 | | GO:0001756 | somitogenesis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1022 | | GO:0035282 | segmentation | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1023 | | GO:0042987 | amyloid precursor protein catabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1024 | | GO:0006516 | glycoprotein catabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1025 | | GO:0006265 | DNA topological change | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1026 | | GO:0043154 | negative regulation of caspase activity | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1027 | | GO:0010466 | negative regulation of peptidase activity | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1028 | | GO:0009405 | pathogenesis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1029 | | GO:0050718 | positive regulation of interleukin\-1 beta secretion | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1030 | | GO:0050716 | positive regulation of interleukin\-1 secretion | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1031 | | GO:0050704 | regulation of interleukin\-1 secretion | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1032 | | GO:0050706 | regulation of interleukin\-1 beta secretion | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1033 | | GO:0050702 | interleukin\-1 beta secretion | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1034 | | GO:0050701 | interleukin\-1 secretion | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1035 | | GO:0016458 | gene silencing | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1036 | | GO:0006338 | chromatin remodeling | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1037 | | GO:0006476 | protein amino acid deacetylation | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1038 | | GO:0006769 | nicotinamide metabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1039 | | GO:0019362 | pyridine nucleotide metabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1040 | | GO:0031647 | regulation of protein stability | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1041 | | GO:0007173 | epidermal growth factor receptor signaling pathway | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1042 | | GO:0030833 | regulation of actin filament polymerization | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1043 | | GO:0008064 | regulation of actin polymerization and/or depolymerization | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1044 | | GO:0030832 | regulation of actin filament length | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1045 | | GO:0032956 | regulation of actin cytoskeleton organization and biogenesis | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1046 | | GO:0032970 | regulation of actin filament\-based process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1047 | | GO:0009066 | aspartate family amino acid metabolic process | 3 | 396 | 2 | 553 | 6.55e-01 | 0.01 | 0.00 | 2.1 |
| 1048 | | GO:0048522 | positive regulation of cellular process | 104 | 295 | 153 | 402 | 6.57e-01 | 0.26 | 0.28 | 0.9 |
| 1049 | | GO:0030097 | hemopoiesis | 20 | 379 | 32 | 523 | 6.66e-01 | 0.05 | 0.06 | 0.9 |
| 1050 | | GO:0042327 | positive regulation of phosphorylation | 8 | 391 | 14 | 541 | 6.67e-01 | 0.02 | 0.03 | 0.8 |
| 1051 | | GO:0000302 | response to reactive oxygen species | 11 | 388 | 12 | 543 | 6.70e-01 | 0.03 | 0.02 | 1.3 |
| 1052 | | GO:0048545 | response to steroid hormone stimulus | 11 | 388 | 12 | 543 | 6.70e-01 | 0.03 | 0.02 | 1.3 |
| 1053 | | GO:0006512 | ubiquitin cycle | 11 | 388 | 12 | 543 | 6.70e-01 | 0.03 | 0.02 | 1.3 |
| 1054 | | GO:0002520 | immune system development | 21 | 378 | 34 | 521 | 6.73e-01 | 0.05 | 0.06 | 0.9 |
| 1055 | | GO:0000902 | cell morphogenesis | 21 | 378 | 34 | 521 | 6.73e-01 | 0.05 | 0.06 | 0.9 |
| 1056 | | GO:0032989 | cellular structure morphogenesis | 21 | 378 | 34 | 521 | 6.73e-01 | 0.05 | 0.06 | 0.9 |
| 1057 | | GO:0016070 | RNA metabolic process | 71 | 328 | 105 | 450 | 6.73e-01 | 0.18 | 0.19 | 0.9 |
| 1058 | | GO:0009790 | embryonic development | 21 | 378 | 33 | 522 | 6.73e-01 | 0.05 | 0.06 | 0.9 |
| 1059 | | GO:0051098 | regulation of binding | 11 | 388 | 13 | 542 | 6.81e-01 | 0.03 | 0.02 | 1.2 |
| 1060 | | GO:0014706 | striated muscle development | 9 | 390 | 16 | 539 | 6.82e-01 | 0.02 | 0.03 | 0.8 |
| 1061 | | GO:0002449 | lymphocyte mediated immunity | 9 | 390 | 16 | 539 | 6.82e-01 | 0.02 | 0.03 | 0.8 |
| 1062 | | GO:0006468 | protein amino acid phosphorylation | 48 | 351 | 62 | 493 | 6.82e-01 | 0.12 | 0.11 | 1.1 |
| 1063 | | GO:0032268 | regulation of cellular protein metabolic process | 23 | 376 | 36 | 519 | 6.85e-01 | 0.06 | 0.06 | 0.9 |
| 1064 | | GO:0042391 | regulation of membrane potential | 12 | 387 | 14 | 541 | 6.90e-01 | 0.03 | 0.03 | 1.2 |
| 1065 | | GO:0010033 | response to organic substance | 12 | 387 | 14 | 541 | 6.90e-01 | 0.03 | 0.03 | 1.2 |
| 1066 | | GO:0008285 | negative regulation of cell proliferation | 24 | 375 | 38 | 517 | 6.90e-01 | 0.06 | 0.07 | 0.9 |
| 1067 | | GO:0009892 | negative regulation of metabolic process | 28 | 371 | 35 | 520 | 6.93e-01 | 0.07 | 0.06 | 1.1 |
| 1068 | | GO:0051240 | positive regulation of multicellular organismal process | 10 | 389 | 17 | 538 | 6.95e-01 | 0.03 | 0.03 | 0.8 |
| 1069 | | GO:0042035 | regulation of cytokine biosynthetic process | 10 | 389 | 17 | 538 | 6.95e-01 | 0.03 | 0.03 | 0.8 |
| 1070 | | GO:0016481 | negative regulation of transcription | 10 | 389 | 17 | 538 | 6.95e-01 | 0.03 | 0.03 | 0.8 |
| 1071 | | GO:0002443 | leukocyte mediated immunity | 10 | 389 | 17 | 538 | 6.95e-01 | 0.03 | 0.03 | 0.8 |
| 1072 | | GO:0002262 | myeloid cell homeostasis | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1073 | | GO:0019218 | regulation of steroid metabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1074 | | GO:0042490 | mechanoreceptor differentiation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1075 | | GO:0014070 | response to organic cyclic substance | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1076 | | GO:0043434 | response to peptide hormone stimulus | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1077 | | GO:0043393 | regulation of protein binding | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1078 | | GO:0002437 | inflammatory response to antigenic stimulus | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1079 | | GO:0002367 | cytokine production during immune response | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1080 | | GO:0007528 | neuromuscular junction development | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1081 | | GO:0033554 | cellular response to stress | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1082 | | GO:0018105 | peptidyl\-serine phosphorylation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1083 | | GO:0018209 | peptidyl\-serine modification | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1084 | | GO:0051353 | positive regulation of oxidoreductase activity | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1085 | | GO:0051341 | regulation of oxidoreductase activity | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1086 | | GO:0006787 | porphyrin catabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1087 | | GO:0033015 | tetrapyrrole catabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1088 | | GO:0043392 | negative regulation of DNA binding | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1089 | | GO:0051100 | negative regulation of binding | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1090 | | GO:0001657 | ureteric bud development | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1091 | | GO:0001656 | metanephros development | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1092 | | GO:0007269 | neurotransmitter secretion | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1093 | | GO:0046666 | retinal cell programmed cell death | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1094 | | GO:0030162 | regulation of proteolysis | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1095 | | GO:0007093 | mitotic cell cycle checkpoint | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1096 | | GO:0001933 | negative regulation of protein amino acid phosphorylation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1097 | | GO:0001963 | synaptic transmission\, dopaminergic | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1098 | | GO:0042416 | dopamine biosynthetic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1099 | | GO:0042423 | catecholamine biosynthetic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1100 | | GO:0001542 | ovulation from ovarian follicle | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1101 | | GO:0030728 | ovulation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1102 | | GO:0051604 | protein maturation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1103 | | GO:0042982 | amyloid precursor protein metabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1104 | | GO:0001504 | neurotransmitter uptake | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1105 | | GO:0007618 | mating | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1106 | | GO:0048304 | positive regulation of isotype switching to IgG isotypes | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1107 | | GO:0048302 | regulation of isotype switching to IgG isotypes | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1108 | | GO:0048291 | isotype switching to IgG isotypes | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1109 | | GO:0045110 | intermediate filament bundle assembly | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1110 | | GO:0045109 | intermediate filament organization | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1111 | | GO:0042176 | regulation of protein catabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1112 | | GO:0046579 | positive regulation of Ras protein signal transduction | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1113 | | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1114 | | GO:0048754 | branching morphogenesis of a tube | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1115 | | GO:0030041 | actin filament polymerization | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1116 | | GO:0008154 | actin polymerization and/or depolymerization | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1117 | | GO:0009069 | serine family amino acid metabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1118 | | GO:0031329 | regulation of cellular catabolic process | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1119 | | GO:0045638 | negative regulation of myeloid cell differentiation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1120 | | GO:0030307 | positive regulation of cell growth | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1121 | | GO:0045793 | positive regulation of cell size | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1122 | | GO:0045604 | regulation of epidermal cell differentiation | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1123 | | GO:0045682 | regulation of epidermis development | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1124 | | GO:0042992 | negative regulation of transcription factor import into nucleus | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1125 | | GO:0042308 | negative regulation of protein import into nucleus | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1126 | | GO:0046823 | negative regulation of nucleocytoplasmic transport | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1127 | | GO:0032387 | negative regulation of intracellular transport | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1128 | | GO:0042347 | negative regulation of NF\-kappaB import into nucleus | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1129 | | GO:0051224 | negative regulation of protein transport | 3 | 396 | 3 | 552 | 6.99e-01 | 0.01 | 0.01 | 1.4 |
| 1130 | | GO:0055082 | cellular chemical homeostasis | 30 | 369 | 38 | 517 | 7.03e-01 | 0.08 | 0.07 | 1.1 |
| 1131 | | GO:0045580 | regulation of T cell differentiation | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1132 | | GO:0045619 | regulation of lymphocyte differentiation | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1133 | | GO:0016126 | sterol biosynthetic process | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1134 | | GO:0006164 | purine nucleotide biosynthetic process | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1135 | | GO:0046330 | positive regulation of JNK cascade | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1136 | | GO:0046328 | regulation of JNK cascade | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1137 | | GO:0031649 | heat generation | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1138 | | GO:0007205 | activation of protein kinase C activity | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1139 | | GO:0030238 | male sex determination | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1140 | | GO:0046632 | alpha\-beta T cell differentiation | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1141 | | GO:0007260 | tyrosine phosphorylation of STAT protein | 2 | 397 | 5 | 550 | 7.06e-01 | 0.01 | 0.01 | 0.6 |
| 1142 | | GO:0007242 | intracellular signaling cascade | 98 | 301 | 143 | 412 | 7.06e-01 | 0.25 | 0.26 | 1.0 |
| 1143 | | GO:0006811 | ion transport | 31 | 368 | 39 | 516 | 7.06e-01 | 0.08 | 0.07 | 1.1 |
| 1144 | | GO:0030098 | lymphocyte differentiation | 11 | 388 | 18 | 537 | 7.07e-01 | 0.03 | 0.03 | 0.9 |
| 1145 | | GO:0001932 | regulation of protein amino acid phosphorylation | 11 | 388 | 18 | 537 | 7.07e-01 | 0.03 | 0.03 | 0.9 |
| 1146 | | GO:0006936 | muscle contraction | 11 | 388 | 19 | 536 | 7.07e-01 | 0.03 | 0.03 | 0.8 |
| 1147 | | GO:0003012 | muscle system process | 11 | 388 | 19 | 536 | 7.07e-01 | 0.03 | 0.03 | 0.8 |
| 1148 | | GO:0043123 | positive regulation of I\-kappaB kinase/NF\-kappaB cascade | 11 | 388 | 19 | 536 | 7.07e-01 | 0.03 | 0.03 | 0.8 |
| 1149 | | GO:0043122 | regulation of I\-kappaB kinase/NF\-kappaB cascade | 11 | 388 | 19 | 536 | 7.07e-01 | 0.03 | 0.03 | 0.8 |
| 1150 | | GO:0044267 | cellular protein metabolic process | 123 | 276 | 178 | 377 | 7.24e-01 | 0.31 | 0.32 | 1.0 |
| 1151 | | GO:0006950 | response to stress | 130 | 269 | 174 | 381 | 7.25e-01 | 0.33 | 0.31 | 1.0 |
| 1152 | | GO:0060052 | neurofilament cytoskeleton organization and biogenesis | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1153 | | GO:0006878 | cellular copper ion homeostasis | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1154 | | GO:0055070 | copper ion homeostasis | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1155 | | GO:0007219 | Notch signaling pathway | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1156 | | GO:0002260 | lymphocyte homeostasis | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1157 | | GO:0043029 | T cell homeostasis | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1158 | | GO:0042036 | negative regulation of cytokine biosynthetic process | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1159 | | GO:0045670 | regulation of osteoclast differentiation | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1160 | | GO:0030316 | osteoclast differentiation | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1161 | | GO:0050806 | positive regulation of synaptic transmission | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1162 | | GO:0051971 | positive regulation of transmission of nerve impulse | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1163 | | GO:0051050 | positive regulation of transport | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1164 | | GO:0031668 | cellular response to extracellular stimulus | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1165 | | GO:0042640 | anagen | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1166 | | GO:0048820 | hair follicle maturation | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1167 | | GO:0042417 | dopamine metabolic process | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1168 | | GO:0006584 | catecholamine metabolic process | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1169 | | GO:0006090 | pyruvate metabolic process | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1170 | | GO:0050871 | positive regulation of B cell activation | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1171 | | GO:0051054 | positive regulation of DNA metabolic process | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1172 | | GO:0008088 | axon cargo transport | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1173 | | GO:0051591 | response to cAMP | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1174 | | GO:0007218 | neuropeptide signaling pathway | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1175 | | GO:0009913 | epidermal cell differentiation | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1176 | | GO:0046546 | development of primary male sexual characteristics | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1177 | | GO:0046661 | male sex differentiation | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1178 | | GO:0032507 | maintenance of cellular protein localization | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1179 | | GO:0006941 | striated muscle contraction | 4 | 395 | 4 | 551 | 7.26e-01 | 0.01 | 0.01 | 1.4 |
| 1180 | | GO:0045934 | negative regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 16 | 383 | 19 | 536 | 7.27e-01 | 0.04 | 0.03 | 1.2 |
| 1181 | | GO:0000003 | reproduction | 33 | 366 | 50 | 505 | 7.28e-01 | 0.08 | 0.09 | 0.9 |
| 1182 | | GO:0045449 | regulation of transcription | 68 | 331 | 100 | 455 | 7.31e-01 | 0.17 | 0.18 | 0.9 |
| 1183 | | GO:0006350 | transcription | 70 | 329 | 103 | 452 | 7.33e-01 | 0.18 | 0.19 | 0.9 |
| 1184 | | GO:0051179 | localization | 149 | 250 | 201 | 354 | 7.34e-01 | 0.37 | 0.36 | 1.0 |
| 1185 | | GO:0007249 | I\-kappaB kinase/NF\-kappaB cascade | 14 | 385 | 23 | 532 | 7.34e-01 | 0.04 | 0.04 | 0.8 |
| 1186 | | GO:0032270 | positive regulation of cellular protein metabolic process | 16 | 383 | 20 | 535 | 7.34e-01 | 0.04 | 0.04 | 1.1 |
| 1187 | | GO:0042063 | gliogenesis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1188 | | GO:0006937 | regulation of muscle contraction | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1189 | | GO:0032615 | interleukin\-12 production | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1190 | | GO:0051091 | positive regulation of transcription factor activity | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1191 | | GO:0043388 | positive regulation of DNA binding | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1192 | | GO:0051099 | positive regulation of binding | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1193 | | GO:0007405 | neuroblast proliferation | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1194 | | GO:0002274 | myeloid leukocyte activation | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1195 | | GO:0042632 | cholesterol homeostasis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1196 | | GO:0055092 | sterol homeostasis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1197 | | GO:0055088 | lipid homeostasis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1198 | | GO:0006641 | triacylglycerol metabolic process | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1199 | | GO:0030593 | neutrophil chemotaxis | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1200 | | GO:0008652 | amino acid biosynthetic process | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1201 | | GO:0030518 | steroid hormone receptor signaling pathway | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1202 | | GO:0016331 | morphogenesis of embryonic epithelium | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1203 | | GO:0006693 | prostaglandin metabolic process | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1204 | | GO:0006692 | prostanoid metabolic process | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1205 | | GO:0046466 | membrane lipid catabolic process | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1206 | | GO:0046631 | alpha\-beta T cell activation | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1207 | | GO:0015698 | inorganic anion transport | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1208 | | GO:0007530 | sex determination | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1209 | | GO:0042092 | T\-helper 2 type immune response | 3 | 396 | 6 | 549 | 7.42e-01 | 0.01 | 0.01 | 0.7 |
| 1210 | | GO:0044262 | cellular carbohydrate metabolic process | 18 | 381 | 22 | 533 | 7.44e-01 | 0.05 | 0.04 | 1.1 |
| 1211 | | GO:0016192 | vesicle\-mediated transport | 16 | 383 | 25 | 530 | 7.49e-01 | 0.04 | 0.05 | 0.9 |
| 1212 | | GO:0002682 | regulation of immune system process | 16 | 383 | 26 | 529 | 7.49e-01 | 0.04 | 0.05 | 0.9 |
| 1213 | | GO:0045104 | intermediate filament cytoskeleton organization and biogenesis | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1214 | | GO:0045103 | intermediate filament\-based process | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1215 | | GO:0048730 | epidermis morphogenesis | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1216 | | GO:0001942 | hair follicle development | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1217 | | GO:0022405 | hair cycle process | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1218 | | GO:0042633 | hair cycle | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1219 | | GO:0042303 | molting cycle | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1220 | | GO:0022404 | molting cycle process | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1221 | | GO:0031646 | positive regulation of neurological system process | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1222 | | GO:0051048 | negative regulation of secretion | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1223 | | GO:0016567 | protein ubiquitination | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1224 | | GO:0032446 | protein modification by small protein conjugation | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1225 | | GO:0048167 | regulation of synaptic plasticity | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1226 | | GO:0044403 | symbiosis\, encompassing mutualism through parasitism | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1227 | | GO:0044419 | interspecies interaction between organisms | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1228 | | GO:0051651 | maintenance of cellular localization | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1229 | | GO:0051493 | regulation of cytoskeleton organization and biogenesis | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1230 | | GO:0046777 | protein amino acid autophosphorylation | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1231 | | GO:0016540 | protein autoprocessing | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1232 | | GO:0006984 | ER\-nuclear signaling pathway | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1233 | | GO:0007292 | female gamete generation | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1234 | | GO:0006836 | neurotransmitter transport | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1235 | | GO:0042446 | hormone biosynthetic process | 5 | 394 | 5 | 550 | 7.50e-01 | 0.01 | 0.01 | 1.4 |
| 1236 | | GO:0051649 | establishment of cellular localization | 44 | 355 | 65 | 490 | 7.58e-01 | 0.11 | 0.12 | 0.9 |
| 1237 | | GO:0048666 | neuron development | 18 | 381 | 28 | 527 | 7.61e-01 | 0.05 | 0.05 | 0.9 |
| 1238 | | GO:0001816 | cytokine production | 19 | 380 | 30 | 525 | 7.67e-01 | 0.05 | 0.05 | 0.9 |
| 1239 | | GO:0030030 | cell projection organization and biogenesis | 19 | 380 | 30 | 525 | 7.67e-01 | 0.05 | 0.05 | 0.9 |
| 1240 | | GO:0048858 | cell projection morphogenesis | 19 | 380 | 30 | 525 | 7.67e-01 | 0.05 | 0.05 | 0.9 |
| 1241 | | GO:0032990 | cell part morphogenesis | 19 | 380 | 30 | 525 | 7.67e-01 | 0.05 | 0.05 | 0.9 |
| 1242 | | GO:0016043 | cellular component organization and biogenesis | 107 | 292 | 154 | 401 | 7.69e-01 | 0.27 | 0.28 | 1.0 |
| 1243 | | GO:0042742 | defense response to bacterium | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 1244 | | GO:0030522 | intracellular receptor\-mediated signaling pathway | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 1245 | | GO:0022613 | ribonucleoprotein complex biogenesis and assembly | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 1246 | | GO:0045596 | negative regulation of cell differentiation | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 1247 | | GO:0001654 | eye development | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 1248 | | GO:0009190 | cyclic nucleotide biosynthetic process | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 1249 | | GO:0009063 | amino acid catabolic process | 4 | 395 | 7 | 548 | 7.69e-01 | 0.01 | 0.01 | 0.8 |
| 1250 | | GO:0001819 | positive regulation of cytokine production | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1251 | | GO:0006694 | steroid biosynthetic process | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1252 | | GO:0019079 | viral genome replication | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1253 | | GO:0019058 | viral infectious cycle | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1254 | | GO:0006662 | glycerol ether metabolic process | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1255 | | GO:0006816 | calcium ion transport | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1256 | | GO:0043623 | cellular protein complex assembly | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1257 | | GO:0050731 | positive regulation of peptidyl\-tyrosine phosphorylation | 4 | 395 | 8 | 547 | 7.70e-01 | 0.01 | 0.01 | 0.7 |
| 1258 | | GO:0051234 | establishment of localization | 119 | 280 | 160 | 395 | 7.73e-01 | 0.30 | 0.29 | 1.0 |
| 1259 | | GO:0009889 | regulation of biosynthetic process | 21 | 378 | 32 | 523 | 7.76e-01 | 0.05 | 0.06 | 0.9 |
| 1260 | | GO:0002377 | immunoglobulin production | 6 | 393 | 7 | 548 | 7.82e-01 | 0.02 | 0.01 | 1.2 |
| 1261 | | GO:0048659 | smooth muscle cell proliferation | 6 | 393 | 7 | 548 | 7.82e-01 | 0.02 | 0.01 | 1.2 |
| 1262 | | GO:0045184 | establishment of protein localization | 25 | 374 | 32 | 523 | 7.83e-01 | 0.06 | 0.06 | 1.1 |
| 1263 | | GO:0009057 | macromolecule catabolic process | 26 | 373 | 33 | 522 | 7.86e-01 | 0.07 | 0.06 | 1.1 |
| 1264 | | GO:0007399 | nervous system development | 61 | 338 | 89 | 466 | 7.87e-01 | 0.15 | 0.16 | 1.0 |
| 1265 | | GO:0008366 | axon ensheathment | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 1266 | | GO:0007272 | ensheathment of neurons | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 1267 | | GO:0007254 | JNK cascade | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 1268 | | GO:0031098 | stress\-activated protein kinase signaling pathway | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 1269 | | GO:0030324 | lung development | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 1270 | | GO:0030323 | respiratory tube development | 5 | 394 | 9 | 546 | 7.87e-01 | 0.01 | 0.02 | 0.8 |
| 1271 | | GO:0006066 | alcohol metabolic process | 27 | 372 | 35 | 520 | 7.91e-01 | 0.07 | 0.06 | 1.1 |
| 1272 | | GO:0051246 | regulation of protein metabolic process | 25 | 374 | 38 | 517 | 7.92e-01 | 0.06 | 0.07 | 0.9 |
| 1273 | | GO:0002440 | production of molecular mediator of immune response | 7 | 392 | 8 | 547 | 7.94e-01 | 0.02 | 0.01 | 1.2 |
| 1274 | | GO:0050714 | positive regulation of protein secretion | 7 | 392 | 8 | 547 | 7.94e-01 | 0.02 | 0.01 | 1.2 |
| 1275 | | GO:0042309 | homoiothermy | 7 | 392 | 8 | 547 | 7.94e-01 | 0.02 | 0.01 | 1.2 |
| 1276 | | GO:0050826 | response to freezing | 7 | 392 | 8 | 547 | 7.94e-01 | 0.02 | 0.01 | 1.2 |
| 1277 | | GO:0065003 | macromolecular complex assembly | 26 | 373 | 39 | 516 | 7.96e-01 | 0.07 | 0.07 | 0.9 |
| 1278 | | GO:0006873 | cellular ion homeostasis | 29 | 370 | 37 | 518 | 7.96e-01 | 0.07 | 0.07 | 1.1 |
| 1279 | | GO:0050801 | ion homeostasis | 29 | 370 | 37 | 518 | 7.96e-01 | 0.07 | 0.07 | 1.1 |
| 1280 | | GO:0043284 | biopolymer biosynthetic process | 72 | 327 | 104 | 451 | 8.00e-01 | 0.18 | 0.19 | 1.0 |
| 1281 | | GO:0050900 | leukocyte migration | 6 | 393 | 10 | 545 | 8.03e-01 | 0.02 | 0.02 | 0.8 |
| 1282 | | GO:0002573 | myeloid leukocyte differentiation | 6 | 393 | 10 | 545 | 8.03e-01 | 0.02 | 0.02 | 0.8 |
| 1283 | | GO:0033002 | muscle cell proliferation | 6 | 393 | 10 | 545 | 8.03e-01 | 0.02 | 0.02 | 0.8 |
| 1284 | | GO:0007519 | skeletal muscle development | 6 | 393 | 10 | 545 | 8.03e-01 | 0.02 | 0.02 | 0.8 |
| 1285 | | GO:0032269 | negative regulation of cellular protein metabolic process | 6 | 393 | 10 | 545 | 8.03e-01 | 0.02 | 0.02 | 0.8 |
| 1286 | | GO:0050870 | positive regulation of T cell activation | 6 | 393 | 10 | 545 | 8.03e-01 | 0.02 | 0.02 | 0.8 |
| 1287 | | GO:0019219 | regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 78 | 321 | 105 | 450 | 8.03e-01 | 0.20 | 0.19 | 1.0 |
| 1288 | | GO:0008406 | gonad development | 8 | 391 | 9 | 546 | 8.05e-01 | 0.02 | 0.02 | 1.2 |
| 1289 | | GO:0048608 | reproductive structure development | 8 | 391 | 9 | 546 | 8.05e-01 | 0.02 | 0.02 | 1.2 |
| 1290 | | GO:0050708 | regulation of protein secretion | 8 | 391 | 9 | 546 | 8.05e-01 | 0.02 | 0.02 | 1.2 |
| 1291 | | GO:0006511 | ubiquitin\-dependent protein catabolic process | 8 | 391 | 9 | 546 | 8.05e-01 | 0.02 | 0.02 | 1.2 |
| 1292 | | GO:0019941 | modification\-dependent protein catabolic process | 8 | 391 | 9 | 546 | 8.05e-01 | 0.02 | 0.02 | 1.2 |
| 1293 | | GO:0043632 | modification\-dependent macromolecule catabolic process | 8 | 391 | 9 | 546 | 8.05e-01 | 0.02 | 0.02 | 1.2 |
| 1294 | | GO:0051301 | cell division | 8 | 391 | 9 | 546 | 8.05e-01 | 0.02 | 0.02 | 1.2 |
| 1295 | | GO:0022008 | neurogenesis | 30 | 369 | 45 | 510 | 8.08e-01 | 0.08 | 0.08 | 0.9 |
| 1296 | | GO:0035264 | multicellular organism growth | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 1297 | | GO:0050880 | regulation of blood vessel size | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 1298 | | GO:0035150 | regulation of tube size | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 1299 | | GO:0031328 | positive regulation of cellular biosynthetic process | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 1300 | | GO:0051603 | proteolysis involved in cellular protein catabolic process | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 1301 | | GO:0044257 | cellular protein catabolic process | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 1302 | | GO:0051259 | protein oligomerization | 8 | 391 | 10 | 545 | 8.14e-01 | 0.02 | 0.02 | 1.1 |
| 1303 | | GO:0030217 | T cell differentiation | 7 | 392 | 12 | 543 | 8.15e-01 | 0.02 | 0.02 | 0.8 |
| 1304 | | GO:0045165 | cell fate commitment | 7 | 392 | 12 | 543 | 8.15e-01 | 0.02 | 0.02 | 0.8 |
| 1305 | | GO:0051248 | negative regulation of protein metabolic process | 7 | 392 | 12 | 543 | 8.15e-01 | 0.02 | 0.02 | 0.8 |
| 1306 | | GO:0019752 | carboxylic acid metabolic process | 34 | 365 | 51 | 504 | 8.18e-01 | 0.09 | 0.09 | 0.9 |
| 1307 | | GO:0006082 | organic acid metabolic process | 34 | 365 | 51 | 504 | 8.18e-01 | 0.09 | 0.09 | 0.9 |
| 1308 | | GO:0051051 | negative regulation of transport | 9 | 390 | 11 | 544 | 8.21e-01 | 0.02 | 0.02 | 1.1 |
| 1309 | | GO:0050767 | regulation of neurogenesis | 8 | 391 | 13 | 542 | 8.25e-01 | 0.02 | 0.02 | 0.9 |
| 1310 | | GO:0001701 | in utero embryonic development | 8 | 391 | 13 | 542 | 8.25e-01 | 0.02 | 0.02 | 0.9 |
| 1311 | | GO:0006644 | phospholipid metabolic process | 8 | 391 | 13 | 542 | 8.25e-01 | 0.02 | 0.02 | 0.9 |
| 1312 | | GO:0007605 | sensory perception of sound | 10 | 389 | 12 | 543 | 8.28e-01 | 0.03 | 0.02 | 1.2 |
| 1313 | | GO:0050954 | sensory perception of mechanical stimulus | 10 | 389 | 12 | 543 | 8.28e-01 | 0.03 | 0.02 | 1.2 |
| 1314 | | GO:0006725 | aromatic compound metabolic process | 10 | 389 | 12 | 543 | 8.28e-01 | 0.03 | 0.02 | 1.2 |
| 1315 | | GO:0050863 | regulation of T cell activation | 9 | 390 | 14 | 541 | 8.34e-01 | 0.02 | 0.03 | 0.9 |
| 1316 | | GO:0046651 | lymphocyte proliferation | 9 | 390 | 14 | 541 | 8.34e-01 | 0.02 | 0.03 | 0.9 |
| 1317 | | GO:0032943 | mononuclear cell proliferation | 9 | 390 | 14 | 541 | 8.34e-01 | 0.02 | 0.03 | 0.9 |
| 1318 | | GO:0030099 | myeloid cell differentiation | 9 | 390 | 14 | 541 | 8.34e-01 | 0.02 | 0.03 | 0.9 |
| 1319 | | GO:0001558 | regulation of cell growth | 9 | 390 | 14 | 541 | 8.34e-01 | 0.02 | 0.03 | 0.9 |
| 1320 | | GO:0030705 | cytoskeleton\-dependent intracellular transport | 9 | 390 | 14 | 541 | 8.34e-01 | 0.02 | 0.03 | 0.9 |
| 1321 | | GO:0031326 | regulation of cellular biosynthetic process | 9 | 390 | 15 | 540 | 8.35e-01 | 0.02 | 0.03 | 0.8 |
| 1322 | | GO:0045937 | positive regulation of phosphate metabolic process | 9 | 390 | 15 | 540 | 8.35e-01 | 0.02 | 0.03 | 0.8 |
| 1323 | | GO:0010562 | positive regulation of phosphorus metabolic process | 9 | 390 | 15 | 540 | 8.35e-01 | 0.02 | 0.03 | 0.8 |
| 1324 | | GO:0019538 | protein metabolic process | 134 | 265 | 191 | 364 | 8.36e-01 | 0.34 | 0.34 | 1.0 |
| 1325 | | GO:0043405 | regulation of MAP kinase activity | 11 | 388 | 14 | 541 | 8.40e-01 | 0.03 | 0.03 | 1.1 |
| 1326 | | GO:0015672 | monovalent inorganic cation transport | 11 | 388 | 14 | 541 | 8.40e-01 | 0.03 | 0.03 | 1.1 |
| 1327 | | GO:0042113 | B cell activation | 11 | 388 | 14 | 541 | 8.40e-01 | 0.03 | 0.03 | 1.1 |
| 1328 | | GO:0006605 | protein targeting | 10 | 389 | 16 | 539 | 8.41e-01 | 0.03 | 0.03 | 0.9 |
| 1329 | | GO:0031401 | positive regulation of protein modification process | 10 | 389 | 16 | 539 | 8.41e-01 | 0.03 | 0.03 | 0.9 |
| 1330 | | GO:0032101 | regulation of response to external stimulus | 10 | 389 | 16 | 539 | 8.41e-01 | 0.03 | 0.03 | 0.9 |
| 1331 | | GO:0006325 | establishment and/or maintenance of chromatin architecture | 12 | 387 | 15 | 540 | 8.44e-01 | 0.03 | 0.03 | 1.1 |
| 1332 | | GO:0007017 | microtubule\-based process | 11 | 388 | 17 | 538 | 8.48e-01 | 0.03 | 0.03 | 0.9 |
| 1333 | | GO:0006643 | membrane lipid metabolic process | 11 | 388 | 17 | 538 | 8.48e-01 | 0.03 | 0.03 | 0.9 |
| 1334 | | GO:0035239 | tube morphogenesis | 13 | 386 | 16 | 539 | 8.49e-01 | 0.03 | 0.03 | 1.1 |
| 1335 | | GO:0002694 | regulation of leukocyte activation | 13 | 386 | 17 | 538 | 8.53e-01 | 0.03 | 0.03 | 1.1 |
| 1336 | | GO:0051046 | regulation of secretion | 13 | 386 | 17 | 538 | 8.53e-01 | 0.03 | 0.03 | 1.1 |
| 1337 | | GO:0007409 | axonogenesis | 12 | 387 | 19 | 536 | 8.54e-01 | 0.03 | 0.03 | 0.9 |
| 1338 | | GO:0050865 | regulation of cell activation | 14 | 385 | 18 | 537 | 8.57e-01 | 0.04 | 0.03 | 1.1 |
| 1339 | | GO:0044265 | cellular macromolecule catabolic process | 13 | 386 | 20 | 535 | 8.59e-01 | 0.03 | 0.04 | 0.9 |
| 1340 | | GO:0042110 | T cell activation | 14 | 385 | 22 | 533 | 8.64e-01 | 0.04 | 0.04 | 0.9 |
| 1341 | | GO:0048812 | neurite morphogenesis | 14 | 385 | 22 | 533 | 8.64e-01 | 0.04 | 0.04 | 0.9 |
| 1342 | | GO:0048667 | neuron morphogenesis during differentiation | 14 | 385 | 22 | 533 | 8.64e-01 | 0.04 | 0.04 | 0.9 |
| 1343 | | GO:0000904 | cellular morphogenesis during differentiation | 14 | 385 | 22 | 533 | 8.64e-01 | 0.04 | 0.04 | 0.9 |
| 1344 | | GO:0019220 | regulation of phosphate metabolic process | 16 | 383 | 21 | 534 | 8.67e-01 | 0.04 | 0.04 | 1.1 |
| 1345 | | GO:0051174 | regulation of phosphorus metabolic process | 16 | 383 | 21 | 534 | 8.67e-01 | 0.04 | 0.04 | 1.1 |
| 1346 | | GO:0051247 | positive regulation of protein metabolic process | 16 | 383 | 21 | 534 | 8.67e-01 | 0.04 | 0.04 | 1.1 |
| 1347 | | GO:0015031 | protein transport | 18 | 381 | 23 | 532 | 8.72e-01 | 0.05 | 0.04 | 1.1 |
| 1348 | | GO:0035295 | tube development | 17 | 382 | 26 | 529 | 8.75e-01 | 0.04 | 0.05 | 0.9 |
| 1349 | | GO:0016044 | membrane organization and biogenesis | 19 | 380 | 25 | 530 | 8.77e-01 | 0.05 | 0.05 | 1.1 |
| 1350 | | GO:0031175 | neurite development | 18 | 381 | 27 | 528 | 8.78e-01 | 0.05 | 0.05 | 0.9 |
| 1351 | | GO:0031323 | regulation of cellular metabolic process | 103 | 296 | 146 | 409 | 8.81e-01 | 0.26 | 0.26 | 1.0 |
| 1352 | | GO:0019222 | regulation of metabolic process | 105 | 294 | 149 | 406 | 8.82e-01 | 0.26 | 0.27 | 1.0 |
| 1353 | | GO:0046649 | lymphocyte activation | 20 | 379 | 30 | 525 | 8.83e-01 | 0.05 | 0.05 | 0.9 |
| 1354 | | GO:0040008 | regulation of growth | 20 | 379 | 30 | 525 | 8.83e-01 | 0.05 | 0.05 | 0.9 |
| 1355 | | GO:0030182 | neuron differentiation | 22 | 377 | 29 | 526 | 8.85e-01 | 0.06 | 0.05 | 1.1 |
| 1356 | | GO:0051338 | regulation of transferase activity | 24 | 375 | 35 | 520 | 8.92e-01 | 0.06 | 0.06 | 1.0 |
| 1357 | | GO:0043549 | regulation of kinase activity | 24 | 375 | 35 | 520 | 8.92e-01 | 0.06 | 0.06 | 1.0 |
| 1358 | | GO:0031324 | negative regulation of cellular metabolic process | 26 | 373 | 34 | 521 | 8.93e-01 | 0.07 | 0.06 | 1.1 |
| 1359 | | GO:0043085 | positive regulation of catalytic activity | 33 | 366 | 44 | 511 | 9.04e-01 | 0.08 | 0.08 | 1.0 |
| 1360 | | GO:0046907 | intracellular transport | 34 | 365 | 46 | 509 | 9.06e-01 | 0.09 | 0.08 | 1.0 |
| 1361 | | GO:0007243 | protein kinase cascade | 41 | 358 | 59 | 496 | 9.15e-01 | 0.10 | 0.11 | 1.0 |
| 1362 | | GO:0044248 | cellular catabolic process | 46 | 353 | 62 | 493 | 9.18e-01 | 0.12 | 0.11 | 1.0 |
| 1363 | | GO:0051641 | cellular localization | 49 | 350 | 67 | 488 | 9.20e-01 | 0.12 | 0.12 | 1.0 |
| 1364 | | GO:0042592 | homeostatic process | 60 | 339 | 82 | 473 | 9.27e-01 | 0.15 | 0.15 | 1.0 |
| 1365 | | GO:0009058 | biosynthetic process | 131 | 268 | 184 | 371 | 9.44e-01 | 0.33 | 0.33 | 1.0 |
| 1366 | | GO:0000187 | activation of MAPK activity | 8 | 391 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1367 | | GO:0043406 | positive regulation of MAP kinase activity | 9 | 390 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1368 | | GO:0045859 | regulation of protein kinase activity | 23 | 376 | 33 | 522 | 1.00e+00 | 0.06 | 0.06 | 1.0 |
| 1369 | | GO:0000303 | response to superoxide | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1370 | | GO:0000305 | response to oxygen radical | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1371 | | GO:0001541 | ovarian follicle development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1372 | | GO:0003006 | reproductive developmental process | 10 | 389 | 13 | 542 | 1.00e+00 | 0.03 | 0.02 | 1.1 |
| 1373 | | GO:0022602 | ovulation cycle process | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1374 | | GO:0042698 | ovulation cycle | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1375 | | GO:0048511 | rhythmic process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1376 | | GO:0001890 | placenta development | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1377 | | GO:0001895 | retina homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1378 | | GO:0001894 | tissue homeostasis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1379 | | GO:0048871 | multicellular organismal homeostasis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1380 | | GO:0065008 | regulation of biological quality | 105 | 294 | 147 | 408 | 1.00e+00 | 0.26 | 0.26 | 1.0 |
| 1381 | | GO:0048869 | cellular developmental process | 139 | 260 | 194 | 361 | 1.00e+00 | 0.35 | 0.35 | 1.0 |
| 1382 | | GO:0030154 | cell differentiation | 139 | 260 | 194 | 361 | 1.00e+00 | 0.35 | 0.35 | 1.0 |
| 1383 | | GO:0009056 | catabolic process | 53 | 346 | 73 | 482 | 1.00e+00 | 0.13 | 0.13 | 1.0 |
| 1384 | | GO:0030005 | cellular di\-\, tri\-valent inorganic cation homeostasis | 17 | 382 | 24 | 531 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1385 | | GO:0030003 | cellular cation homeostasis | 20 | 379 | 29 | 526 | 1.00e+00 | 0.05 | 0.05 | 1.0 |
| 1386 | | GO:0048878 | chemical homeostasis | 32 | 367 | 45 | 510 | 1.00e+00 | 0.08 | 0.08 | 1.0 |
| 1387 | | GO:0055080 | cation homeostasis | 20 | 379 | 29 | 526 | 1.00e+00 | 0.05 | 0.05 | 1.0 |
| 1388 | | GO:0055066 | di\-\, tri\-valent inorganic cation homeostasis | 17 | 382 | 24 | 531 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1389 | | GO:0019953 | sexual reproduction | 15 | 384 | 20 | 535 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1390 | | GO:0007600 | sensory perception | 17 | 382 | 25 | 530 | 1.00e+00 | 0.04 | 0.05 | 0.9 |
| 1391 | | GO:0003008 | system process | 79 | 320 | 111 | 444 | 1.00e+00 | 0.20 | 0.20 | 1.0 |
| 1392 | | GO:0009266 | response to temperature stimulus | 12 | 387 | 16 | 539 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1393 | | GO:0031667 | response to nutrient levels | 9 | 390 | 13 | 542 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1394 | | GO:0009991 | response to extracellular stimulus | 10 | 389 | 13 | 542 | 1.00e+00 | 0.03 | 0.02 | 1.1 |
| 1395 | | GO:0032287 | myelin maintenance in the peripheral nervous system | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1396 | | GO:0022011 | myelination in the peripheral nervous system | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1397 | | GO:0032292 | ensheathment of axons in the peripheral nervous system | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1398 | | GO:0043217 | myelin maintenance | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1399 | | GO:0042552 | myelination | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1400 | | GO:0014044 | Schwann cell development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1401 | | GO:0021782 | glial cell development | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1402 | | GO:0010001 | glial cell differentiation | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1403 | | GO:0014037 | Schwann cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1404 | | GO:0007009 | plasma membrane organization and biogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1405 | | GO:0007422 | peripheral nervous system development | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1406 | | GO:0033081 | regulation of T cell differentiation in the thymus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1407 | | GO:0051249 | regulation of lymphocyte activation | 11 | 388 | 16 | 539 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1408 | | GO:0033077 | T cell differentiation in the thymus | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1409 | | GO:0040014 | regulation of multicellular organism growth | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1410 | | GO:0051094 | positive regulation of developmental process | 45 | 354 | 63 | 492 | 1.00e+00 | 0.11 | 0.11 | 1.0 |
| 1411 | | GO:0045471 | response to ethanol | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1412 | | GO:0045541 | negative regulation of cholesterol biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1413 | | GO:0045939 | negative regulation of steroid metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1414 | | GO:0009890 | negative regulation of biosynthetic process | 6 | 393 | 9 | 546 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1415 | | GO:0045540 | regulation of cholesterol biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1416 | | GO:0050810 | regulation of steroid biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1417 | | GO:0046890 | regulation of lipid biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1418 | | GO:0019216 | regulation of lipid metabolic process | 6 | 393 | 9 | 546 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1419 | | GO:0006695 | cholesterol biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1420 | | GO:0046620 | regulation of organ growth | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1421 | | GO:0035265 | organ growth | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1422 | | GO:0046688 | response to copper ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1423 | | GO:0010038 | response to metal ion | 7 | 392 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1424 | | GO:0010035 | response to inorganic substance | 9 | 390 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1425 | | GO:0046716 | muscle maintenance | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1426 | | GO:0048538 | thymus development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1427 | | GO:0048678 | response to axon injury | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1428 | | GO:0050665 | hydrogen peroxide biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1429 | | GO:0060047 | heart contraction | 10 | 389 | 14 | 541 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1430 | | GO:0003015 | heart process | 10 | 389 | 14 | 541 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1431 | | GO:0060087 | relaxation of vascular smooth muscle | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1432 | | GO:0045986 | negative regulation of smooth muscle contraction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1433 | | GO:0045932 | negative regulation of muscle contraction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1434 | | GO:0006940 | regulation of smooth muscle contraction | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1435 | | GO:0042311 | vasodilation | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1436 | | GO:0003018 | vascular process in circulatory system | 9 | 390 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1437 | | GO:0006939 | smooth muscle contraction | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1438 | | GO:0060088 | auditory receptor cell stereocilium organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1439 | | GO:0002093 | auditory receptor cell morphogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1440 | | GO:0060117 | auditory receptor cell development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1441 | | GO:0060119 | inner ear receptor cell development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1442 | | GO:0060122 | inner ear receptor stereocilium organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1443 | | GO:0042491 | auditory receptor cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1444 | | GO:0060113 | inner ear receptor cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1445 | | GO:0048839 | inner ear development | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1446 | | GO:0043583 | ear development | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1447 | | GO:0015986 | ATP synthesis coupled proton transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1448 | | GO:0006754 | ATP biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1449 | | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1450 | | GO:0009145 | purine nucleoside triphosphate biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1451 | | GO:0009142 | nucleoside triphosphate biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1452 | | GO:0009141 | nucleoside triphosphate metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1453 | | GO:0009201 | ribonucleoside triphosphate biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1454 | | GO:0009144 | purine nucleoside triphosphate metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1455 | | GO:0046034 | ATP metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1456 | | GO:0009205 | purine ribonucleoside triphosphate metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1457 | | GO:0009199 | ribonucleoside triphosphate metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1458 | | GO:0009152 | purine ribonucleotide biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1459 | | GO:0009260 | ribonucleotide biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1460 | | GO:0006163 | purine nucleotide metabolic process | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1461 | | GO:0009150 | purine ribonucleotide metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1462 | | GO:0009259 | ribonucleotide metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1463 | | GO:0015985 | energy coupled proton transport\, down electrochemical gradient | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1464 | | GO:0015992 | proton transport | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1465 | | GO:0006818 | hydrogen transport | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1466 | | GO:0050905 | neuromuscular process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1467 | | GO:0001935 | endothelial cell proliferation | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1468 | | GO:0001974 | blood vessel remodeling | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1469 | | GO:0007199 | G\-protein signaling\, coupled to cGMP nucleotide second messenger | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1470 | | GO:0019934 | cGMP\-mediated signaling | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1471 | | GO:0048384 | retinoic acid receptor signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1472 | | GO:0050829 | defense response to Gram\-negative bacterium | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1473 | | GO:0001315 | age\-dependent response to reactive oxygen species | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1474 | | GO:0010467 | gene expression | 88 | 311 | 123 | 432 | 1.00e+00 | 0.22 | 0.22 | 1.0 |
| 1475 | | GO:0007584 | response to nutrient | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1476 | | GO:0010039 | response to iron ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1477 | | GO:0031000 | response to caffeine | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1478 | | GO:0043279 | response to alkaloid | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1479 | | GO:0014074 | response to purine | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1480 | | GO:0031069 | hair follicle morphogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1481 | | GO:0048729 | tissue morphogenesis | 6 | 393 | 8 | 547 | 1.00e+00 | 0.02 | 0.01 | 1.0 |
| 1482 | | GO:0008544 | epidermis development | 11 | 388 | 15 | 540 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1483 | | GO:0007398 | ectoderm development | 12 | 387 | 16 | 539 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1484 | | GO:0032848 | negative regulation of cellular pH reduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1485 | | GO:0032845 | negative regulation of homeostatic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1486 | | GO:0032847 | regulation of cellular pH reduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1487 | | GO:0051452 | intracellular pH reduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1488 | | GO:0051453 | regulation of intracellular pH | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1489 | | GO:0030641 | regulation of cellular pH | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1490 | | GO:0030004 | cellular monovalent inorganic cation homeostasis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1491 | | GO:0055067 | monovalent inorganic cation homeostasis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1492 | | GO:0045851 | pH reduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1493 | | GO:0006885 | regulation of pH | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1494 | | GO:0035094 | response to nicotine | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1495 | | GO:0043627 | response to estrogen stimulus | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1496 | | GO:0045069 | regulation of viral genome replication | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1497 | | GO:0050792 | regulation of viral reproduction | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1498 | | GO:0051607 | defense response to virus | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1499 | | GO:0002252 | immune effector process | 14 | 385 | 20 | 535 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1500 | | GO:0051902 | negative regulation of mitochondrial depolarization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1501 | | GO:0045822 | negative regulation of heart contraction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1502 | | GO:0001782 | B cell homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1503 | | GO:0008625 | induction of apoptosis via death domain receptors | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1504 | | GO:0008624 | induction of apoptosis by extracellular signals | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1505 | | GO:0008631 | induction of apoptosis by oxidative stress | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1506 | | GO:0030216 | keratinocyte differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1507 | | GO:0030889 | negative regulation of B cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1508 | | GO:0050869 | negative regulation of B cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1509 | | GO:0051250 | negative regulation of lymphocyte activation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1510 | | GO:0002695 | negative regulation of leukocyte activation | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1511 | | GO:0050866 | negative regulation of cell activation | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1512 | | GO:0050672 | negative regulation of lymphocyte proliferation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1513 | | GO:0032945 | negative regulation of mononuclear cell proliferation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1514 | | GO:0002683 | negative regulation of immune system process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1515 | | GO:0050670 | regulation of lymphocyte proliferation | 6 | 393 | 8 | 547 | 1.00e+00 | 0.02 | 0.01 | 1.0 |
| 1516 | | GO:0032944 | regulation of mononuclear cell proliferation | 6 | 393 | 8 | 547 | 1.00e+00 | 0.02 | 0.01 | 1.0 |
| 1517 | | GO:0046007 | negative regulation of activated T cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1518 | | GO:0042130 | negative regulation of T cell proliferation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1519 | | GO:0050868 | negative regulation of T cell activation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1520 | | GO:0042129 | regulation of T cell proliferation | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1521 | | GO:0046006 | regulation of activated T cell proliferation | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1522 | | GO:0045083 | negative regulation of interleukin\-12 biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1523 | | GO:0010558 | negative regulation of macromolecule biosynthetic process | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1524 | | GO:0045075 | regulation of interleukin\-12 biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1525 | | GO:0042090 | interleukin\-12 biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1526 | | GO:0006886 | intracellular protein transport | 15 | 384 | 20 | 535 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1527 | | GO:0031399 | regulation of protein modification process | 15 | 384 | 21 | 534 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1528 | | GO:0042325 | regulation of phosphorylation | 15 | 384 | 20 | 535 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1529 | | GO:0002037 | negative regulation of L\-glutamate transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1530 | | GO:0051956 | negative regulation of amino acid transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1531 | | GO:0051953 | negative regulation of amine transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1532 | | GO:0032891 | negative regulation of organic acid transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1533 | | GO:0051049 | regulation of transport | 16 | 383 | 23 | 532 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1534 | | GO:0032879 | regulation of localization | 19 | 380 | 27 | 528 | 1.00e+00 | 0.05 | 0.05 | 1.0 |
| 1535 | | GO:0051952 | regulation of amine transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1536 | | GO:0051955 | regulation of amino acid transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1537 | | GO:0002036 | regulation of L\-glutamate transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1538 | | GO:0032890 | regulation of organic acid transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1539 | | GO:0009612 | response to mechanical stimulus | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1540 | | GO:0043525 | positive regulation of neuron apoptosis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1541 | | GO:0002761 | regulation of myeloid leukocyte differentiation | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1542 | | GO:0045637 | regulation of myeloid cell differentiation | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1543 | | GO:0045840 | positive regulation of mitosis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1544 | | GO:0045787 | positive regulation of cell cycle | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1545 | | GO:0045994 | positive regulation of translational initiation by iron | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1546 | | GO:0045948 | positive regulation of translational initiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1547 | | GO:0045727 | positive regulation of translation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1548 | | GO:0051128 | regulation of cellular component organization and biogenesis | 18 | 381 | 25 | 530 | 1.00e+00 | 0.05 | 0.05 | 1.0 |
| 1549 | | GO:0006447 | regulation of translational initiation by iron | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1550 | | GO:0022618 | protein\-RNA complex assembly | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1551 | | GO:0006412 | translation | 8 | 391 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1552 | | GO:0046325 | negative regulation of glucose import | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1553 | | GO:0046324 | regulation of glucose import | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1554 | | GO:0046323 | glucose import | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1555 | | GO:0015758 | glucose transport | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1556 | | GO:0008645 | hexose transport | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1557 | | GO:0015749 | monosaccharide transport | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1558 | | GO:0008643 | carbohydrate transport | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1559 | | GO:0051969 | regulation of transmission of nerve impulse | 9 | 390 | 13 | 542 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1560 | | GO:0050804 | regulation of synaptic transmission | 9 | 390 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1561 | | GO:0031644 | regulation of neurological system process | 11 | 388 | 16 | 539 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1562 | | GO:0051023 | regulation of immunoglobulin secretion | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1563 | | GO:0048305 | immunoglobulin secretion | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1564 | | GO:0009306 | protein secretion | 9 | 390 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1565 | | GO:0032940 | secretion by cell | 13 | 386 | 19 | 536 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1566 | | GO:0051092 | activation of NF\-kappaB transcription factor | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1567 | | GO:0051090 | regulation of transcription factor activity | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1568 | | GO:0051101 | regulation of DNA binding | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1569 | | GO:0051222 | positive regulation of protein transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1570 | | GO:0051223 | regulation of protein transport | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1571 | | GO:0002439 | chronic inflammatory response to antigenic stimulus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1572 | | GO:0002544 | chronic inflammatory response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1573 | | GO:0050901 | leukocyte tethering or rolling | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1574 | | GO:0002740 | negative regulation of cytokine secretion during immune response | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1575 | | GO:0050710 | negative regulation of cytokine secretion | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1576 | | GO:0050709 | negative regulation of protein secretion | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1577 | | GO:0002739 | regulation of cytokine secretion during immune response | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1578 | | GO:0002374 | cytokine secretion during immune response | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1579 | | GO:0032715 | negative regulation of interleukin\-6 production | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1580 | | GO:0001818 | negative regulation of cytokine production | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1581 | | GO:0032675 | regulation of interleukin\-6 production | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1582 | | GO:0032635 | interleukin\-6 production | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1583 | | GO:0045071 | negative regulation of viral genome replication | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1584 | | GO:0048525 | negative regulation of viral reproduction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1585 | | GO:0042346 | positive regulation of NF\-kappaB import into nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1586 | | GO:0042993 | positive regulation of transcription factor import into nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1587 | | GO:0042307 | positive regulation of protein import into nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1588 | | GO:0046824 | positive regulation of nucleocytoplasmic transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1589 | | GO:0032388 | positive regulation of intracellular transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1590 | | GO:0032386 | regulation of intracellular transport | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1591 | | GO:0042306 | regulation of protein import into nucleus | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1592 | | GO:0033157 | regulation of intracellular protein transport | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1593 | | GO:0042990 | regulation of transcription factor import into nucleus | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1594 | | GO:0042345 | regulation of NF\-kappaB import into nucleus | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1595 | | GO:0046822 | regulation of nucleocytoplasmic transport | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1596 | | GO:0042348 | NF\-kappaB import into nucleus | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1597 | | GO:0042991 | transcription factor import into nucleus | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1598 | | GO:0045080 | positive regulation of chemokine biosynthetic process | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1599 | | GO:0045073 | regulation of chemokine biosynthetic process | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1600 | | GO:0042033 | chemokine biosynthetic process | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1601 | | GO:0050755 | chemokine metabolic process | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1602 | | GO:0032602 | chemokine production | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1603 | | GO:0032722 | positive regulation of chemokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1604 | | GO:0032642 | regulation of chemokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1605 | | GO:0048661 | positive regulation of smooth muscle cell proliferation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1606 | | GO:0048660 | regulation of smooth muscle cell proliferation | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1607 | | GO:0032800 | receptor biosynthetic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1608 | | GO:0043112 | receptor metabolic process | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1609 | | GO:0051384 | response to glucocorticoid stimulus | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1610 | | GO:0033209 | tumor necrosis factor\-mediated signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1611 | | GO:0007411 | axon guidance | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1612 | | GO:0048699 | generation of neurons | 28 | 371 | 40 | 515 | 1.00e+00 | 0.07 | 0.07 | 1.0 |
| 1613 | | GO:0030433 | ER\-associated protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1614 | | GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1615 | | GO:0030163 | protein catabolic process | 12 | 387 | 16 | 539 | 1.00e+00 | 0.03 | 0.03 | 1.0 |
| 1616 | | GO:0008582 | regulation of synaptic growth at neuromuscular junction | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1617 | | GO:0051963 | regulation of synaptogenesis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1618 | | GO:0050807 | regulation of synapse organization and biogenesis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1619 | | GO:0048638 | regulation of developmental growth | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1620 | | GO:0050803 | regulation of synapse structure and activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1621 | | GO:0051124 | synaptic growth at neuromuscular junction | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1622 | | GO:0048741 | skeletal muscle fiber development | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1623 | | GO:0048747 | muscle fiber development | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1624 | | GO:0050808 | synapse organization and biogenesis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1625 | | GO:0007416 | synaptogenesis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1626 | | GO:0048589 | developmental growth | 8 | 391 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1627 | | GO:0009267 | cellular response to starvation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1628 | | GO:0031669 | cellular response to nutrient levels | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1629 | | GO:0042594 | response to starvation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1630 | | GO:0019836 | hemolysis by symbiont of host red blood cells | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1631 | | GO:0001897 | cytolysis by symbiont of host cells | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1632 | | GO:0051801 | cytolysis of cells in other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1633 | | GO:0051715 | cytolysis of cells of another organism | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1634 | | GO:0031640 | killing of cells of another organism | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1635 | | GO:0052331 | hemolysis by organism of red blood cells in other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1636 | | GO:0051883 | killing of cells in other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1637 | | GO:0001907 | killing by symbiont of host cells | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1638 | | GO:0044004 | disruption by symbiont of host cells | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1639 | | GO:0044003 | modification by symbiont of host morphology or physiology | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1640 | | GO:0051701 | interaction with host | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1641 | | GO:0052025 | modification by symbiont of host cell membrane | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1642 | | GO:0052043 | modification by symbiont of host cellular component | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1643 | | GO:0052111 | modification by symbiont of host structure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1644 | | GO:0051818 | disruption of cells of other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1645 | | GO:0051817 | modification of morphology or physiology of other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1646 | | GO:0052185 | modification of structure of other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1647 | | GO:0052332 | modification by organism of cell membrane in other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1648 | | GO:0052188 | modification of cellular component in other organism during symbiotic interaction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1649 | | GO:0043072 | negative regulation of non\-apoptotic programmed cell death | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1650 | | GO:0046689 | response to mercury ion | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1651 | | GO:0051659 | maintenance of mitochondrion localization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1652 | | GO:0051235 | maintenance of localization | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1653 | | GO:0051657 | maintenance of organelle localization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1654 | | GO:0051646 | mitochondrion localization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1655 | | GO:0019858 | cytosine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1656 | | GO:0006206 | pyrimidine base metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1657 | | GO:0009112 | nucleobase metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1658 | | GO:0031663 | lipopolysaccharide\-mediated signaling pathway | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1659 | | GO:0032496 | response to lipopolysaccharide | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1660 | | GO:0002237 | response to molecule of bacterial origin | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1661 | | GO:0043330 | response to exogenous dsRNA | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1662 | | GO:0043331 | response to dsRNA | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1663 | | GO:0000226 | microtubule cytoskeleton organization and biogenesis | 7 | 392 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1664 | | GO:0031110 | regulation of microtubule polymerization or depolymerization | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1665 | | GO:0032886 | regulation of microtubule\-based process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1666 | | GO:0031109 | microtubule polymerization or depolymerization | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1667 | | GO:0045773 | positive regulation of axon extension | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1668 | | GO:0050772 | positive regulation of axonogenesis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1669 | | GO:0050769 | positive regulation of neurogenesis | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1670 | | GO:0050770 | regulation of axonogenesis | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1671 | | GO:0030516 | regulation of axon extension | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1672 | | GO:0048675 | axon extension | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1673 | | GO:0006101 | citrate metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1674 | | GO:0005977 | glycogen metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1675 | | GO:0006073 | glucan metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1676 | | GO:0044264 | cellular polysaccharide metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1677 | | GO:0006112 | energy reserve metabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1678 | | GO:0005976 | polysaccharide metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1679 | | GO:0005978 | glycogen biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1680 | | GO:0009250 | glucan biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1681 | | GO:0033692 | cellular polysaccharide biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1682 | | GO:0000271 | polysaccharide biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1683 | | GO:0006924 | activated T cell apoptosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1684 | | GO:0008286 | insulin receptor signaling pathway | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1685 | | GO:0040018 | positive regulation of multicellular organism growth | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1686 | | GO:0045927 | positive regulation of growth | 8 | 391 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1687 | | GO:0021700 | developmental maturation | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1688 | | GO:0045884 | regulation of survival gene product expression | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1689 | | GO:0015680 | intracellular copper ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1690 | | GO:0015694 | mercury ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1691 | | GO:0015674 | di\-\, tri\-valent inorganic cation transport | 7 | 392 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1692 | | GO:0050787 | detoxification of mercury ion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1693 | | GO:0006364 | rRNA processing | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1694 | | GO:0016072 | rRNA metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1695 | | GO:0007616 | long\-term memory | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1696 | | GO:0007613 | memory | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1697 | | GO:0007611 | learning and/or memory | 9 | 390 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1698 | | GO:0031623 | receptor internalization | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1699 | | GO:0030856 | regulation of epithelial cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1700 | | GO:0030855 | epithelial cell differentiation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1701 | | GO:0050930 | induction of positive chemotaxis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1702 | | GO:0050927 | positive regulation of positive chemotaxis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1703 | | GO:0050921 | positive regulation of chemotaxis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1704 | | GO:0048520 | positive regulation of behavior | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1705 | | GO:0050795 | regulation of behavior | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1706 | | GO:0050920 | regulation of chemotaxis | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1707 | | GO:0050926 | regulation of positive chemotaxis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1708 | | GO:0050918 | positive chemotaxis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1709 | | GO:0006788 | heme oxidation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1710 | | GO:0031670 | cellular response to nutrient | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1711 | | GO:0032764 | negative regulation of mast cell cytokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1712 | | GO:0002719 | negative regulation of cytokine production during immune response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1713 | | GO:0002701 | negative regulation of production of molecular mediator of immune response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1714 | | GO:0002698 | negative regulation of immune effector process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1715 | | GO:0002697 | regulation of immune effector process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1716 | | GO:0002700 | regulation of production of molecular mediator of immune response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1717 | | GO:0002718 | regulation of cytokine production during immune response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1718 | | GO:0032763 | regulation of mast cell cytokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1719 | | GO:0032762 | mast cell cytokine production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1720 | | GO:0042167 | heme catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1721 | | GO:0046149 | pigment catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1722 | | GO:0043305 | negative regulation of mast cell degranulation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1723 | | GO:0033004 | negative regulation of mast cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1724 | | GO:0043301 | negative regulation of leukocyte degranulation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1725 | | GO:0045920 | negative regulation of exocytosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1726 | | GO:0033003 | regulation of mast cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1727 | | GO:0043304 | regulation of mast cell degranulation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1728 | | GO:0043300 | regulation of leukocyte degranulation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1729 | | GO:0017157 | regulation of exocytosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1730 | | GO:0043303 | mast cell degranulation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1731 | | GO:0045576 | mast cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1732 | | GO:0043299 | leukocyte degranulation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1733 | | GO:0045055 | regulated secretory pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1734 | | GO:0002448 | mast cell mediated immunity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1735 | | GO:0002444 | myeloid leukocyte mediated immunity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1736 | | GO:0043433 | negative regulation of transcription factor activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1737 | | GO:0045768 | positive regulation of anti\-apoptosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1738 | | GO:0045767 | regulation of anti\-apoptosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1739 | | GO:0001822 | kidney development | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1740 | | GO:0001655 | urogenital system development | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1741 | | GO:0007406 | negative regulation of neuroblast proliferation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1742 | | GO:0007412 | axon target recognition | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1743 | | GO:0007631 | feeding behavior | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1744 | | GO:0008038 | neuron recognition | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1745 | | GO:0008037 | cell recognition | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1746 | | GO:0014047 | glutamate secretion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1747 | | GO:0016358 | dendrite development | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1748 | | GO:0021675 | nerve development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1749 | | GO:0045666 | positive regulation of neuron differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1750 | | GO:0045664 | regulation of neuron differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1751 | | GO:0046668 | regulation of retinal cell programmed cell death | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1752 | | GO:0048592 | eye morphogenesis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1753 | | GO:0032488 | Cdc42 protein signal transduction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1754 | | GO:0007266 | Rho protein signal transduction | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1755 | | GO:0007265 | Ras protein signal transduction | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1756 | | GO:0006707 | cholesterol catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1757 | | GO:0016127 | sterol catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1758 | | GO:0006706 | steroid catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1759 | | GO:0033344 | cholesterol efflux | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1760 | | GO:0042158 | lipoprotein biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1761 | | GO:0043407 | negative regulation of MAP kinase activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1762 | | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1763 | | GO:0030336 | negative regulation of cell migration | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1764 | | GO:0051271 | negative regulation of cell motility | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1765 | | GO:0051270 | regulation of cell motility | 7 | 392 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1766 | | GO:0030334 | regulation of cell migration | 7 | 392 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1767 | | GO:0001936 | regulation of endothelial cell proliferation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1768 | | GO:0050728 | negative regulation of inflammatory response | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1769 | | GO:0031348 | negative regulation of defense response | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1770 | | GO:0048585 | negative regulation of response to stimulus | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1771 | | GO:0032102 | negative regulation of response to external stimulus | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1772 | | GO:0050727 | regulation of inflammatory response | 7 | 392 | 11 | 544 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1773 | | GO:0010544 | negative regulation of platelet activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1774 | | GO:0010543 | regulation of platelet activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1775 | | GO:0030168 | platelet activation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1776 | | GO:0007263 | nitric oxide mediated signal transduction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1777 | | GO:0030828 | positive regulation of cGMP biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1778 | | GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1779 | | GO:0030810 | positive regulation of nucleotide biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1780 | | GO:0030825 | positive regulation of cGMP metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1781 | | GO:0030801 | positive regulation of cyclic nucleotide metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1782 | | GO:0045981 | positive regulation of nucleotide metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1783 | | GO:0030808 | regulation of nucleotide biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1784 | | GO:0030802 | regulation of cyclic nucleotide biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1785 | | GO:0030826 | regulation of cGMP biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1786 | | GO:0006140 | regulation of nucleotide metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1787 | | GO:0030799 | regulation of cyclic nucleotide metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1788 | | GO:0030823 | regulation of cGMP metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1789 | | GO:0006182 | cGMP biosynthetic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1790 | | GO:0046068 | cGMP metabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1791 | | GO:0009187 | cyclic nucleotide metabolic process | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1792 | | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1793 | | GO:0051043 | regulation of membrane protein ectodomain proteolysis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1794 | | GO:0006509 | membrane protein ectodomain proteolysis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1795 | | GO:0033619 | membrane protein proteolysis | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1796 | | GO:0051000 | positive regulation of nitric\-oxide synthase activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1797 | | GO:0032770 | positive regulation of monooxygenase activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1798 | | GO:0032768 | regulation of monooxygenase activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1799 | | GO:0050999 | regulation of nitric\-oxide synthase activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1800 | | GO:0051262 | protein tetramerization | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1801 | | GO:0032801 | receptor catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1802 | | GO:0048168 | regulation of neuronal synaptic plasticity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1803 | | GO:0007271 | synaptic transmission\, cholinergic | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1804 | | GO:0046928 | regulation of neurotransmitter secretion | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1805 | | GO:0043009 | chordate embryonic development | 15 | 384 | 21 | 534 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1806 | | GO:0009792 | embryonic development ending in birth or egg hatching | 15 | 384 | 21 | 534 | 1.00e+00 | 0.04 | 0.04 | 1.0 |
| 1807 | | GO:0030308 | negative regulation of cell growth | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1808 | | GO:0045792 | negative regulation of cell size | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1809 | | GO:0031571 | G1 DNA damage checkpoint | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1810 | | GO:0031575 | G1/S transition checkpoint | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1811 | | GO:0042149 | cellular response to glucose starvation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1812 | | GO:0051097 | negative regulation of helicase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1813 | | GO:0051095 | regulation of helicase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1814 | | GO:0018144 | RNA\-protein covalent cross\-linking | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1815 | | GO:0018143 | nucleic acid\-protein covalent cross\-linking | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1816 | | GO:0002347 | response to tumor cell | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1817 | | GO:0006306 | DNA methylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1818 | | GO:0006305 | DNA alkylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1819 | | GO:0006304 | DNA modification | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1820 | | GO:0043414 | biopolymer methylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1821 | | GO:0032259 | methylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1822 | | GO:0006730 | one\-carbon compound metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1823 | | GO:0031953 | negative regulation of protein amino acid autophosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1824 | | GO:0031952 | regulation of protein amino acid autophosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1825 | | GO:0035026 | leading edge cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1826 | | GO:0006096 | glycolysis | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1827 | | GO:0006007 | glucose catabolic process | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1828 | | GO:0019320 | hexose catabolic process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1829 | | GO:0046365 | monosaccharide catabolic process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1830 | | GO:0046164 | alcohol catabolic process | 6 | 393 | 8 | 547 | 1.00e+00 | 0.02 | 0.01 | 1.0 |
| 1831 | | GO:0044275 | cellular carbohydrate catabolic process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1832 | | GO:0016052 | carbohydrate catabolic process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1833 | | GO:0008210 | estrogen metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1834 | | GO:0000910 | cytokinesis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1835 | | GO:0010155 | regulation of proton transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1836 | | GO:0043269 | regulation of ion transport | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1837 | | GO:0043012 | regulation of fusion of sperm to egg plasma membrane | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1838 | | GO:0007342 | fusion of sperm to egg plasma membrane | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1839 | | GO:0045026 | plasma membrane fusion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1840 | | GO:0006944 | membrane fusion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1841 | | GO:0007270 | nerve\-nerve synaptic transmission | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1842 | | GO:0018958 | phenol metabolic process | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1843 | | GO:0009309 | amine biosynthetic process | 7 | 392 | 9 | 546 | 1.00e+00 | 0.02 | 0.02 | 1.1 |
| 1844 | | GO:0051926 | negative regulation of calcium ion transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1845 | | GO:0043271 | negative regulation of ion transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1846 | | GO:0043267 | negative regulation of potassium ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1847 | | GO:0043266 | regulation of potassium ion transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1848 | | GO:0048662 | negative regulation of smooth muscle cell proliferation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1849 | | GO:0002028 | regulation of sodium ion transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1850 | | GO:0000188 | inactivation of MAPK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1851 | | GO:0002026 | regulation of the force of heart contraction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1852 | | GO:0046626 | regulation of insulin receptor signaling pathway | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1853 | | GO:0009952 | anterior/posterior pattern formation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1854 | | GO:0003002 | regionalization | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1855 | | GO:0007389 | pattern specification process | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1856 | | GO:0001764 | neuron migration | 5 | 394 | 7 | 548 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1857 | | GO:0007059 | chromosome segregation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1858 | | GO:0007220 | Notch receptor processing | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1859 | | GO:0051605 | protein maturation via proteolysis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1860 | | GO:0030326 | embryonic limb morphogenesis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1861 | | GO:0035113 | embryonic appendage morphogenesis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1862 | | GO:0035107 | appendage morphogenesis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1863 | | GO:0035108 | limb morphogenesis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1864 | | GO:0048736 | appendage development | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1865 | | GO:0060173 | limb development | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1866 | | GO:0009100 | glycoprotein metabolic process | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1867 | | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1868 | | GO:0032469 | endoplasmic reticulum calcium ion homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1869 | | GO:0001570 | vasculogenesis | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1870 | | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1871 | | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1872 | | GO:0043117 | positive regulation of vascular permeability | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1873 | | GO:0043114 | regulation of vascular permeability | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1874 | | GO:0045779 | negative regulation of bone resorption | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1875 | | GO:0045124 | regulation of bone resorption | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1876 | | GO:0045453 | bone resorption | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1877 | | GO:0048255 | mRNA stabilization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1878 | | GO:0043488 | regulation of mRNA stability | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1879 | | GO:0043487 | regulation of RNA stability | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1880 | | GO:0043489 | RNA stabilization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1881 | | GO:0048286 | alveolus development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1882 | | GO:0001660 | fever | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1883 | | GO:0001659 | temperature homeostasis | 10 | 389 | 15 | 540 | 1.00e+00 | 0.03 | 0.03 | 0.9 |
| 1884 | | GO:0032755 | positive regulation of interleukin\-6 production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1885 | | GO:0045410 | positive regulation of interleukin\-6 biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1886 | | GO:0045408 | regulation of interleukin\-6 biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1887 | | GO:0042226 | interleukin\-6 biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1888 | | GO:0006744 | ubiquinone biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1889 | | GO:0045426 | quinone cofactor biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1890 | | GO:0006743 | ubiquinone metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1891 | | GO:0042375 | quinone cofactor metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1892 | | GO:0006542 | glutamine biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1893 | | GO:0006541 | glutamine metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1894 | | GO:0001881 | receptor recycling | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1895 | | GO:0010226 | response to lithium ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1896 | | GO:0051966 | regulation of synaptic transmission\, glutamatergic | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1897 | | GO:0035249 | synaptic transmission\, glutamatergic | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1898 | | GO:0030185 | nitric oxide transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1899 | | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1900 | | GO:0051173 | positive regulation of nitrogen compound metabolic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1901 | | GO:0045428 | regulation of nitric oxide biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1902 | | GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1903 | | GO:0030091 | protein repair | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1904 | | GO:0010269 | response to selenium ion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1905 | | GO:0009441 | glycolate metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1906 | | GO:0033143 | regulation of steroid hormone receptor signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1907 | | GO:0030166 | proteoglycan biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1908 | | GO:0006029 | proteoglycan metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1909 | | GO:0001843 | neural tube closure | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1910 | | GO:0014020 | primary neural tube formation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1911 | | GO:0001841 | neural tube formation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1912 | | GO:0001838 | embryonic epithelial tube formation | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1913 | | GO:0001839 | neural plate morphogenesis | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1914 | | GO:0001840 | neural plate development | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1915 | | GO:0021915 | neural tube development | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1916 | | GO:0007258 | JUN phosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1917 | | GO:0051503 | adenine nucleotide transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1918 | | GO:0015865 | purine nucleotide transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1919 | | GO:0006862 | nucleotide transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1920 | | GO:0015931 | nucleobase\, nucleoside\, nucleotide and nucleic acid transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1921 | | GO:0015867 | ATP transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1922 | | GO:0006826 | iron ion transport | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1923 | | GO:0015682 | ferric iron transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1924 | | GO:0031643 | positive regulation of myelination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1925 | | GO:0031641 | regulation of myelination | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1926 | | GO:0001967 | suckling behavior | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1927 | | GO:0051705 | behavioral interaction between organisms | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1928 | | GO:0007617 | mating behavior | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1929 | | GO:0019098 | reproductive behavior | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1930 | | GO:0030901 | midbrain development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1931 | | GO:0009409 | response to cold | 8 | 391 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1932 | | GO:0050885 | neuromuscular process controlling balance | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 1933 | | GO:0008033 | tRNA processing | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1934 | | GO:0006399 | tRNA metabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1935 | | GO:0001781 | neutrophil apoptosis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1936 | | GO:0001780 | neutrophil homeostasis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1937 | | GO:0033028 | myeloid cell apoptosis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1938 | | GO:0006925 | inflammatory cell apoptosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1939 | | GO:0030968 | unfolded protein response | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1940 | | GO:0006986 | response to unfolded protein | 9 | 390 | 13 | 542 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1941 | | GO:0051789 | response to protein stimulus | 9 | 390 | 13 | 542 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 1942 | | GO:0031642 | negative regulation of myelination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1943 | | GO:0045348 | positive regulation of MHC class II biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1944 | | GO:0045346 | regulation of MHC class II biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1945 | | GO:0045342 | MHC class II biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1946 | | GO:0045830 | positive regulation of isotype switching | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1947 | | GO:0051251 | positive regulation of lymphocyte activation | 8 | 391 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1948 | | GO:0002696 | positive regulation of leukocyte activation | 8 | 391 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1949 | | GO:0050867 | positive regulation of cell activation | 8 | 391 | 12 | 543 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 1950 | | GO:0045911 | positive regulation of DNA recombination | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1951 | | GO:0045191 | regulation of isotype switching | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1952 | | GO:0045190 | isotype switching | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1953 | | GO:0002204 | somatic recombination of immunoglobulin genes during immune response | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1954 | | GO:0016447 | somatic recombination of immunoglobulin gene segments | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1955 | | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1956 | | GO:0016444 | somatic cell DNA recombination | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1957 | | GO:0002200 | somatic diversification of immune receptors | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1958 | | GO:0002208 | somatic diversification of immunoglobulins during immune response | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1959 | | GO:0016445 | somatic diversification of immunoglobulins | 5 | 394 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 1.2 |
| 1960 | | GO:0002381 | immunoglobulin production during immune response | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1961 | | GO:0032735 | positive regulation of interleukin\-12 production | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1962 | | GO:0032655 | regulation of interleukin\-12 production | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1963 | | GO:0006585 | dopamine biosynthetic process from tyrosine | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1964 | | GO:0042755 | eating behavior | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1965 | | GO:0045995 | regulation of embryonic development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1966 | | GO:0001755 | neural crest cell migration | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1967 | | GO:0014032 | neural crest cell development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1968 | | GO:0014033 | neural crest cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1969 | | GO:0001759 | induction of an organ | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1970 | | GO:0031128 | induction | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1971 | | GO:0045168 | cell\-cell signaling during cell fate commitment | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1972 | | GO:0010092 | specification of organ identity | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 1973 | | GO:0001941 | postsynaptic membrane organization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1974 | | GO:0030432 | peristalsis | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1975 | | GO:0014821 | phasic smooth muscle contraction | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1976 | | GO:0051584 | regulation of dopamine uptake | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1977 | | GO:0051940 | regulation of catecholamine uptake during transmission of nerve impulse | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1978 | | GO:0051580 | regulation of neurotransmitter uptake | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1979 | | GO:0051588 | regulation of neurotransmitter transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1980 | | GO:0051583 | dopamine uptake | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1981 | | GO:0051934 | catecholamine uptake during transmission of nerve impulse | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1982 | | GO:0051937 | catecholamine transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1983 | | GO:0015872 | dopamine transport | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1984 | | GO:0050671 | positive regulation of lymphocyte proliferation | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1985 | | GO:0032946 | positive regulation of mononuclear cell proliferation | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 1986 | | GO:0000086 | G2/M transition of mitotic cell cycle | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1987 | | GO:0007168 | receptor guanylyl cyclase signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1988 | | GO:0019371 | cyclooxygenase pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1989 | | GO:0001516 | prostaglandin biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1990 | | GO:0046457 | prostanoid biosynthetic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 1991 | | GO:0019369 | arachidonic acid metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1992 | | GO:0016575 | histone deacetylation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 1993 | | GO:0016570 | histone modification | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1994 | | GO:0016569 | covalent chromatin modification | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 1995 | | GO:0030150 | protein import into mitochondrial matrix | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1996 | | GO:0043681 | protein import into mitochondrion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 1997 | | GO:0009239 | enterobactin biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1998 | | GO:0019540 | siderophore biosynthetic process from catechol | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 1999 | | GO:0009712 | catechol metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2000 | | GO:0009238 | enterobactin metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2001 | | GO:0019290 | siderophore biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2002 | | GO:0009237 | siderophore metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2003 | | GO:0014012 | axon regeneration in the peripheral nervous system | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2004 | | GO:0031103 | axon regeneration | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2005 | | GO:0031102 | neurite regeneration | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2006 | | GO:0031133 | regulation of axon diameter | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2007 | | GO:0032536 | regulation of cell projection size | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2008 | | GO:0008089 | anterograde axon cargo transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2009 | | GO:0007018 | microtubule\-based movement | 7 | 392 | 10 | 545 | 1.00e+00 | 0.02 | 0.02 | 1.0 |
| 2010 | | GO:0019896 | axon transport of mitochondrion | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2011 | | GO:0033693 | neurofilament bundle assembly | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2012 | | GO:0008090 | retrograde axon cargo transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2013 | | GO:0006650 | glycerophospholipid metabolic process | 5 | 394 | 8 | 547 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2014 | | GO:0048041 | focal adhesion formation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2015 | | GO:0007160 | cell\-matrix adhesion | 6 | 393 | 9 | 546 | 1.00e+00 | 0.02 | 0.02 | 0.9 |
| 2016 | | GO:0031589 | cell\-substrate adhesion | 7 | 392 | 9 | 546 | 1.00e+00 | 0.02 | 0.02 | 1.1 |
| 2017 | | GO:0007162 | negative regulation of cell adhesion | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 2018 | | GO:0009065 | glutamine family amino acid catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2019 | | GO:0006746 | FADH2 metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2020 | | GO:0002456 | T cell mediated immunity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2021 | | GO:0045065 | cytotoxic T cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2022 | | GO:0050850 | positive regulation of calcium\-mediated signaling | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2023 | | GO:0050848 | regulation of calcium\-mediated signaling | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2024 | | GO:0031577 | spindle checkpoint | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2025 | | GO:0021983 | pituitary gland development | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2026 | | GO:0021536 | diencephalon development | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2027 | | GO:0035270 | endocrine system development | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 2028 | | GO:0006418 | tRNA aminoacylation for protein translation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2029 | | GO:0043039 | tRNA aminoacylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2030 | | GO:0043038 | amino acid activation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2031 | | GO:0006427 | histidyl\-tRNA aminoacylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2032 | | GO:0006611 | protein export from nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2033 | | GO:0051168 | nuclear export | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2034 | | GO:0050860 | negative regulation of T cell receptor signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2035 | | GO:0050858 | negative regulation of antigen receptor\-mediated signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2036 | | GO:0050854 | regulation of antigen receptor\-mediated signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2037 | | GO:0050856 | regulation of T cell receptor signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2038 | | GO:0007525 | somatic muscle development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2039 | | GO:0042177 | negative regulation of protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2040 | | GO:0009895 | negative regulation of catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2041 | | GO:0009894 | regulation of catabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 2042 | | GO:0045908 | negative regulation of vasodilation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2043 | | GO:0042312 | regulation of vasodilation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2044 | | GO:0045909 | positive regulation of vasodilation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2045 | | GO:0007041 | lysosomal transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2046 | | GO:0007034 | vacuolar transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2047 | | GO:0008206 | bile acid metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2048 | | GO:0046686 | response to cadmium ion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2049 | | GO:0001662 | behavioral fear response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2050 | | GO:0042596 | fear response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2051 | | GO:0033555 | multicellular organismal response to stress | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2052 | | GO:0002209 | behavioral defense response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2053 | | GO:0032313 | regulation of Rab GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2054 | | GO:0032483 | regulation of Rab protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2055 | | GO:0046578 | regulation of Ras protein signal transduction | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2056 | | GO:0051056 | regulation of small GTPase mediated signal transduction | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 2057 | | GO:0032318 | regulation of Ras GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2058 | | GO:0032482 | Rab protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2059 | | GO:0035023 | regulation of Rho protein signal transduction | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2060 | | GO:0051036 | regulation of endosome size | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2061 | | GO:0007032 | endosome organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2062 | | GO:0032855 | positive regulation of Rac GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2063 | | GO:0032321 | positive regulation of Rho GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2064 | | GO:0032320 | positive regulation of Ras GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2065 | | GO:0032319 | regulation of Rho GTPase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2066 | | GO:0043547 | positive regulation of GTPase activity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2067 | | GO:0035022 | positive regulation of Rac protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2068 | | GO:0035020 | regulation of Rac protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2069 | | GO:0016601 | Rac protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2070 | | GO:0006817 | phosphate transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2071 | | GO:0006820 | anion transport | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2072 | | GO:0006367 | transcription initiation from RNA polymerase II promoter | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2073 | | GO:0006352 | transcription initiation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2074 | | GO:0009083 | branched chain family amino acid catabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2075 | | GO:0009081 | branched chain family amino acid metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2076 | | GO:0045687 | positive regulation of glial cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2077 | | GO:0014015 | positive regulation of gliogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2078 | | GO:0045685 | regulation of glial cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2079 | | GO:0014013 | regulation of gliogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2080 | | GO:0009268 | response to pH | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2081 | | GO:0045980 | negative regulation of nucleotide metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2082 | | GO:0051289 | protein homotetramerization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2083 | | GO:0051260 | protein homooligomerization | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2084 | | GO:0007213 | acetylcholine receptor signaling\, muscarinic pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2085 | | GO:0007274 | neuromuscular synaptic transmission | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2086 | | GO:0000186 | activation of MAPKK activity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2087 | | GO:0001763 | morphogenesis of a branching structure | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2088 | | GO:0045741 | positive regulation of epidermal growth factor receptor activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2089 | | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2090 | | GO:0021940 | positive regulation of granule cell precursor proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2091 | | GO:0021936 | regulation of granule cell precursor proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2092 | | GO:0021930 | granule cell precursor proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2093 | | GO:0021924 | cell proliferation in the external granule layer | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2094 | | GO:0021534 | cell proliferation in hindbrain | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2095 | | GO:0046836 | glycolipid transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2096 | | GO:0032367 | intracellular cholesterol transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2097 | | GO:0032366 | intracellular sterol transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2098 | | GO:0032365 | intracellular lipid transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2099 | | GO:0015914 | phospholipid transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2100 | | GO:0019747 | regulation of isoprenoid metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2101 | | GO:0006720 | isoprenoid metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2102 | | GO:0007608 | sensory perception of smell | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2103 | | GO:0015844 | monoamine transport | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2104 | | GO:0021984 | adenohypophysis development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2105 | | GO:0042053 | regulation of dopamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2106 | | GO:0042069 | regulation of catecholamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2107 | | GO:0033238 | regulation of amine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2108 | | GO:0042420 | dopamine catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2109 | | GO:0042135 | neurotransmitter catabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2110 | | GO:0042424 | catecholamine catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2111 | | GO:0042402 | biogenic amine catabolic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2112 | | GO:0042219 | amino acid derivative catabolic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2113 | | GO:0060134 | prepulse inhibition | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2114 | | GO:0001964 | startle response | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2115 | | GO:0050779 | RNA destabilization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2116 | | GO:0016579 | protein deubiquitination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2117 | | GO:0006972 | hyperosmotic response | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2118 | | GO:0006970 | response to osmotic stress | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2119 | | GO:0030032 | lamellipodium biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2120 | | GO:0031529 | ruffle organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2121 | | GO:0035025 | positive regulation of Rho protein signal transduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2122 | | GO:0043552 | positive regulation of phosphoinositide 3\-kinase activity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2123 | | GO:0043551 | regulation of phosphoinositide 3\-kinase activity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2124 | | GO:0043550 | regulation of lipid kinase activity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2125 | | GO:0048261 | negative regulation of receptor\-mediated endocytosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2126 | | GO:0045806 | negative regulation of endocytosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2127 | | GO:0030100 | regulation of endocytosis | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2128 | | GO:0048259 | regulation of receptor\-mediated endocytosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2129 | | GO:0006665 | sphingolipid metabolic process | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 2130 | | GO:0046513 | ceramide biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2131 | | GO:0046520 | sphingoid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2132 | | GO:0030148 | sphingolipid biosynthetic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2133 | | GO:0006672 | ceramide metabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2134 | | GO:0046519 | sphingoid metabolic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2135 | | GO:0006487 | protein amino acid N\-linked glycosylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2136 | | GO:0006486 | protein amino acid glycosylation | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2137 | | GO:0009101 | glycoprotein biosynthetic process | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2138 | | GO:0043413 | biopolymer glycosylation | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2139 | | GO:0031331 | positive regulation of cellular catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2140 | | GO:0009896 | positive regulation of catabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2141 | | GO:0045732 | positive regulation of protein catabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2142 | | GO:0009410 | response to xenobiotic stimulus | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2143 | | GO:0016068 | type I hypersensitivity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2144 | | GO:0002524 | hypersensitivity | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2145 | | GO:0002438 | acute inflammatory response to antigenic stimulus | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2146 | | GO:0008584 | male gonad development | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2147 | | GO:0019102 | male somatic sex determination | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2148 | | GO:0018993 | somatic sex determination | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2149 | | GO:0030521 | androgen receptor signaling pathway | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2150 | | GO:0030850 | prostate gland development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2151 | | GO:0001678 | cellular glucose homeostasis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2152 | | GO:0042593 | glucose homeostasis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2153 | | GO:0033500 | carbohydrate homeostasis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2154 | | GO:0035066 | positive regulation of histone acetylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2155 | | GO:0031058 | positive regulation of histone modification | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2156 | | GO:0031056 | regulation of histone modification | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2157 | | GO:0035065 | regulation of histone acetylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2158 | | GO:0045722 | positive regulation of gluconeogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2159 | | GO:0045913 | positive regulation of carbohydrate metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2160 | | GO:0006111 | regulation of gluconeogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2161 | | GO:0043255 | regulation of carbohydrate biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2162 | | GO:0006109 | regulation of carbohydrate metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2163 | | GO:0046321 | positive regulation of fatty acid oxidation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2164 | | GO:0045923 | positive regulation of fatty acid metabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2165 | | GO:0045834 | positive regulation of lipid metabolic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2166 | | GO:0019217 | regulation of fatty acid metabolic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2167 | | GO:0046320 | regulation of fatty acid oxidation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2168 | | GO:0050821 | protein stabilization | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2169 | | GO:0050873 | brown fat cell differentiation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2170 | | GO:0043526 | neuroprotection | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2171 | | GO:0043588 | skin development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2172 | | GO:0006044 | N\-acetylglucosamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2173 | | GO:0006041 | glucosamine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2174 | | GO:0006040 | amino sugar metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2175 | | GO:0006688 | glycosphingolipid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2176 | | GO:0009247 | glycolipid biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2177 | | GO:0015810 | aspartate transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2178 | | GO:0042102 | positive regulation of T cell proliferation | 3 | 396 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 0.8 |
| 2179 | | GO:0046635 | positive regulation of alpha\-beta T cell activation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2180 | | GO:0046634 | regulation of alpha\-beta T cell activation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2181 | | GO:0031572 | G2/M transition DNA damage checkpoint | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2182 | | GO:0031576 | G2/M transition checkpoint | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2183 | | GO:0000209 | protein polyubiquitination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2184 | | GO:0030579 | ubiquitin\-dependent SMAD protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2185 | | GO:0031398 | positive regulation of protein ubiquitination | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2186 | | GO:0031943 | regulation of glucocorticoid metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2187 | | GO:0032350 | regulation of hormone metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2188 | | GO:0008211 | glucocorticoid metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2189 | | GO:0006378 | mRNA polyadenylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2190 | | GO:0031124 | mRNA 3'\-end processing | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2191 | | GO:0031123 | RNA 3'\-end processing | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2192 | | GO:0043631 | RNA polyadenylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2193 | | GO:0006379 | mRNA cleavage | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2194 | | GO:0006493 | protein amino acid O\-linked glycosylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2195 | | GO:0009062 | fatty acid catabolic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2196 | | GO:0046395 | carboxylic acid catabolic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2197 | | GO:0016054 | organic acid catabolic process | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2198 | | GO:0045843 | negative regulation of striated muscle development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2199 | | GO:0048635 | negative regulation of muscle development | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2200 | | GO:0007096 | regulation of exit from mitosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2201 | | GO:0010458 | exit from mitosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2202 | | GO:0006857 | oligopeptide transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2203 | | GO:0007156 | homophilic cell adhesion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2204 | | GO:0016339 | calcium\-dependent cell\-cell adhesion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2205 | | GO:0006518 | peptide metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2206 | | GO:0045213 | neurotransmitter receptor metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2207 | | GO:0042832 | defense response to protozoan | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2208 | | GO:0001562 | response to protozoan | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2209 | | GO:0046888 | negative regulation of hormone secretion | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2210 | | GO:0045630 | positive regulation of T\-helper 2 cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2211 | | GO:0045628 | regulation of T\-helper 2 cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2212 | | GO:0033138 | positive regulation of peptidyl\-serine phosphorylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2213 | | GO:0033135 | regulation of peptidyl\-serine phosphorylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2214 | | GO:0030183 | B cell differentiation | 4 | 395 | 6 | 549 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2215 | | GO:0030335 | positive regulation of cell migration | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2216 | | GO:0051272 | positive regulation of cell motility | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2217 | | GO:0045671 | negative regulation of osteoclast differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2218 | | GO:0002762 | negative regulation of myeloid leukocyte differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2219 | | GO:0001777 | T cell homeostatic proliferation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2220 | | GO:0045930 | negative regulation of mitotic cell cycle | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2221 | | GO:0006621 | protein retention in ER | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2222 | | GO:0045185 | maintenance of protein localization | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 2223 | | GO:0032880 | regulation of protein localization | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 2224 | | GO:0001543 | ovarian follicle rupture | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2225 | | GO:0001658 | ureteric bud branching | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2226 | | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2227 | | GO:0003084 | positive regulation of systemic arterial blood pressure | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2228 | | GO:0045777 | positive regulation of blood pressure | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2229 | | GO:0002034 | regulation of blood vessel size by renin\-angiotensin | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2230 | | GO:0003072 | regulation of systemic arterial blood pressure by renal control of peripheral vascular resistence | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2231 | | GO:0003071 | regulation of systemic arterial blood pressure by renal system process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2232 | | GO:0003081 | regulation of systemic arterial blood pressure by renin\-angiotensin | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2233 | | GO:0001990 | regulation of systemic arterial blood pressure by hormone | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2234 | | GO:0042310 | vasoconstriction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2235 | | GO:0050886 | endocrine process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2236 | | GO:0001999 | renal response to blood flow during renin\-angiotensin regulation of systemic arterial blood pressure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2237 | | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin\-angiotensin | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2238 | | GO:0002018 | renin\-angiotensin regulation of aldosterone production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2239 | | GO:0002016 | regulation of blood volume by renin\-angiotensin | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2240 | | GO:0002019 | regulation of renal output by angiotensin | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2241 | | GO:0002035 | brain renin\-angiotensin system | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2242 | | GO:0008065 | establishment of blood\-nerve barrier | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2243 | | GO:0001885 | endothelial cell development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2244 | | GO:0045446 | endothelial cell differentiation | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2245 | | GO:0042756 | drinking behavior | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2246 | | GO:0045723 | positive regulation of fatty acid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2247 | | GO:0046889 | positive regulation of lipid biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2248 | | GO:0042304 | regulation of fatty acid biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2249 | | GO:0046622 | positive regulation of organ growth | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2250 | | GO:0048143 | astrocyte activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2251 | | GO:0014002 | astrocyte development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2252 | | GO:0048708 | astrocyte differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2253 | | GO:0051145 | smooth muscle cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2254 | | GO:0045785 | positive regulation of cell adhesion | 4 | 395 | 5 | 550 | 1.00e+00 | 0.01 | 0.01 | 1.1 |
| 2255 | | GO:0006171 | cAMP biosynthetic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2256 | | GO:0046058 | cAMP metabolic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2257 | | GO:0030263 | apoptotic chromosome condensation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2258 | | GO:0030261 | chromosome condensation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2259 | | GO:0042335 | cuticle development | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2260 | | GO:0006909 | phagocytosis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2261 | | GO:0045415 | negative regulation of interleukin\-8 biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2262 | | GO:0045414 | regulation of interleukin\-8 biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2263 | | GO:0042228 | interleukin\-8 biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2264 | | GO:0032637 | interleukin\-8 production | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2265 | | GO:0045416 | positive regulation of interleukin\-8 biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2266 | | GO:0006805 | xenobiotic metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2267 | | GO:0009070 | serine family amino acid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2268 | | GO:0006563 | L\-serine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2269 | | GO:0021506 | anterior neuropore closure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2270 | | GO:0021995 | neuropore closure | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2271 | | GO:0048701 | embryonic cranial skeleton morphogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2272 | | GO:0048704 | embryonic skeletal morphogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2273 | | GO:0048705 | skeletal morphogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2274 | | GO:0001955 | blood vessel maturation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2275 | | GO:0044243 | multicellular organismal catabolic process | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2276 | | GO:0032374 | regulation of cholesterol transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2277 | | GO:0032371 | regulation of sterol transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2278 | | GO:0032368 | regulation of lipid transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2279 | | GO:0006649 | phospholipid transfer to membrane | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2280 | | GO:0007603 | phototransduction\, visible light | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2281 | | GO:0007602 | phototransduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2282 | | GO:0050908 | detection of light stimulus involved in visual perception | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2283 | | GO:0050962 | detection of light stimulus involved in sensory perception | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2284 | | GO:0050906 | detection of stimulus involved in sensory perception | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2285 | | GO:0009583 | detection of light stimulus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2286 | | GO:0009582 | detection of abiotic stimulus | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2287 | | GO:0051606 | detection of stimulus | 3 | 396 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
| 2288 | | GO:0009584 | detection of visible light | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2289 | | GO:0045494 | photoreceptor cell maintenance | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2290 | | GO:0042364 | water\-soluble vitamin biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2291 | | GO:0009110 | vitamin biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2292 | | GO:0001556 | oocyte maturation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2293 | | GO:0048469 | cell maturation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2294 | | GO:0048599 | oocyte development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2295 | | GO:0009994 | oocyte differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2296 | | GO:0048477 | oogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2297 | | GO:0010225 | response to UV\-C | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2298 | | GO:0033205 | cytokinesis during cell cycle | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2299 | | GO:0050680 | negative regulation of epithelial cell proliferation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2300 | | GO:0045931 | positive regulation of mitotic cell cycle | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2301 | | GO:0000747 | conjugation with cellular fusion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2302 | | GO:0000746 | conjugation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2303 | | GO:0045058 | T cell selection | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2304 | | GO:0022409 | positive regulation of cell\-cell adhesion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2305 | | GO:0050766 | positive regulation of phagocytosis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2306 | | GO:0045807 | positive regulation of endocytosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2307 | | GO:0050764 | regulation of phagocytosis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2308 | | GO:0022600 | digestive system process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2309 | | GO:0030299 | cholesterol absorption | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2310 | | GO:0050892 | intestinal absorption | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2311 | | GO:0044241 | lipid digestion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2312 | | GO:0044240 | multicellular organismal lipid catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2313 | | GO:0030149 | sphingolipid catabolic process | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2314 | | GO:0006704 | glucocorticoid biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2315 | | GO:0007567 | parturition | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2316 | | GO:0001954 | positive regulation of cell\-matrix adhesion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2317 | | GO:0042488 | positive regulation of odontogenesis of dentine\-containing teeth | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2318 | | GO:0042482 | positive regulation of odontogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2319 | | GO:0042481 | regulation of odontogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2320 | | GO:0042487 | regulation of odontogenesis of dentine\-containing teeth | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2321 | | GO:0042475 | odontogenesis of dentine\-containing teeth | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2322 | | GO:0042476 | odontogenesis | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2323 | | GO:0045672 | positive regulation of osteoclast differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2324 | | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2325 | | GO:0045639 | positive regulation of myeloid cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2326 | | GO:0006929 | substrate\-bound cell migration | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2327 | | GO:0030218 | erythrocyte differentiation | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2328 | | GO:0034101 | erythrocyte homeostasis | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2329 | | GO:0043249 | erythrocyte maturation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2330 | | GO:0048821 | erythrocyte development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2331 | | GO:0008045 | motor axon guidance | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2332 | | GO:0001569 | patterning of blood vessels | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2333 | | GO:0009880 | embryonic pattern specification | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2334 | | GO:0006543 | glutamine catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2335 | | GO:0045745 | positive regulation of G\-protein coupled receptor protein signaling pathway | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2336 | | GO:0060037 | pharyngeal system development | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2337 | | GO:0042026 | protein refolding | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2338 | | GO:0051149 | positive regulation of muscle cell differentiation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2339 | | GO:0051147 | regulation of muscle cell differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2340 | | GO:0045445 | myoblast differentiation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2341 | | GO:0007253 | cytoplasmic sequestering of NF\-kappaB | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2342 | | GO:0042994 | cytoplasmic sequestering of transcription factor | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2343 | | GO:0051220 | cytoplasmic sequestering of protein | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2344 | | GO:0030886 | negative regulation of myeloid dendritic cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2345 | | GO:0030885 | regulation of myeloid dendritic cell activation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2346 | | GO:0001773 | myeloid dendritic cell activation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2347 | | GO:0032695 | negative regulation of interleukin\-12 production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2348 | | GO:0045347 | negative regulation of MHC class II biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2349 | | GO:0045355 | negative regulation of interferon\-alpha biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2350 | | GO:0045354 | regulation of interferon\-alpha biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2351 | | GO:0045349 | interferon\-alpha biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2352 | | GO:0032607 | interferon\-alpha production | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2353 | | GO:0030101 | natural killer cell activation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2354 | | GO:0042104 | positive regulation of activated T cell proliferation | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2355 | | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2356 | | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2357 | | GO:0046427 | positive regulation of JAK\-STAT cascade | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2358 | | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2359 | | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2360 | | GO:0046425 | regulation of JAK\-STAT cascade | 2 | 397 | 3 | 552 | 1.00e+00 | 0.01 | 0.01 | 0.9 |
| 2361 | | GO:0042506 | tyrosine phosphorylation of Stat5 protein | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2362 | | GO:0046013 | regulation of T cell homeostatic proliferation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2363 | | GO:0051024 | positive regulation of immunoglobulin secretion | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2364 | | GO:0045189 | connective tissue growth factor biosynthetic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2365 | | GO:0032601 | connective tissue growth factor production | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2366 | | GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2367 | | GO:0048293 | regulation of isotype switching to IgE isotypes | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2368 | | GO:0048289 | isotype switching to IgE isotypes | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2369 | | GO:0000185 | activation of MAPKKK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2370 | | GO:0007257 | activation of JNK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2371 | | GO:0043507 | positive regulation of JNK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2372 | | GO:0043506 | regulation of JNK activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2373 | | GO:0042116 | macrophage activation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2374 | | GO:0006555 | methionine metabolic process | 2 | 397 | 2 | 553 | 1.00e+00 | 0.01 | 0.00 | 1.4 |
| 2375 | | GO:0009086 | methionine biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2376 | | GO:0009067 | aspartate family amino acid biosynthetic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2377 | | GO:0008360 | regulation of cell shape | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2378 | | GO:0030048 | actin filament\-based movement | 2 | 397 | 4 | 551 | 1.00e+00 | 0.01 | 0.01 | 0.7 |
| 2379 | | GO:0006200 | ATP catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2380 | | GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2381 | | GO:0009146 | purine nucleoside triphosphate catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2382 | | GO:0009143 | nucleoside triphosphate catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2383 | | GO:0009203 | ribonucleoside triphosphate catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2384 | | GO:0009166 | nucleotide catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2385 | | GO:0006195 | purine nucleotide catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2386 | | GO:0009154 | purine ribonucleotide catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2387 | | GO:0009261 | ribonucleotide catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2388 | | GO:0045746 | negative regulation of Notch signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2389 | | GO:0008593 | regulation of Notch signaling pathway | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2390 | | GO:0009595 | detection of biotic stimulus | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2391 | | GO:0032088 | inhibition of NF\-kappaB transcription factor | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2392 | | GO:0051457 | maintenance of protein localization in nucleus | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2393 | | GO:0018401 | peptidyl\-proline hydroxylation to 4\-hydroxy\-L\-proline | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2394 | | GO:0019471 | 4\-hydroxyproline metabolic process | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2395 | | GO:0019511 | peptidyl\-proline hydroxylation | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2396 | | GO:0018208 | peptidyl\-proline modification | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2397 | | GO:0042787 | protein ubiquitination during ubiquitin\-dependent protein catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2398 | | GO:0035307 | positive regulation of protein amino acid dephosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2399 | | GO:0035306 | positive regulation of dephosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2400 | | GO:0035304 | regulation of protein amino acid dephosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2401 | | GO:0035303 | regulation of dephosphorylation | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2402 | | GO:0051004 | regulation of lipoprotein lipase activity | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2403 | | GO:0060191 | regulation of lipase activity | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2404 | | GO:0015893 | drug transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2405 | | GO:0050796 | regulation of insulin secretion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2406 | | GO:0002791 | regulation of peptide secretion | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2407 | | GO:0019439 | aromatic compound catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2408 | | GO:0015695 | organic cation transport | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2409 | | GO:0045817 | positive regulation of transcription from RNA polymerase II promoter\, global | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2410 | | GO:0006358 | regulation of transcription from RNA polymerase II promoter\, global | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2411 | | GO:0006002 | fructose 6\-phosphate metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2412 | | GO:0006000 | fructose metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2413 | | GO:0006110 | regulation of glycolysis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2414 | | GO:0043471 | regulation of cellular carbohydrate catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2415 | | GO:0043470 | regulation of carbohydrate catabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2416 | | GO:0030388 | fructose 1\,6\-bisphosphate metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2417 | | GO:0045987 | positive regulation of smooth muscle contraction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2418 | | GO:0045933 | positive regulation of muscle contraction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2419 | | GO:0006670 | sphingosine metabolic process | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2420 | | GO:0007635 | chemosensory behavior | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2421 | | GO:0007051 | spindle organization and biogenesis | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2422 | | GO:0019048 | virus\-host interaction | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2423 | | GO:0045070 | positive regulation of viral genome replication | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2424 | | GO:0048524 | positive regulation of viral reproduction | 1 | 398 | 1 | 554 | 1.00e+00 | 0.00 | 0.00 | 1.4 |
| 2425 | | GO:0030317 | sperm motility | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
| 2426 | | GO:0006821 | chloride transport | 1 | 398 | 2 | 553 | 1.00e+00 | 0.00 | 0.00 | 0.7 |